
<html lang="en"     class="pb-page"  data-request-id="37f028f1-dc7b-4c7d-8926-cdb4456ab10c"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";article:article:10.1021/jm9013828;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2009.52.issue-24"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Discovery of 4-Morpholino-6-aryl-1H-pyrazolo[3,4-d]pyrimidines as Highly Potent and Selective ATP-Competitive Inhibitors of the Mammalian Target of Rapamycin (mTOR): Optimization of the 6-Aryl Substituent" /></meta><meta name="dc.Creator" content="Jeroen C.  Verheijen" /></meta><meta name="dc.Creator" content="David J.  Richard" /></meta><meta name="dc.Creator" content="Kevin  Curran" /></meta><meta name="dc.Creator" content="Joshua  Kaplan" /></meta><meta name="dc.Creator" content="Mark  Lefever" /></meta><meta name="dc.Creator" content="Pawel  Nowak" /></meta><meta name="dc.Creator" content="David J.  Malwitz" /></meta><meta name="dc.Creator" content="Natasja  Brooijmans" /></meta><meta name="dc.Creator" content="Lourdes  Toral-Barza" /></meta><meta name="dc.Creator" content="Wei-Guo  Zhang" /></meta><meta name="dc.Creator" content="Judy  Lucas" /></meta><meta name="dc.Creator" content="Irwin  Hollander" /></meta><meta name="dc.Creator" content="Semiramis  Ayral-Kaloustian" /></meta><meta name="dc.Creator" content="Tarek S.  Mansour" /></meta><meta name="dc.Creator" content="Ker  Yu" /></meta><meta name="dc.Creator" content="Arie  Zask" /></meta><meta name="dc.Description" content="Design and synthesis of a series of 4-morpholino-6-aryl-1H-pyrazolo[3,4-d]pyrimidines as potent and selective inhibitors of the mammalian target of rapamycin (mTOR) are described. Optimization of t..." /></meta><meta name="Description" content="Design and synthesis of a series of 4-morpholino-6-aryl-1H-pyrazolo[3,4-d]pyrimidines as potent and selective inhibitors of the mammalian target of rapamycin (mTOR) are described. Optimization of t..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="November 6, 2009" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm9013828" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2009 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm9013828" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm9013828" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm9013828" /></link>
        
    
    

<title>Discovery of 4-Morpholino-6-aryl-1H-pyrazolo[3,4-d]pyrimidines as Highly Potent and Selective ATP-Competitive Inhibitors of the Mammalian Target of Rapamycin (mTOR): Optimization of the 6-Aryl Substituent | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm9013828" /></meta><meta property="og:title" content="Discovery of 4-Morpholino-6-aryl-1H-pyrazolo[3,4-d]pyrimidines as Highly Potent and Selective ATP-Competitive Inhibitors of the Mammalian Target of Rapamycin (mTOR): Optimization of the 6-Aryl Substituent" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-24/jm9013828/production/images/large/jm-2009-013828_0023.jpeg" /></meta><meta property="og:description" content="Design and synthesis of a series of 4-morpholino-6-aryl-1H-pyrazolo[3,4-d]pyrimidines as potent and selective inhibitors of the mammalian target of rapamycin (mTOR) are described. Optimization of the 6-aryl substituent led to the discovery of inhibitors carrying 6-ureidophenyl groups, the first reported active site inhibitors of mTOR with subnanomolar inhibitory concentrations. The data presented in this paper show that 6-arylureidophenyl substituents led to potent mixed inhibitors of mTOR and phosphatidylinositol 3-kinase α (PI3K-α), whereas 6-alkylureidophenyl appendages gave highly selective mTOR inhibitors. Combination of 6-alkylureidophenyl groups with 1-carbamoylpiperidine substitution resulted in compounds with subnanomolar IC50 against mTOR and greater than 1000-fold selectivity over PI3K-α. In addition, structure based drug design resulted in the preparation of several 6-arylureidophenyl-1H-pyrazolo[3,4-d]pyrimidines, substituted in the 4-position of the arylureido moiety with water solubilizing groups. These compounds combined potent mTOR inhibition (IC50 &lt; 1 nM) with unprecedented activity in cellular proliferation assays (IC50 &lt; 1 nM)." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm9013828"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm9013828">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm9013828&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm9013828&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm9013828&amp;href=/doi/10.1021/jm9013828" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2009</span><span class="cit-fg-volume">, 52</span><span class="cit-fg-issue">, 24</span><span class="cit-fg-pageRange">, 8010-8024</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/52/24" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm901092h" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm901117d" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of 4-Morpholino-6-aryl-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidines as Highly Potent and Selective ATP-Competitive Inhibitors of the Mammalian Target of Rapamycin (mTOR): Optimization of the 6-Aryl Substituent</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jeroen+C.++Verheijen">Jeroen C. Verheijen</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=David+J.++Richard">David J. Richard</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kevin++Curran">Kevin Curran</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Joshua++Kaplan">Joshua Kaplan</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mark++Lefever">Mark Lefever</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Pawel++Nowak">Pawel Nowak</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=David+J.++Malwitz">David J. Malwitz</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Natasja++Brooijmans">Natasja Brooijmans</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lourdes++Toral-Barza">Lourdes Toral-Barza</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Wei-Guo++Zhang">Wei-Guo Zhang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Judy++Lucas">Judy Lucas</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Irwin++Hollander">Irwin Hollander</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Semiramis++Ayral-Kaloustian">Semiramis Ayral-Kaloustian</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Tarek+S.++Mansour">Tarek S. Mansour</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ker++Yu">Ker Yu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Arie++Zask">Arie Zask</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Chemical Sciences</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Oncology Research</span></div><div class="aff-info" id="wr"><span class="aff-text">Wyeth Research, 401 N. Middletown Road, Pearl River, New York 10965</span></div><div class="corresp-info"><strong>*</strong>To whom correspondence should be addressed. Phone: +1 845 602 2800. Fax: +1 845 602 5561. E-mail: <a href="/cdn-cgi/l/email-protection#abddced9c3cec2c1ebdcd2cedfc385c8c4c6"><span class="__cf_email__" data-cfemail="354350475d505c5f75424c50415d1b565a58">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm9013828&amp;href=/doi/10.1021%2Fjm9013828" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2009</span></span><span class="cit-volume">, 52</span><span class="cit-issue">, 24</span><span class="cit-pageRange">, 8010–8024</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">November 6, 2009</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>23 July 2009</li><li><span class="item_label"><b>Published</b> online</span>6 November 2009</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 24 December 2009</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm9013828" title="DOI URL">https://doi.org/10.1021/jm9013828</a></div><div class="article_header-article-copyright"><strong>Copyright © 2009 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D8010%26pageCount%3D15%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DJeroen%2BC.%2BVerheijen%252C%2BDavid%2BJ.%2BRichard%252C%2BKevin%2BCurran%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D52%26issueNum%3D24%26contentID%3Djm9013828%26title%3DDiscovery%2Bof%2B4-Morpholino-6-aryl-1H-pyrazolo%255B3%252C4-d%255Dpyrimidines%2Bas%2BHighly%2BPotent%2Band%2BSelective%2BATP-Competitive%2BInhibitors%2Bof%2Bthe%2BMammalian%2BTarget%2Bof%2BRapamycin%2B%2528mTOR%2529%253A%2BOptimization%2Bof%2Bthe%2B6-Aryl%2BSubstituent%26numPages%3D15%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D8024%26publicationDate%3DDecember%2B2009">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm9013828"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">4301</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">41</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm9013828" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of 4-Morpholino-6-aryl-1H-pyrazolo[3,4-d]pyrimidines as Highly Potent and Selective ATP-Competitive Inhibitors of the Mammalian Target of Rapamycin (mTOR): Optimization of the 6-Aryl Substituent&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Jeroen&quot;,&quot;last_name&quot;:&quot;C. Verheijen&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;J. Richard&quot;},{&quot;first_name&quot;:&quot;Kevin&quot;,&quot;last_name&quot;:&quot;Curran&quot;},{&quot;first_name&quot;:&quot;Joshua&quot;,&quot;last_name&quot;:&quot;Kaplan&quot;},{&quot;first_name&quot;:&quot;Mark&quot;,&quot;last_name&quot;:&quot;Lefever&quot;},{&quot;first_name&quot;:&quot;Pawel&quot;,&quot;last_name&quot;:&quot;Nowak&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;J. Malwitz&quot;},{&quot;first_name&quot;:&quot;Natasja&quot;,&quot;last_name&quot;:&quot;Brooijmans&quot;},{&quot;first_name&quot;:&quot;Lourdes&quot;,&quot;last_name&quot;:&quot;Toral-Barza&quot;},{&quot;first_name&quot;:&quot;Wei-Guo&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Judy&quot;,&quot;last_name&quot;:&quot;Lucas&quot;},{&quot;first_name&quot;:&quot;Irwin&quot;,&quot;last_name&quot;:&quot;Hollander&quot;},{&quot;first_name&quot;:&quot;Semiramis&quot;,&quot;last_name&quot;:&quot;Ayral-Kaloustian&quot;},{&quot;first_name&quot;:&quot;Tarek&quot;,&quot;last_name&quot;:&quot;S. Mansour&quot;},{&quot;first_name&quot;:&quot;Ker&quot;,&quot;last_name&quot;:&quot;Yu&quot;},{&quot;first_name&quot;:&quot;Arie&quot;,&quot;last_name&quot;:&quot;Zask&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2009&quot;,&quot;month&quot;:&quot;11&quot;,&quot;day&quot;:&quot;06&quot;,&quot;issue&quot;:&quot;24&quot;,&quot;volume&quot;:&quot;52&quot;,&quot;pages&quot;:&quot;8010-8024&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm9013828&quot;},&quot;abstract&quot;:&quot;Design and synthesis of a series of 4-morpholino-6-aryl-1H-pyrazolo[3,4-d]pyrimidines as potent and selective inhibitors of the mammalian target of rapamycin (mTOR) are described. Optimization of the 6-aryl substituent led to the discovery of inhibitors carrying 6-ureidophenyl groups, the first reported active site inhibitors of mTOR with subnanomolar inhibitory concentrations. The data presented in this paper show that 6-arylureidophenyl substituents led to potent mixed inhibitors of mTOR and phosphatidylinositol 3-kinase α (PI3K-α), whereas 6-alkylureidophenyl appendages gave highly selective mTOR inhibitors. Combination of 6-alkylureidophenyl groups with 1-carbamoylpiperidine substitution resulted in compounds with subnanomolar IC50 against mTOR and greater than 1000-fold selectivity over PI3K-α. In addition, structure based drug design resulted in the preparation of several 6-arylureidophenyl-1H-pyrazolo[3,4-d]pyrimidines, substituted in the 4-position of the arylureido moiety with water solubilizing grou&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm9013828&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm9013828" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm9013828&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm9013828" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm9013828&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm9013828" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm9013828&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm9013828&amp;href=/doi/10.1021/jm9013828" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm9013828" /></input><a href="/doi/pdf/10.1021/jm9013828" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm9013828&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm9013828%26sid%3Dliteratum%253Aachs%26pmid%3D19894727%26genre%3Darticle%26aulast%3DVerheijen%26date%3D2009%26atitle%3DDiscovery%2Bof%2B4-Morpholino-6-aryl-1H-pyrazolo%255B3%252C4-d%255Dpyrimidines%2Bas%2BHighly%2BPotent%2Band%2BSelective%2BATP-Competitive%2BInhibitors%2Bof%2Bthe%2BMammalian%2BTarget%2Bof%2BRapamycin%2B%2528mTOR%2529%253A%2BOptimization%2Bof%2Bthe%2B6-Aryl%2BSubstituent%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D52%26issue%3D24%26spage%3D8010%26epage%3D8024%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=291763" title="Noncovalent interactions">Noncovalent interactions</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/52/24" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-24/jm9013828/production/images/medium/jm-2009-013828_0023.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-24/jm9013828/production/images/large/jm-2009-013828_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9013828&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Design and synthesis of a series of 4-morpholino-6-aryl-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidines as potent and selective inhibitors of the mammalian target of rapamycin (mTOR) are described. Optimization of the 6-aryl substituent led to the discovery of inhibitors carrying 6-ureidophenyl groups, the first reported active site inhibitors of mTOR with subnanomolar inhibitory concentrations. The data presented in this paper show that 6-arylureidophenyl substituents led to potent mixed inhibitors of mTOR and phosphatidylinositol 3-kinase α (PI3K-α), whereas 6-alkylureidophenyl appendages gave highly selective mTOR inhibitors. Combination of 6-alkylureidophenyl groups with 1-carbamoylpiperidine substitution resulted in compounds with subnanomolar IC<sub>50</sub> against mTOR and greater than 1000-fold selectivity over PI3K-α. In addition, structure based drug design resulted in the preparation of several 6-arylureidophenyl-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidines, substituted in the 4-position of the arylureido moiety with water solubilizing groups. These compounds combined potent mTOR inhibition (IC<sub>50</sub> < 1 nM) with unprecedented activity in cellular proliferation assays (IC<sub>50</sub> < 1 nM).</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_45341" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_45341" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Inhibition of components of the PI3K-Akt-mTOR<a class="ref internalNav" href="#fnabbrev" aria-label="a">a</a><div class="NLM_fn" id="fnabbrev">a<p class="last">Abbreviations: ACE-Cl, α-chloroethyl chloroformate; ATP, adenosine triphosphate; ATR, ataxia telangiectasia and Rad3 related; Delfia, dissociation-enhanced lanthanide fluorescent immunoassay; EDC, 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide; HTS, high-throughput screening; mTOR, mammalian target of rapamycin; mTORC1, mammalian target of rapamycin complex 1; mTORC2, mammalian target of rapamycin complex 2; PI3K, phosphatidylinositol 3-kinase; PIKK, phosphatidylinositol 3-kinase related kinase; SAR, structure−activity relationships; SEM, standard error of the mean; TFA, trifluoroacetic acid.</p></div> cascade, one of the most universally up-regulated signaling pathways in human cancers, is currently the focus of an intense effort directed at the identification of novel cancer drugs.<a onclick="showRef(event, 'ref1 ref2 ref3 ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3 ref4 ref5">(1-5)</a> Rapamycin and its analogues (“rapalogues”), which inhibit the downstream component mTOR, have shown clinical efficacy in the treatment of cancer. Two rapalogues, temsirolimus and everolimus, were recently approved for the treatment of advanced, metastatic renal cell carcinoma. Rapamycin and its analogues inhibit only one of two functional complexes of mTOR (mTOR complex 1, mTORC1) while not affecting signaling through mTOR complex 2 (mTORC2).<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> mTORC2 phosphorylates Akt at serine-473, thereby contributing to full activation of Akt.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> mTORC1 inhibition with rapalogues can lead to increased PI3K-Akt signaling, through removal of a negative feedback mechanism.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Increased Akt activity has antiapoptotic effects and may limit the anticancer efficacy of the rapalogues. In addition, recent reports suggest that rapalogues only partially inhibit mTORC1 activity.<a onclick="showRef(event, 'ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref9 ref10">(9, 10)</a> Inhibition of mTOR at the active site by ATP-competitive inhibitors would be expected to decrease signaling through both mTORC1 and mTORC2 and could therefore give access to mTOR inhibitors with improved efficacy over the rapalogues.</div><div class="NLM_p">Most of the reported ATP competitive inhibitors of mTOR also inhibit one or several related kinases, particularly PI3K.<a onclick="showRef(event, 'ref11 ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref11 ref12 ref13">(11-13)</a> PI3K is positioned upstream in the PI3K-Akt-mTOR signaling pathway and is a key mediator for signaling through the insulin receptor. Selective inhibition of mTOR without inhibiting PI3K could result in compounds with increased efficacy compared to the rapalogues and with increased tolerability compared to mixed PI3K/mTOR inhibitors. Very recently, several papers have appeared describing the biological activity of selective ATP competitive mTOR inhibitors.<a onclick="showRef(event, 'ref14 ref15 ref16 ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref14 ref15 ref16 ref17 ref18">(14-18)</a> In addition, our laboratory has revealed a series of 4-morpholino-6-aryl-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidines (e.g., <b>1</b> and <b>2</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) as ATP-competitive inhibitors of mTOR.<a onclick="showRef(event, 'ref19 ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref19 ref20 ref21">(19-21)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-24/jm9013828/production/images/medium/jm-2009-013828_0025.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-24/jm9013828/production/images/large/jm-2009-013828_0025.jpeg" id="_i2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Pyrazolopyrimidine mTOR inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-24/jm9013828/production/images/large/jm-2009-013828_0025.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9013828&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">An mTOR Delfia HTS screen of our HTS collection followed by hit to lead optimization resulted in the discovery of <b>1</b>. Initial SAR studies revealed that the phenol in the 6-position of the pyrazolopyrimidine could be replaced with a 5-indolyl group, resulting in compounds such as <b>2</b> that are potent and selective inhibitors of mTOR.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> We recently published preliminary data in a Letter describing the discovery of the 6-ureidophenyl group as an additional bioisostere for the phenol or indole groups. The resulting mTOR inhibitors combined excellent enzyme and cellular potency with high selectivity over PI3K.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> We now follow up with an Article, presenting a comprehensive report of our modeling studies and lead optimization efforts leading to the discovery of 6-ureidophenyl containing mTOR inhibitors, as well as a detailed SAR study of this substituent and full experimental details. In addition, we present additional data highlighting the potency and selectivity of the resulting inhibitors at the enzymatic and cellular levels as well as in vivo.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_41643" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_41643" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The synthesis of the 4-morpholino-6-aryl-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidines is depicted in the following schemes. As shown in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>, condensation of 2,4,6-trichloropyrimidine-5-carbaldehyde<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> (<b>3</b>) with commercially available phenylhydrazine provided 4,6-dichloropyrazolopyrimidine core <b>4</b>. Nucleophilic displacement of the 4-chloride with morpholine, to give 4-morpholinopyrazolopyrimidine <b>5</b>, was followed by Suzuki−Miyaura coupling to give target compounds <b>6</b>. In the case of <i>N</i>-methylaniline <b>6h</b>, the aniline was acylated to give amidoaryl <b>7</b>.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-24/jm9013828/production/images/medium/jm-2009-013828_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-24/jm9013828/production/images/large/jm-2009-013828_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-24/jm9013828/production/images/large/jm-2009-013828_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9013828&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) phenylhydrazine; (b) morpholine, NEt<sub>3</sub>; (c) ArB(OR)<sub>2</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>; (d) Ac<sub>2</sub>O.</p></p></figure><div class="NLM_p">Following a similar procedure, compounds <b>13a</b>−<b>c</b>, containing an <i>N</i>-benzylpiperidine at the 1-position, could be prepared (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>). Thus, 1-benzyl-4-piperidone (<b>8</b>) was condensed with benzoic hydrazide, followed by debenzoylation of resulting <b>9</b> to give hydrazine <b>10</b>. Condensation of <i>N</i>-benzylpiperidinylhydrazine <b>10</b> with <b>3</b> was followed by the same sequence of reactions as described in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>, to give target compounds <b>13a</b>−<b>c</b>.</div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-24/jm9013828/production/images/medium/jm-2009-013828_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-24/jm9013828/production/images/large/jm-2009-013828_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-24/jm9013828/production/images/large/jm-2009-013828_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9013828&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) benzoic hydrazide; (b) conc HCl, reflux; (c) <b>10</b>, NEt<sub>3</sub>; (d) morpholine, NEt<sub>3</sub>; (e) ArB(OR)<sub>2</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>.</p></p></figure><div class="NLM_p">Pyrazolopyrimidines equipped with a ureidophenyl substituent in the 6-position were accessible as shown in Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>. Reaction of 4-isocyanatophenyl boronate <b>14</b> with amines gave ureidophenyl boronate <b>15</b>. Suzuki−Miyaura coupling of boronates <b>15</b> with aryl chloride <b>12</b> gave access to <b>16</b>.</div><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-24/jm9013828/production/images/medium/jm-2009-013828_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-24/jm9013828/production/images/large/jm-2009-013828_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-24/jm9013828/production/images/large/jm-2009-013828_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9013828&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) R<sub>1</sub>R<sub>2</sub>NH; (b) <b>12</b>, Pd(PPh<sub>3</sub>)<sub>4</sub>.</p></p></figure><div class="NLM_p">An alternative approach to ureidophenyl compounds is shown in Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>. A 4-aminophenyl group was introduced in the 6-position as described above (<b>13a</b>). Activation of <b>13a</b> with triphosgene, followed by condensation with amines, provided <b>17</b>. The synthesis of compound <b>18</b>, an analogue of 4-ureidophenyl compounds <b>17</b> lacking one of the nitrogens, is presented in Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a> as well. Thus, Suzuki−Miyaura coupling with 2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetic acid gave carboxylate <b>13b</b>, which was condensed with methylamine under the agency of EDC to give <b>18</b>.</div><figure id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-24/jm9013828/production/images/medium/jm-2009-013828_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-24/jm9013828/production/images/large/jm-2009-013828_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 4. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-24/jm9013828/production/images/large/jm-2009-013828_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9013828&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) ArB(OR)<sub>2</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>; (b) (1) triphosgene, NEt<sub>3</sub>; (2) RNH<sub>2</sub>; (c) MeNH<sub>2</sub>, EDC.</p></p></figure><div class="NLM_p">Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a> outlines synthetic approaches to inhibitors containing various piperidine substituents. Replacement of the benzyl group in <b>12</b> with a methyl carbamate (<b>23a</b>) was effected by treatment with methylcarbamoyl chloride. Alternatively, carbamoyl piperidine compounds <b>23b</b>,<b>c</b> were accessible from free piperidine <b>19</b>, obtained after ACE chloride debenzylation of <b>12</b>. Piperidine <b>19</b> could also be converted into picolyl-functionalized <b>20</b> by reductive amination. Aryl chlorides <b>20</b> and <b>23</b> were subjected to Suzuki−Miyaura coupling conditions to give anilines <b>21</b> and <b>24</b>, respectively. Conversion of the aniline into a carbamoylphenyl or ureidophenyl group was effected as before, to give <b>22</b> and <b>25</b>−<b>27</b>.</div><figure id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-24/jm9013828/production/images/medium/jm-2009-013828_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-24/jm9013828/production/images/large/jm-2009-013828_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 5. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-24/jm9013828/production/images/large/jm-2009-013828_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9013828&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) R<sup>1</sup>OCOCl; (b) ACE-Cl; (c) 3-pyridine carboxaldehyde, NaHB(OAc)<sub>3</sub>; (d) ArB(OR)<sub>2</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>; (e) (1) triphosgene, NEt<sub>3</sub>, (2) R<sup>2</sup>OH/R<sup>2</sup>NH<sub>2</sub>.</p></p></figure><div class="NLM_p">An alternative approach to methylureido compounds <b>25a</b> and <b>26a</b> is presented in Scheme <a class="ref internalNav" href="#sch6" aria-label="6">6</a>. Boc-protected analogue <b>27a</b> was converted into the free piperidine <b>28</b> by treatment with TFA. Treatment of <b>28</b> with chloroformates afforded carbamoylpiperidines <b>25a</b> and <b>26a</b>.</div><figure id="sch6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-24/jm9013828/production/images/medium/jm-2009-013828_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-24/jm9013828/production/images/large/jm-2009-013828_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 6. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-24/jm9013828/production/images/large/jm-2009-013828_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9013828&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) TFA; (b) ROCOCl.</p></p></figure><div class="NLM_p">Further derivatization of hydroxyethylphenylureido compound <b>25f</b> is depicted in Scheme <a class="ref internalNav" href="#sch7" aria-label="7">7</a>. Treatment of <b>25f</b> with <i>p</i>-toluenesulfonyl chloride followed by reaction with excess amine gave access to <b>25g</b>−<b>i</b>.</div><figure id="sch7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-24/jm9013828/production/images/medium/jm-2009-013828_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-24/jm9013828/production/images/large/jm-2009-013828_0007.jpeg" id="_i4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 7. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-24/jm9013828/production/images/large/jm-2009-013828_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9013828&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NEt<sub>3</sub>, TsCl, then R<sub>1</sub>R<sub>2</sub>NH.</p></p></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i5">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_00306" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_00306" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Our initial efforts to discover bioisosteres of the 3-phenol group (cf. <b>1</b>) and 5-indole group (cf. <b>2</b>) focused on anilines and aminopyridines (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). SAR studies were performed on the readily available 1-phenyl substituted pyrazolopyrimidine core. Comparison of indole analogue <b>6a</b> with aniline analogues <b>6b</b> and <b>6c</b> revealed that 3- or 4-anilino substitution in the pyrazolopyrimidine 6-position led to compounds with decreased mTOR inhibitory activity. However, introduction of a nitrogen into the ring, to give 2-aminopyridin-5-yl derivative <b>6d</b>, led to an 8-fold increase in potency compared to <b>6c</b>. Similar results were obtained for aminopyrimidines (<a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>, Table S1). In contrast, no such increase in potency was observed for regioisomeric aminopyridines (<b>6e</b> and <b>6f</b>). Molecular modeling provided an explanation for these findings. An mTOR homology model, based on the crystal structure of the related PI3K-γ in complex with a compound from the pyrazolopyrimidine series,<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> was used to examine SAR. The catalytic domain of mTOR is 25% homologous to that of PI3K-γ, but the binding sites show significantly more conservation with 68% of the residues being identical. Modeling studies showed that the morpholinopyrimidines form a critical hydrogen bond to the backbone of the hinge region (Val2240) through the morpholine oxygen, while the indole NH of <b>6a</b> or the anilines of <b>6b</b>−<b>d</b> interact with Asp2195. In the case of aminopyridine <b>6d</b>, an additional hydrogen bond was observed between the catalytic lysine (Lys2187) and the pyridine nitrogen (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>A). This interaction is not possible for regioisomers <b>6e</b> and <b>6f</b>. Finally, an additional interaction between Glu2190 and the exocyclic amine in <b>6d</b> was observed (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>A).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Anilines and Aminopyridines</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-24/jm9013828/production/images/medium/jm-2009-013828_0008.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table single-image" border="0"><colgroup><col align="center" /></col></colgroup><tbody><tr valign="top"><td align="center"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-24/jm9013828/production/images/medium/jm-2009-013828_0009.gif" alt="" id="fx2" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">Mean ± SEM.</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">Selectivity (IC<sub>50</sub> PI3K-α)/(IC<sub>50</sub> mTOR).</p></div></div></div><div class="NLM_p">It was clear from the data in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> that combination of an H-bond donor (amino group) and H-bond acceptor (ring nitrogen) in the 6-substituent (“R” in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) could give potent mTOR inhibitors. Interestingly, it was found that mTOR potency could be maintained when the H-bond donor (amino group) was combined with an exocyclic H-bond acceptor (carbonyl oxygen). Thus, acetamide <b>6g</b> possessed similar potency as aminopyridine <b>6d</b>. Methylation of the amide in <b>6g</b> to give <b>7</b> resulted in a 30-fold decrease in activity, highlighting the importance of the presence of an H-bond donor in that position. Molecular modeling of the binding mode of acetamide inhibitors confirmed the formation of H-bonds between the acetamide and Asp2195 and Lys2187 (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>B). A comparison of the binding modes of aminopyridine <b>6d</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>A) and acetamide <b>6g</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>B) showed a concerted motion by the catalytic lysine (Lys2187) and its salt bridge partner Glu2190 to maintain hydrogen bonding interactions with the inhibitors.</div><figure id="fig2" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-24/jm9013828/production/images/medium/jm-2009-013828_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-24/jm9013828/production/images/large/jm-2009-013828_0010.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Close-up of binding interactions of inhibitors with mTOR homology model: (A) binding mode of aminopyridine <b>6d</b> showing hydrogen bonds (dashed lines) with Asp2195, Lys2187, and Glu2190 and the salt bridge between Lys2187 and Glu2190; (B) interactions of acetamide <b>6g</b> showing hydrogen bonds between the acetamide and Asp2195 and Lys2187 and the salt bridge between Lys2187 and Glu2190. Comparison of parts A and B highlights the observed concerted motion by Lys2187 and Glu2190 to maintain hydrogen bonding interactions with the inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-24/jm9013828/production/images/large/jm-2009-013828_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9013828&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> showed that the <i>m</i>-aniline possessed similar potency as the corresponding para-substituted inhibitor (compare <b>6b</b> and <b>6c</b>). The effect of meta- vs para-substitution was investigated in more detail. Small substituents (hydroxyl, amino) were equally tolerated in the meta and para positions, while larger amide substitutents were only tolerated at the para-position (<a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>, Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). Molecular modeling showed that incorporation of <i>m</i>-amidophenyl groups resulted in significant steric hindrance. Therefore, further efforts focused on the investigation of para-substituted aryl groups. Initially, the use of substituted amides for the introduction of water-solubilizing groups was explored. Although a variety of groups were tolerated, all substituted acetamides were only poorly selective over PI3K-α (<a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>, Table S3). In contrast, methyl carbamate <b>6i</b> possessed promising selectivity, although the potency (IC<sub>50</sub> = 10 μM) of <b>6i</b> in a prostate cancer cell line (LNCaP) proliferation assay required further optimization. When the corresponding 1-benzylpiperidinepyrazolopyrimidine (<b>13c</b>, Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>) was prepared, it was found to possess greater potency in this cellular proliferation assay. Therefore, <b>13c</b> was selected as the starting point for further optimization.</div><div class="NLM_p">SAR had shown that the 1-benzylpiperidine group could be replaced with a picolylpiperidine group.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> This replacement was accompanied by a moderate increase in potency and selectivity (<b>22a</b>, Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). For further SAR studies, the benzylpiperidine and picolylpiperidine substituents at the pyrazolopyrimidine 1-position were used interchangeably. Larger alkyl carbamates (Et, Pr, <sup><i>i</i></sup>Pr) resulted in 4- to 13-fold decreased potency (data not shown). Interestingly, the hydroxyethyl carbamate (<b>22b</b>) was 3-fold more potent than the corresponding methyl carbamate (<b>22a</b>). Molecular modeling provided an explanation for the high potency of hydroxyethyl carbamate <b>22b</b>. As shown in Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>A, the critical hydrogen bond to the backbone of the hinge region (Val2240) through the morpholine oxygen was maintained. The hydroxyethyl carbamate of <b>22b</b> was able to form three additional hydrogen bonding interactions. The carbamate NH formed a hydrogen bond to the side chain of Asp2195, while the carbonyl interacted with the catalytic lysine (Lys2187). The hydroxyl group interacted with another aspartic acid further away from the ATP binding site (Asp2191) by forming a hydrogen bond to its backbone carbonyl group. A comparison to the binding modes of inhibitors containing an aminopyridine (cf. Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>A, one hydrogen bond to Asp2195 in addition to the hinge region interaction), 5-indole (one hydrogen bond to Asp2195 in addition to the hinge region interaction<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a>) or 4-acetamide (cf. Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>B, two hydrogen bonds to Asp2195 and Lys2187 in addition to the hinge region interaction) reveals that the increased potency of the hydroxyethyl carbamate is likely caused by the formation of the additional hydrogen bond to Asp2191.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Carbamoyl and Ureidophenyl Analogues and Isosteres</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-24/jm9013828/production/images/medium/jm-2009-013828_0011.gif" alt="" id="fx3" /></img><div class="scrollable-table-wrap"><table class="table single-image" border="0"><colgroup><col align="center" /></col></colgroup><tbody><tr valign="top"><td align="center"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-24/jm9013828/production/images/medium/jm-2009-013828_0012.gif" alt="" id="fx4" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">Mean ± SEM.</p></div><div class="footnote" id="t2fn2"><sup>b</sup><p class="last">Selectivity (IC<sub>50</sub> PI3K-α)/(IC<sub>50</sub> mTOR).</p></div><div class="footnote" id="t2fn3"><sup>c</sup><p class="last">The average error for LNCaP IC<sub>50</sub> determinations was <25%.</p></div></div></div><div class="NLM_p">A further increase in enzyme inhibition was observed when the carbamoylphenyl group was replaced with a ureidophenyl group. Thus, methylureas <b>16a</b> and <b>22c</b> were 10- to 20-fold more potent than the corresponding methyl carbamates <b>13c</b> and <b>22a</b> and represent the first known subnanomolar inhibitors of mTOR. In addition, ureas <b>16a</b> and <b>22c</b> inhibited cellular proliferation at single digit nanomolar concentrations, a several-hundred-fold improvement over the corresponding carbamates <b>13c</b> and <b>22a</b>, respectively. Molecular modeling, based on an X-ray structure of a urea analogue bound to PI3K-γ (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3IBE">3IBE</a>), again provided an explanation for the increased potency of the urea analogues. As shown in Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>B, in addition to the critical hinge region interaction, the urea of <b>22c</b> formed three hydrogen bonds. The carbonyl bound to the catalytic lysine (Lys2187) and both NH groups interacted with Asp2195.</div><div class="NLM_p">In order to evaluate whether the potency in LNCaP cellular proliferation was predictive of activity in other cancer cell lines, several representative compounds were screened against a broad panel of tumor cells (<a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>, Table S4). The same trends as observed in LNCaP cells were evident in other cell lines as well. Ureas <b>16a</b> and <b>22c</b> were significantly more active than the corresponding carbamates <b>13c</b> and <b>22a</b> in all cell lines studied. Because mTOR mediates the PI3K-Akt signaling functions and PI3K/Akt hyperactive tumors more likely depend on mTOR for growth and survival, mTOR inhibitors may be more effective against a subset of tumors that express dysregulated PI3K/Akt signaling status. Thus, cell lines characterized by mutations that lead to hyperactive PI3K/Akt signaling (PTEN −/− or PIK3CA) were especially sensitive to mTOR inhibitors (LNCaP, U87MG, PC3MM2, MDA361, and MCF7). Several cell lines not known to express dysregulation of PI3K/Akt signaling were somewhat less sensitive (MDA435, MDA231, DUI45, and HT29). The excellent potency of the urea-containing mTOR inhibitors is illustrated by the fact that even some of these less sensitive cell lines responded well to submicromolar concentrations of ATP-competitive mTOR inhibitors.</div><div class="NLM_p">On the basis of this excellent activity, analogues of <b>16a</b> and <b>22c</b> were explored in more detail. First, consistent with the proposed binding mode, the importance of the presence of both urea NH groups as potential hydrogen bond donors was confirmed by compounds <b>16b</b> and <b>18</b>. Thus, 1-N-methylation (<b>16b</b>) resulted in a greater than 100-fold decrease in potency. Similarly, removal of the urea 3-NH (<b>18</b>) led to a greater than 300-fold decrease in activity. Modifying the electronics of the ureido NH by conversion to a 1-methoxyurea (<b>16c</b>, <b>22d</b>) or a hydrazinecarboxamide group (<b>16d</b>) also led to significantly decreased potency.</div><figure id="fig3" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-24/jm9013828/production/images/medium/jm-2009-013828_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-24/jm9013828/production/images/large/jm-2009-013828_0013.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Close-up of binding interactions of inhibitors with mTOR homology model: (A) binding mode of hydroxyethyl carbamate <b>22b</b>; (B) interactions of methylurea <b>22c</b>. Hydrogen bonds are indicated by dashed blue lines. mTOR residue numbers are shown in part A.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-24/jm9013828/production/images/large/jm-2009-013828_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9013828&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Additional analogues and isosteres of the urea group were explored (e.g., thiourea, cyanoguanidine), but in all cases their potency against mTOR was inferior to that of the corresponding urea compounds (<a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>, Table S5). Substitution on the ureidophenyl group was explored in more detail (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). Alkylureas (<b>16a</b>, <b>16f</b>, and <b>16g</b>) were more potent than unsubstituted urea <b>16e</b>. Ethyl- and 2-fluoroethylureas <b>16f</b> and <b>16g</b> possessed similar enzyme potency and somewhat decreased cellular potency compared to methylurea <b>16a</b>, but their selectivity was much higher. Branched urea <b>16h</b> was not as potent as <b>16a</b>. The increased activity of the smaller cyclopropyl analogue (<b>17a</b>) compared to the isopropyl  compound (<b>16h</b>) suggests that this was due to steric hindrance. With the exception of hydroxyethylurea <b>16i</b>, attempts to introduce water solubilizing ureas (<b>16j</b>−<b>l</b>) resulted in decreased potency and selectivity. Arylureido compounds (<b>16m</b>, <b>16n</b>, <b>17b</b>) led to highly potent mTOR inhibitors that were slightly less selective over PI3K-α than short chain alkylureido compounds.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Ureidophenyl SAR</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-24/jm9013828/production/images/medium/jm-2009-013828_0014.gif" alt="" id="fx5" /></img><div class="scrollable-table-wrap"><table class="table single-image" border="0"><colgroup><col align="center" /></col></colgroup><tbody><tr valign="top"><td align="center"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-24/jm9013828/production/images/medium/jm-2009-013828_0015.gif" alt="" id="fx6" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">Mean ± SEM.</p></div><div class="footnote" id="t3fn2"><sup>b</sup><p class="last">Selectivity (IC<sub>50</sub> PI3K-α)/(IC<sub>50</sub> mTOR).</p></div><div class="footnote" id="t3fn3"><sup>c</sup><p class="last">The average error for LNCaP IC<sub>50</sub> determinations was <25%.</p></div></div></div><div class="NLM_p">Compounds incorporating benzylpiperidines and picolylpiperidines at the 1-position generally possessed poor microsomal stability. For instance, picolylpiperidine <b>22c</b> was degraded in nude mouse microsomes with a half-life of 12 min, whereas the benzylpiperidines were even more rapidly metabolized. We have previously reported that carbamoylpiperidines in the 1-position can improve microsomal stability.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Combination of carbamoylpiperidines in the 1-position with ureidophenyl groups in the 6-position led to several compounds that combined highly potent inhibition of mTOR (IC<sub>50</sub> < 1 nM) with excellent selectivity over PI3K-α (>1000-fold) and potent (low double-digit nanomolar) inhibition of cellular proliferation (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). In order to explore whether this unprecedented selectivity was specific to the α-isoform of PI3K, the IC<sub>50</sub> values against PI3K-γ and another PIKK, ATR, were also determined. In all cases, selectivity over PI3K-γ and ATR was greater than over PI3K-α. In this respect, incorporation of isopropylcarbamoylpiperidines in the 1-position led to the most selective compounds. It was also evident that 2-fluoroethylureidophenyl and cyclopropylureidophenyl groups in the 6-position led to more selective mTOR inhibitors compared to methylureidophenyl groups.</div><div class="NLM_p">The microsomal stability data revealed that the carbamoylpiperidines were significantly more stable than the benzyl- and picolylpiperidines. We also explored the potential for drug−drug interaction by examining inhibition of various cytochrome P450 isoforms. At 3 μM, approximately 5000-fold the mTOR IC<sub>50</sub>, none of the carbamoylpiperidines inhibited CYP 2D6 more than 20%. The methylcarbamoylpiperidines showed no inhibition of CYP 2C9 (<20%) and low inhibition of CYP 3A4 (<40%). The more lipophilic isopropyl- and <i>tert</i>-butylcarbamoylpiperidines showed slightly increased inhibition of the last two isoforms (3A4, 23−70%; 2C9, 40−75% at 3 μM).</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Highly Selective mTOR Inhibitors Combining Alkylureidophenyl Substitution in the 6-Position with Carbamoylpiperdine Substitution in the 1-Position</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-24/jm9013828/production/images/medium/jm-2009-013828_0017.gif" alt="" id="fx7" /></img><div class="scrollable-table-wrap"><table class="table single-image" border="0"><colgroup><col align="center" /></col></colgroup><tbody><tr valign="top"><td align="center"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-24/jm9013828/production/images/medium/jm-2009-013828_0016.gif" alt="" id="fx8" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">Mean ± SEM.</p></div><div class="footnote" id="t4fn2"><sup>b</sup><p class="last">Selectivity (IC<sub>50</sub> PI3K-α)/(IC<sub>50</sub> mTOR).</p></div><div class="footnote" id="t4fn3"><sup>c</sup><p class="last">The average error for PI3K-γ and ATR IC<sub>50</sub> determinations was <50%.</p></div><div class="footnote" id="t4fn4"><sup>d</sup><p class="last">The average error for LNCaP IC<sub>50</sub> determinations was <25%.</p></div><div class="footnote" id="t4fn5"><sup>e</sup><p class="last">Microsomal stability (<i>t</i><sub>1/2</sub>, min.).</p></div></div></div><div class="NLM_p">In order to further evaluate the selectivity of the urea-containing inhibitors, representative compounds were assayed against a broad panel of 26 kinases (<a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>, Table S6). Although the methyl carbamate <b>22a</b> displayed excellent selectivity over all non-PIKKs in the panel (>3500-fold), the selectivity of urea inhibitors <b>22c</b> and <b>27a</b> was particularly impressive (>100000-fold over all non-PIKKs in the panel). The latter observation could be explained by the unique interaction of the urea with the active site in mTOR and PI3K involving the formation of three hydrogen bonds. Kinases outside the PIKK family do not have the ability to form these same interactions. Methylurea <b>22c</b> was also highly selective over the β- and δ-isoforms of PI3K (IC<sub>50</sub> of 141 and 64 nM, respectively). Finally, the less selective methyl carbamate (<b>22a</b>) was screened in a panel of 59 kinases by Invitrogen. At 1 μM, the only kinase showing >20% inhibition was RAF1 (cRAF, 31%), providing further evidence that this class of inhibitors is highly selective for mTOR and the PIKKs.</div><div class="NLM_p">Having identified potent and selective inhibitors of mTOR, we were interested in exploring how these inhibitors compared to previously disclosed ATP-competitive mTOR inhibitors. To this end, <b>31</b> (Ku-0063794),<a onclick="showRef(event, 'ref16 ref18'); return false;" href="javascript:void(0);" class="ref ref16 ref18">(16, 18)</a> one of the most potent and selective inhibitors reported to date, was synthesized according to literature procedures. Under our assay conditions, <b>31</b> inhibited mTOR with an IC<sub>50</sub> of 2.5 nM, was ∼200-fold selective over PI3K-α, and inhibited LNCaP cellular proliferation with an IC<sub>50</sub> of 500 nM. Comparison of these values to the compounds in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a> revealed that the pyrazolopyrimidines were significantly more potent inhibitors of mTOR and cellular proliferation than <b>31</b>. In addition, several pyrazolopyrimidines were significantly more selective over PI3K (<b>25b</b>,<b>c</b>, <b>26a</b>−<b>c</b>, <b>27b</b>,<b>c</b>) than the selective inhibitor <b>31</b>.</div><div class="NLM_p">mTOR inhibition was also explored at the cellular level in U87MG tumor cells (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>). The ATP competitive inhibitors potently inhibited phosphorylation of the mTORC1 substrate P-S6K (T389) (<100 nM). Slightly higher concentrations were required for inhibition of another mTORC1 substrate (P-4EBP1 (T70)) and the mTORC2 substrate P-Akt (S473) (<300 nM). These values correlate well with the observed IC<sub>50</sub> values for inhibition of cellular proliferation in this cell line (12−120 nM). Selectivity over PI3K was evident at the cellular level as well. Thus, whereas the mTORC1 and mTORC 2 biomarkers were completely inhibited below 300 nM, inhibition of the PI3K/PDK1 biomarker P-Akt (T308) required significantly higher levels.</div><figure id="fig4" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-24/jm9013828/production/images/medium/jm-2009-013828_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-24/jm9013828/production/images/large/jm-2009-013828_0018.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Inhibition of mTOR signaling after treatment with mTOR kinase inhibitors. U87MG cells were treated in growth medium for 6 h with the indicated concentrations of <b>22a</b>, <b>25a</b>, and <b>27a</b>. Total cell lysates were prepared and subjected to immunoblotting with antibodies against P-S6K, P-4EBP1 (T70), 4EBP1, P-Akt (S473), P-Akt (T308). The blots were also stained for Ponceau-S, a dye for total protein, for sample loading control.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-24/jm9013828/production/images/large/jm-2009-013828_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9013828&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To confirm that the selectivity observed in vitro translated to selective inhibition of mTORC1 and mTORC2 in vivo, PC3MM tumor bearing nude mice were dosed intravenously with 50 mg/kg of compounds <b>25a</b> and <b>27a</b>. One hour after dosing, complete suppression of the mTORC1 substrate S6K was observed in the tumors (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>), resulting in a significant decrease in phosphorylation of its target (P-S6). Likewise, near complete suppression of mTORC2 activity was observed (P-Akt (S473)). In sharp contrast, only negligible inhibition of phosphorylation of the PI3K/PDK1 biomarker (P-Akt (T308)) was observed, illustrating the fact that these compounds behave as selective inhibitors of mTOR in vivo.</div><figure id="fig5" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-24/jm9013828/production/images/medium/jm-2009-013828_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-24/jm9013828/production/images/large/jm-2009-013828_0019.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Inhibition of mTOR signaling in vivo following a single dose of mTOR kinase inhibitors. Nude mice bearing sc PC3MM2 tumors were injected iv with vehicle or 50 mg/kg test article. Tumor lysates were prepared 1 h after injection and were immunoblotted with antibodies against P-S6K (T389), P-Akt (S473), P-Akt (T308), P-S6, and β-actin.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-24/jm9013828/production/images/large/jm-2009-013828_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9013828&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Water solubilizing groups are often incorporated in kinase inhibitors to improve their physicochemical properties. It has already been shown (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>) that incorporation of water solubilizing alkylureidophenyl groups at the 6-position led to decreased potency and selectivity. Similar results were observed when water solubilizing groups were introduced at the 1-position of the pyrazolopyrimidines (data not shown). A careful examination of the three-dimensional structure of phenylureidophenyl inhibitor <b>25d</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>), docked in an mTOR homology model based on a human PI3K-γ crystal structure (PDB code 3IBE), indicated that the 4-position of the phenyl ring was exposed to solvent (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>). The latter observation suggested that water solubilizing groups might be introduced in the para-position of arylureidophenyl groups at the 6-position of the pyrazolopyrimidines. Indeed, as shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>, introduction of an <i>N</i>-methylpiperazine in the para-position of the phenylureido moiety led to a compound (<b>25e</b>) that was as potent as the unsubstituted phenylureido analogue (<b>25d</b>). Selectivity over PI3K-α was also not affected by introduction of the water solubilizing group. A variety of other polar groups could also be incorporated in the same position while maintaining mTOR inhibitory activity and selectivity over PI3K-α (<b>25f</b>−<b>i</b>). In all cases, the selectivity over PI3K-γ and ATR was even greater, with ATR selectivity in all cases >20000-fold. Moreover, the cellular potency was greatly increased by the introduction of water solubilizing groups, resulting in the first known mTOR inhibitors with subnanomolar potency in cellular proliferation assays. These observations are in sharp contrast to the pronounced decrease in activity that was observed for direct linkage of polar groups on an alkyl chain to the ureidophenyl moiety (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). The <i>N</i>-methylpiperazinophenylurea analogue <b>25e</b> displayed excellent stability in nude mouse microsomes. Although aminoethylphenylureas (<b>25g</b>−<b>i</b>) possessed poor to moderate stability in this assay, all compounds containing a basic amine had excellent stability in human microsomes (<b>25e</b>,<b>g</b>−<b>i</b>). In contrast, the hydroxyethyl substituent led to poor stability in human and nude mouse microsomes (<b>25f</b>). While unsubstituted phenylurea <b>25d</b> significantly inhibited CYP 3A4 (87% at 3 μM), analogues <b>25e</b>, <b>25g</b>, and <b>25h</b> showed no inhibition of CYP isoforms (<10% inhibition at 3 μM). Moderate inhibition of CYP 3A4 was observed for hydroxyethylurea <b>25f</b> and morpholinophenylurea <b>25i</b> (50% and 28%, respectively). Interestingly, the introduction of the morpholine moiety led to increased inhibition of CYP2C9 (58% for <b>25i</b> at 3 μM).</div><figure id="fig6" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-24/jm9013828/production/images/medium/jm-2009-013828_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-24/jm9013828/production/images/large/jm-2009-013828_0020.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Surface representations of the mTOR binding site highlighting the tight fit of inhibitors as exemplified by phenylureidophenyl <b>25d</b>. (A) Overview of the mTOR catalytic domain in cartoon representation and the binding site in surface representation. <b>25d</b> is sandwiched between the N-lobe and C-lobe of the catalytic domain. (B) Close-up view of <b>25d</b> rotated 90° compared to part A. The hydrogen atom in the 4-position of the terminal phenyl ring is shown to illustrate the directionality toward solvent from this position. Hydrogen bonds between the urea and Lys2187 and Asp2195 are maintained (cf. Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>B) and are shown by dashed lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-24/jm9013828/production/images/large/jm-2009-013828_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9013828&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Water Solubilizing Groups in 4-Position of Arylureidophenyl Substituents</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-24/jm9013828/production/images/medium/jm-2009-013828_0021.gif" alt="" id="fx9" /></img><div class="scrollable-table-wrap"><table class="table single-image" border="0"><colgroup><col align="center" /></col></colgroup><tbody><tr valign="top"><td align="center"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-24/jm9013828/production/images/medium/jm-2009-013828_0022.gif" alt="" id="fx10" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">Mean ± SEM.</p></div><div class="footnote" id="t5fn2"><sup>b</sup><p class="last">Selectivity (IC<sub>50</sub> PI3K-α)/(IC<sub>50</sub> mTOR).</p></div><div class="footnote" id="t5fn3"><sup>c</sup><p class="last">The average error for LNCaP IC<sub>50</sub> determinations was <25%.</p></div><div class="footnote" id="t5fn4"><sup>d</sup><p class="last">Microsomal stability (<i>t</i><sub>1/2</sub>, min.).</p></div></div></div><div class="NLM_p last">Comparison of the data in Tables <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a> and <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a> revealed that the tools are now available to design highly potent inhibitors (enzyme IC<sub>50</sub> < 1 nM, cellular IC<sub>50</sub> < 50 nM) with excellent selectivity (>1000-fold over PI3K-α) or to design compounds with further increased cellular potency (IC<sub>50</sub> < 1nM) but decreased selectivity (∼50-fold over PI3K-α). It is currently not clear what levels of selectivity are required for optimal clinical efficacy. On one hand, highly selective mTOR inhibitors (i.e., the rapalogues) have proven efficacious in the treatment of certain cancers. On the other hand, ATP competitive mixed inhibitors of mTOR and PI3K are currently advancing through clinical development. With the tools now at our disposal, we expect to be able to further advance our understanding of the biology of inhibition of the mTOR pathway and to elucidate in more detail the role that PI3K and mTOR play in determining efficacy and side effects.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_81443" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_81443" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">The 4-ureidophenyl group was identified as an essential substituent in the 6-position of pyrazolopyrimidine inhibitors of mTOR, leading to highly potent (subnanomolar) inhibitors. Moreover, several highly selective compounds (>1000-fold selective over PI3K-α) with good cellular potency (IC<sub>50</sub> = 20−50 nM) were reported. In addition, we have presented compounds with good selectivity (50- to 100-fold over PI3K-α) that are extremely potent in cellular proliferation assays (IC<sub>50</sub> < 1 nM). The pharmacological tools now at our disposal should prove valuable in advancing our understanding of the role of this fascinating signaling pathway in cancer biology.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_77564" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_77564" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Materials and Methods</h3><div class="NLM_p last">All solvents were HPLC grade, and all other chemicals were analytical reagent or equivalent. All chemicals were used as received. <sup>1</sup>H NMR spectra were determined with a Bruker DRX400 spectrometer at 400 MHz or a NT-300 WB spectrometer at 300 MHz. Chemical shifts (δ) are expressed in parts per million relative to the internal standard tetramethylsilane. Electrospray mass spectra were recorded in positive mode on a Micromass Platform spectrometer. High-resolution mass spectra (HRMS) were obtained on a Finnigan MAT-90 spectrometer or a Bruker 9.4T FTMS spectrometer. Chromatographic purifications were by flash chromatography using Baker 40 μm silica gel. Semipreparative reverse-phase high-pressure liquid chromtography (RP-HPLC) was performed using a Gilson Preparatory HPLC. The sample was dissolved in DMSO, applied on a Waters Atlantis Prep T3 OBD column (30 mm × 150 mm, 5 μm), and eluted at 30 mL/min with a 20 min gradient (from 5% B to 100% B), where solvent A is water (0.05% TFA buffer) and solvent B is acetonitrile (0.05% TFA buffer). An alternative solvent system consisted of solvent A being water (0.1% NH<sub>4</sub>OH buffer) and solvent B being acetonitrile (0.1% NH<sub>4</sub>OH buffer). The purity of tested compounds was determined by HPLC and was ≥95% except as noted.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> mTOR, PI3K, and ATR Assays</h3><div class="NLM_p last">A Flag-tagged truncated human TOR (Flag-TOR(3.5), amino acids 1360−2549) was expressed in HEK293 cells and affinity purified. The routine inhibitor assays were performed in 96-well plates for 2 h at room temperature in 25 μL containing 6 nM Flag-TOR(3.5) (estimated 5−10% purity), 1 μM His6-S6K, and 100 uM ATP. The assays were performed and detected by DELFIA employing the Eu-phospho-p70S6K T389 antibody.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> The PI3K assays were performed as described previously,<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> using enzymes from Upstate Biotech (now Millipore). ATR kinase activity was evaluated using a DELFIA assay format.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> LNCap Tumor Cell Growth Assay<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a></h3><div class="NLM_p last">The LNCap cell line was obtained from the American Type Culture Collection (ATCC) and was maintained in a 37 °C incubator with 5% CO<sub>2</sub>, and was cultured using standard cell culture methods. Cells were plated in 96-well culture plates at 1000−3000 cells per well for 24 h, treated with DMSO or various doses of mTOR inhibitors. Viable cell densities were determined 3 days later by MTS assay employing an assay kit (CellTiter 96 AQ<sub>ueous</sub>, catalog no. G5421, Promega) following the kit assay protocol. The effect of each treatment was calculated as percent of control growth relative to the DMSO-treated cells grown in the same culture plate. Inhibitor dose−response curves were plotted for determination of IC<sub>50</sub> values.</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Determination of mTOR Inhibition in U87 Cells<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a></h3><div class="NLM_p last">Total cell lysates were prepared using NuPAGE-LDS sample buffer (Invitrogen), quantified by RCDC protein assay (Bio-Rad), and immunoblotted using NuPAGE electrophoresis system (Invitrogen). The following antibodies were obtained from Cell Signaling Technology: P-Akt (S473), P-Akt (T308), P-S6K1 (T389), P-4EBP1 (T70), 4EBP1.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Inhibition of mTOR in Nude Mouse Xenograft Tumors</h3><div class="NLM_p last">U87MG tumors (400 mm<sup>3</sup>) were grown subcutaneously in Balb/c nu/nu female mice, and vehicle or compound was dosed by a single intravenous injection (iv). Tumor lysates were prepared and immunoblotted.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a></div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Microsomal Stability</h3><div class="NLM_p last">Microsomal stability was determined as described previously.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a></div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> mTOR Homology Model</h3><div class="NLM_p">An mTOR homology model was built based on an in-house PI3K-γ crystal structure in complex with a compound from the pyrazolopyrimidine series.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> PRIME 1.5 [Prime, version 1.5, Schrödinger, LLC, New York, NY, 2005] was used to build the initial model, which was further optimized using EMBRACE (MacroModel, version 9.1, Schrödinger, LLC, New York, NY, 2005) minimizations in complex with the cocrystallized ligand.</div><div class="NLM_p last">Subsequent docking studies were performed using Glide 4.0 (Glide, version 4.0, Schrödinger, LLC, New York, NY, 2005) and 4.5 (Glide, version 4.5, Schrödinger, LLC, New York, NY, 2005) with the Single Precision (SP) scoring function. A hydrogen bonding constraint to valine-2240 of the hinge region was used during the docking.</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> 2,4,6-Trichloropyrimidine-5-carbaldehyde (<b>3</b>)</h3><div class="NLM_p last">To a solution of POCl<sub>3</sub> (200 mL) in DMF (42 mL) cooled to 0 °C was slowly added barbituric acid (30 g) over 1.5 h. The mixture was then heated to reflux for 16 h and then evaporated (the distillate was carefully decomposed by slowly pouring into a stirred ice methanol slush). The remainder was cooled to 0 °C and added very slowly to a solution of ice−water upon which a beige solid formed. The solid was filtered, dissolved in DCM, washed with water, washed with a saturated NaHCO<sub>3</sub> solution, dried (MgSO<sub>4</sub>), and concentrated in vacuo to give white crystals (24 g). <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 10.42 (1H, s).</div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> 6-Chloro-4-morpholin-4-yl-1-phenyl-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidine (<b>5</b>)</h3><div class="NLM_p last">To a solution of 5.0 g (23.6 mmol) of 2,4,6-trichloropyrimidine-5-carbaldehyde (<b>3</b>) in ethanol, cooled at −78 °C, was added triethylamine (10 mL). Phenylhydrazine (2.32 mL, 23.6 mmol) was added slowly, and the mixture was allowed to warm to ambient temperature. The mixture was cooled to −78 °C again, and morpholine (2.2 mL, 25 mmol) was added. The mixture was allowed to warm to room temperature, and the resulting solids were collected by filtration, washed with ethanol, and dried to give 5.6 g (17.7 mmol) of the title compound. HRMS: <i>m</i>/<i>z</i> 316.0960 ([M + H]<sup>+</sup>). For [M + H]<sup>+</sup> mass error = 0.1 mDa or 0.16 ppm. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 8.62 (1H, s), 8.03 (2H, d, <i>J</i> = 8.8 Hz), 7.58 (2H, t, <i>J</i> = 7.8 Hz), 7.40 (1H, t, <i>J</i> = 7.4 Hz), 3.95 (4H, t, <i>J</i> = 4.8 Hz), 3.78 (4H, t, <i>J</i> = 4.8 Hz).</div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> General Procedure for Suzuki−Miyaura Coupling of 6-Chloro-4-morpholin-4-yl-1-phenyl-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidine (<b>5</b>)</h3><div class="NLM_p">6-Chloro-4-morpholin-4-yl-1-phenyl-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidine (<b>5</b>, 38 mg, 0.12 mmol) was placed in a 0.5−2 mL microwave vial. Then 0.2 mmol of a boronic acid or boronate pinacol ester was added, followed by addition of 2 mL of dimethoxyethane and 0.25 mL of a 2 M aqueous solution of sodium carbonate. Tetrakis(triphenylphosphine)palladium(0) (14 mg, 0.1 equiv) was added, and the mixture was heated for 10−30 min at 185 °C under microwave irradiation. The mixture was concentrated, dissolved in DMSO, filtered, and purified by reversed phase HPLC (TFA buffers) to give the target compound.</div><div class="NLM_p last">The following compounds were made according to the general procedure.</div></div><div id="sec5_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> 4-(4-Morpholin-4-yl-1-phenyl-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-6-yl)aniline (<b>6c</b>)</h3><div class="NLM_p last">Yield: 31 mg (0.086 μmol, 71%). LCMS: 91% pure, <i>t</i><sub>R</sub> = 2.33 min, <i>m</i>/<i>z</i> 373.2 ([M + H]<sup>+</sup>). HRMS: <i>m</i>/<i>z</i> 373.177 99 ([M + H]<sup>+</sup>). For [M + H]<sup>+</sup> mass error = 0.85 mDa or 2.29 ppm. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 8.50 (1H, s), 8.32 (2H, d, <i>J</i> = 8.4 Hz), 8.16 (2H, d, <i>J</i> = 8.8 Hz), 7.60 (2H, t, <i>J</i> = 8.0 Hz), 7.36 (1H, t, <i>J</i> = 7.4 Hz), 6.64 (2H, d, <i>J</i> = 8.8 Hz), 5.64 (2H, bs), 4.02 (4H, t, <i>J</i> = 4.2 Hz), 3.81 (4H, t, <i>J</i> = 4.4 Hz).</div></div><div id="sec5_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> 5-(4-Morpholino-1-phenyl-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-6-yl)pyridin-2-amine (<b>6d</b>)</h3><div class="NLM_p last">Yield: 21 mg (0.056 μmol, 47%). LCMS: 100% pure, <i>t</i><sub>R</sub> = 1.94 min, <i>m</i>/<i>z</i> 374.2 ([M + H]<sup>+</sup>).</div></div><div id="sec5_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> <i>N</i>-[4-(4-Morpholin-4-yl-1-phenyl-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-6- yl)phenyl]acetamide (<b>6g</b>)</h3><div class="NLM_p last">Yield: 14 mg (0.033 μmol, 28%). LCMS: 96.5% pure, <i>t</i><sub>R</sub> = 2.41 min, <i>m</i>/<i>z</i> 415.2 ([M + H]<sup>+</sup>).</div></div><div id="sec5_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> <i>N</i>-Methyl-4-(4-morpholino-1-phenyl-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-6-yl)aniline (<b>6h</b>)</h3><div class="NLM_p last">By use of 4-(<i>tert</i>-butoxycarbonyl-<i>N</i>-methylamino)phenylboronic acid, pinacol ester in the Suzuki−Miyaura coupling, the crude, hot reaction mixture was filtered and the residue was rinsed with hot dimethoxyethane (0.5 mL). The Boc group was removed from the resulting crude product by addition of 2 mL of TFA to the filtrate and stirring at room temperature overnight. The crude product was concentrated and used without further purification in the next step (preparation of <b>7</b>).</div></div><div id="sec5_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> Methyl [4-(4-Morpholin-4-yl-1-phenyl-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-6- yl)phenyl]carbamate (<b>6i</b>)</h3><div class="NLM_p">Yield: 7 mg (0.016 μmol, 13%). LCMS: 99.1% pure, <i>t</i><sub>R</sub> = 2.51 min, <i>m</i>/<i>z</i> 431.2 ([M + H]<sup>+</sup>).</div><div class="NLM_p last">Additional compounds (<b>6a</b>,<b>b</b>,<b>e</b>,<b>f</b>) are summarized in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</div></div><div id="sec5_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> <i>N</i>-Methyl-<i>N</i>-[4-(4-morpholin-4-yl-1-phenyl-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-6-yl)phenyl]acetamide (<b>7</b>)</h3><div class="NLM_p last">Crude <i>N</i>-methyl-4-(4-morpholino-1-phenyl-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-6-yl)aniline (<b>6h</b>, 0.12 mmol) was treated with acetic anhydride (0.5 mL) for 2 h. The solvents were removed and the crude product was dissolved in DMSO, filtered, and purified by HPLC (TFA buffers) to give 21 mg (0.049 mmol, 41%) of the title compound. LCMS: 96% pure, <i>t</i><sub>R</sub> = 2.61 min, <i>m</i>/<i>z</i> 429.2 ([M + H]<sup>+</sup>).</div></div><div id="sec5_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> (1-Benzylpiperidin-4-yl)hydrazine Dihydrochloride (<b>10</b>)</h3><div class="NLM_p">Benzoic hydrazide (27 g) was dissolved in methanol (150 mL). 1-Benzylpiperidin-4-one (<b>8</b>, 37.8 g) was added and the solution heated at 30 °C for 1 h and 60 °C for a further 2 h. The solution was then cooled to 0 °C and sodium borohydride (6.8 g) added in portions. After 2 h, the solution was evaporated and the residue was partitioned between dichloromethane and water. The organic phase was then dried with anhydrous magnesium sulfate and evaporated, leaving an oil (102 g).</div><div class="NLM_p last">The oil was dissolved in water (80 mL) containing concentrated hydrochloric acid (140 mL) (any extra organic solvent released at this stage was separated). The aqueous solution was then refluxed overnight. After the mixture was cooled to 0 °C the precipitate of benzoic acid was filtered off. Water was evaporated, anhydrous ethanol was added, and the resulting precipitate was collected by filtration and dried in high vacuum. The title compound was obtained as a white solid (32.4 g). HRMS: <i>m</i>/<i>z</i> 206.164 82 ([M + H]<sup>+</sup>). Exptl − calcd = −0.36 mmu. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) indicated a mixture of diastereomeric salts: δ 11.10 (1H, bs), 7.63 (2H, m), 7.45 (3H, m), 4.27 (2H, m), 3.37−2.89 (5H, m), 2.16−1.72 (4H, m).</div></div><div id="sec5_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> 1-(1-Benzylpiperidin-4-yl)-4,6-dichloro-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidine (<b>11</b>)</h3><div class="NLM_p last">To a solution of 2,4,6-trichloropyrimidine-5-carbaldehyde (<b>3</b>, 10.0 g, 47.3 mmol) in ethanol at −78 °C was added (1-benzylpiperidin-4-yl)hydrazine dihydrochloride (13.2 g, 47.3 mmol). The mixture was stirred at −78 °C for 20 min. Triethylamine (22 mL) was added slowly over 20 min. The mixture was stirred for an additional 20 min at −78 °C, followed by stirring at 0 °C for 1 h. The mixture was concentrated in vacuo without heating. The mixture was diluted with ethyl acetate (500 mL) and saturated NaHCO<sub>3</sub> (400 mL) and filtered over Celite. The layers were shaken in a separatory funnel, and the organic phase was dried (MgSO<sub>4</sub>), filtered over a silica gel plug, and rinsed with ethyl acetate. The filtrate was concentrated to give 12.5 g of a red foam (34.4 mmol, 73%). MS: <i>m</i>/<i>z</i> 362.1/364.1 ([M + H]<sup>+</sup>). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 10.77 (1H, bs), 8.61 (1H, s), 7.62 (2H, m), 7.48 (3H, m), 5.07 (1H, m), 4.33 (2H, m), 3.49 (2H, d, <i>J</i> = 12 Hz), 3.27 (2H, d, <i>J</i> = 12 Hz), 2.53 (2H, m), 2.17 (2H, d, <i>J</i> = 12 Hz).</div></div><div id="sec5_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> 4-(1-(1-Benzylpiperidin-4-yl)-6-chloro-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-4-yl)morpholine (<b>12</b>)</h3><div class="NLM_p last">1-(1-Benzylpiperidin-4-yl)-4,6-dichloro-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidine (<b>11</b>) (4.5 g, 11.3 mmol) was dissolved in ethanol (35 mL) and triethylamine (1.7 mL) and stirred at room temperature for 1 h. The mixture was diluted with water (200 mL) and 10 N sodium hydroxide (2.0 mL) and extracted three times with ethyl acetate. The organics were combined and dried over sodium sulfate, filtered through Magnesol, and concentrated to an oil that crystallized upon standing. The white crystals were collected by filtration, using a minimum amount of hexanes, to give 4.1 g of (<b>12</b>) (89%). MS: <i>m</i>/<i>z</i> 413.3/415.3 ([M + H]<sup>+</sup>). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 8.34 (1H, s), 7.34 (4H, d, <i>J</i> = 4.0 Hz), 7.26 (1H, m), 4.57 (1H, m), 3.88 (4H, t, <i>J</i> = 5.0 Hz), 3.73 (4H, t, <i>J</i> = 4.9 Hz), 3.53 (2H, s), 2.93 (2H, m), 2.50 (4H, m), 1.82 (2H, m).</div></div><div id="sec5_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> General Procedure for Suzuki−Miyaura Coupling of 4-(1-(1-Benzylpiperidin-4-yl)-6-chloro-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-4-yl)morpholine (<b>12</b>)</h3><div class="NLM_p">4-(1-(1-Benzylpiperidin-4-yl)-6-chloro-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-4-yl)morpholine hydrochloride (<b>12</b>, 50 mg, 0.12 mmol) was placed in a 0.5−2 mL microwave vial. Then 0.2 mmol of a boronic acid or boronate pinacol ester was added, followed by addition of 2 mL of dimethoxyethane and 0.25 mL of a 2 M aqueous solution of sodium carbonate. Tetrakis(triphenylphosphine)palladium(0) (14 mg, 0.1 equiv) was added, and the mixture was heated for 10−20 min at 185 °C under microwave irradiation. The mixture was concentrated, dissolved in DMSO, filtered, and purified by reversed phase HPLC (TFA buffers) to give the target compounds as TFA salts unless otherwise noted.</div><div class="NLM_p last">The following compounds were prepared according to the general procedure.</div></div><div id="sec5_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> 4-[1-(1-Benzylpiperidin-4-yl)-4-morpholin-4-yl-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-6- yl]aniline (<b>13a</b>)</h3><div class="NLM_p last">Yield: 53 mg (90 μmol, 75%). LCMS: 100% pure, <i>t</i><sub>R</sub> = 1.90 min, <i>m</i>/<i>z</i> 470.3 ([M + H]<sup>+</sup>). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 8.21 (1H, s), 8.14 (2H, d, <i>J</i> = 8.7 Hz), 7.35 (4H, m), 7.27 (1H, m), 6.61 (2H, d, <i>J</i> = 8.4 hz), 6.55 (2H, bs), 4.75 (1H, m), 3.94 (4H, m), 3.77 (4H, t, <i>J</i> = 4.4 Hz), 3.56 (2H, s), 2.96 (2H, m), 2.18 (4H, m), 1.86 (2H, m).</div></div><div id="sec5_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> {4-[1-(1-Benzylpiperidin-4-yl)-4-morpholin-4-yl-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-6-yl]phenyl}acetic Acid (<b>13b</b>)</h3><div class="NLM_p last">4-(1-(1-Benzylpiperidin-4-yl)-6-chloro-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-4-yl)morpholine hydrochloride (<b>12</b>, 400 mg, 0.97 mmol) was placed in a 20 mL microwave vial. Phenylacetic acid−4-boronic acid (380 mg, 1.45 mmol) was added, followed by addition of 5 mL of dimethoxyethane and 1.5 mL of a 2 M aqueous solution of sodium carbonate. Tetrakis(triphenylphosphine)palladium(0) (20 mg) was added, and the mixture was heated for 15 min at 175 °C under microwave irradiation. The mixture was neutralized by addition of 1 N HCl (3 mL) and was extracted with EtOAc. The organic phase was dried (MgSO<sub>4</sub>). Trituration with Et<sub>2</sub>O yielded 150 mg of the title compound as a white powder. HRMS: <i>m</i>/<i>z</i> 513.258 91 ([M + H]<sup>+</sup>). Exptl − calcd = −1.96 mmu.</div></div><div id="sec5_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> Methyl {4-[1-(1-Benzylpiperidin-4-yl)-4-morpholin-4-yl-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-6-yl]phenyl}carbamate (<b>13c</b>)</h3><div class="NLM_p last">Yield: 21 mg (33 μmol, 28%). LCMS: 100% pure, <i>t</i><sub>R</sub> = 2.05 min, <i>m</i>/<i>z</i> 528.3 ([M + H]<sup>+</sup>). HRMS: <i>m</i>/<i>z</i> 528.269 89 ([M + H]<sup>+</sup>). Exptl − calcd = −1.88 mmu. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 9.88 (1H, s), 8.36 (2H, d, <i>J</i> = 9.2 Hz), 8.28 (1H, s), 7.58 (2H, d, <i>J</i> = 8.8 Hz), 7.35 (4H, m), 7.26 (1H, m), 4.79 (1H, m), 3.99 (4H, bs), 3.78 (4H, t, <i>J</i> = 4.4 Hz), 3.69 (3H, s), 3.56 (2H, s), 2.96 (2H, m), 2.20 (4H, m), 1.88 (2H, m).</div></div><div id="sec5_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> General Procedure for Formation of Ureas <b>16</b></h3><div class="NLM_p last">To commercially available 4-isocyanatophenylboronic acid, pinacol ester (49 mg, 0.2 mmol) in a microwave vial was added a solution of amine (see individual compounds for details), and the mixture was stirred for 0.5−16 h. To the resulting ureidophenylboronic acid, pinacol ester <b>15</b> were added 4-(1-(1-benzylpiperidin-4-yl)-6-chloro-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-4-yl)morpholine hydrochloride (<b>12</b>, 50 mg, 0.12 mmol) and 0.25 mL of a 2 M aqueous solution of sodium carbonate. Tetrakis(triphenylphosphine)palladium(0) (14 mg, 0.1 equiv) was added, and the mixture was heated for 6−10 min at 185 °C under microwave irradiation. The mixture was concentrated, dissolved in DMSO, filtered, and purified by reversed phase HPLC (TFA buffers) to give the target compound as the trifluoroacetate salt.</div></div><div id="sec5_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> <i>N</i>-{4-[1-(1-Benzylpiperidin-4-yl)-4-morpholin-4-yl-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-6-yl]phenyl}-<i>N</i>′-methylurea (<b>16a</b>)</h3><div class="NLM_p">An amount of 1 mL of a 2 N solution of methylamine in THF was used. Excess amine and solvent were removed under a stream of nitrogen, and the ureidophenylboronic acid, pinacol ester was dissolved in dimethoxyethane (2 mL) prior to Suzuki−Miyaura coupling. Yield: 15 mg (23 μmol, 20%). LCMS: 100% pure, <i>t</i><sub>R</sub> = 1.90 min, <i>m</i>/<i>z</i> 527.3 ([M + H]<sup>+</sup>).</div><div class="NLM_p last">Additional compounds (<b>16b</b>−<b>n</b>) are summarized in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</div></div><div id="sec5_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> 1-{4-[1-(1-Benzylpiperidin-4-yl)-4-morpholin-4-yl-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-6- yl]phenyl}-3-cyclopropylurea (<b>17a</b>)</h3><div class="NLM_p last">To a solution of aniline <b>13a</b> (50 mg, 0.11 mmol) in dichloromethane was added triethylamine (26 μL) and triphosgene (18 mg, 0.06 mmol). The mixture was stirred for 15 min at room temperature and was then added to a solution of cyclopropylamine (35 μL, 0.5 mmol) in dichloromethane (1 mL). After the mixture was stirred at room temperature for 25 min, the solvents were evaporated and the crude product was dissolved in DMSO, filtered, and purified by HPLC (TFA buffers) to give the title compound as the trifluoroacetate salt. Yield: 25 mg, 0.037 mmol, 34%. LCMS: 96% pure, <i>t</i><sub>R</sub> = 2.00 min, <i>m</i>/<i>z</i> 553.3 ([M + H]<sup>+</sup>).</div></div><div id="sec5_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> 1-{4-[1-(1-Benzylpiperidin-4-yl)-4-morpholin-4-yl-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-6- yl]phenyl}-3-(1<i>H</i>-imidazol-2-yl)urea (<b>17b</b>)</h3><div class="NLM_p last">To a solution of aniline <b>13a</b> (50 mg, 0.11 mmol) in dichloromethane (1 mL) containing Huenig’s base (75 μL) was added triphosgene (15 mg, 0.05 mmol). The mixture was stirred for 5 min at room temperature and was then added to a suspension of 2-aminoimidazole sulfate (106 mg, 0.4 mmol) in dichloromethane (1 mL) containing Huenig’s base (75 μL). The mixture was stirred at room temperature overnight, the solvents were evaporated, and the crude product was dissolved in DMSO, filtered, and purified by HPLC (TFA buffers) to give the title compound as the trifluoroacetate salt. Yield: 5 mg, 0.007 mmol, 7%. LCMS: 100% pure, <i>t</i><sub>R</sub> = 1.77 min, <i>m</i>/<i>z</i> 579.3 ([M + H]<sup>+</sup>).</div></div><div id="sec5_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> 2-{4-[1-(1-Benzylpiperidin-4-yl)-4-morpholin-4-yl-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-6-yl]phenyl}-<i>N</i>-methylacetamide (<b>18</b>)</h3><div class="NLM_p last">{4-[1-(1-Benzylpiperidin-4-yl)-4-morpholin-4-yl-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-6- yl]phenyl}acetic acid (<b>13b</b>, 50 mg, 0.098 mmol) was dissolved in DMF (2 mL). To the solution was added EDC (25 mg, 0.13 mmol) and HOBT (16 mg, 0.12 mmol), and the mixture was stirred for 2 h. A solution of methylamine (0.25 mL, 2 M in THF) was added, and the mixture was stirred for an additional 18 h. The mixture was purified by HPLC (TFA buffers) to give the title compound as the trifluoroacetate salt. Yield: 22 mg (34 μmol, 35%). LCMS: 100% pure, <i>t</i><sub>R</sub> = 1.86 min, <i>m</i>/<i>z</i> 526.3 ([M + H]<sup>+</sup>).</div></div><div id="sec5_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> 4-(6-Chloro-4-morpholin-4-ylpyrazolo[3,4-<i>d</i>]pyrimidin-1-yl)piperidine-1-carboxylic Acid Methyl Ester (<b>23a</b>)</h3><div class="NLM_p last">1-(1-Benzylpiperidin-4-yl)-6-chloro-4-morpholin-4-yl-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidine (<b>12</b>, 499 mg, 1.2 mmol) was dissolved in 0.4 mL (5.2 mmol) of methyl chloroformate and 1 mL of DCM. After 3 h at room temperature the solvents were removed under reduced pressure to give the title compound. HRMS: <i>m</i>/<i>z</i> 413.184 45 ([M + H]<sup>+</sup>). Exptl − calcd = 0.89 mmu. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 8.35 (1H, s), 4.83 (1H, m), 4.08 (2H, m), 3.89 (4H, t, <i>J</i> = 5.0 Hz), 3.74 (1H, t, <i>J</i> = 4.8 Hz), 3.72 (3H, s), 3.07 (2H, bs), 2.50 (4H, m).</div></div><div id="sec5_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> 6-Chloro-4-morpholin-4-yl-1-piperidin-4-yl-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidine Hydrochloride (<b>19</b>)</h3><div class="NLM_p last">The HCl salt of 1-(1-benzylpiperidin-4-yl)-6-chloro-4-morpholin-4-yl-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidine (100 mg, 0.24 mmol) was converted into the free base by extraction with an aqueous 1 N NaOH solution. Traces of moisture were removed by coevaporation with 1,2-dichloroethane (DCE). The residue was dissolved in DCE (2 mL), and 1.9 mmol (0.2 mL) of α-chloroethyl chloroformate (ACE-Cl) was added along with a small amount of K<sub>2</sub>CO<sub>3</sub>, and the mixture was stirred for 5.5 h at room temperature. The reaction was quenched by addition of MeOH, and the mixture was filtered and concentrated to dryness. The mixture was dissolved in MeOH and briefly heated to reflux. The title compound was obtained in quantitative yield by evaporation of the methanol. HRMS: <i>m</i>/<i>z</i> 323.140 09 ([M + H]<sup>+</sup>). Exptl − calcd = 1.92 mmu.</div></div><div id="sec5_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> 6-Chloro-4-morpholin-4-yl-1-[1-(pyridin-3-ylmethyl)piperidin-4-yl]-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidine (<b>20</b>)</h3><div class="NLM_p last">6-Chloro-4-morpholin-4-yl-1-piperidin-4-yl-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidine hydrochloride (<b>19</b>, 1.2 mmol) was suspended in THF (10 mL). 3-Pyridinecarboxaldehyde (0.19 mL, 2.0 mmol) was added, followed by addition of acetic acid (85 μL) and NaHB(OAc)<sub>3</sub> (0.47 g, 2.0 mmol). The mixture was stirred at room temperature for 30 min, diluted with dichloromethane, and washed with saturated NaHCO<sub>3</sub> and a solution of NaOH (1 N). The organic phase was dried (MgSO<sub>4</sub>) and concentrated. The crude product was applied to a silica gel column and eluted with a gradient of methanol (0−8%) in ethyl acetate containing 1% triethylamine. The title compound was obtained as 249 mg of an off-white powder (0.6 mmol, 50%). HRMS: <i>m</i>/<i>z</i> 414.183 99 ([M + H]<sup>+</sup>). Exptl − calcd = 0.38 mmu. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 8.57 (1H, d, <i>J</i> = 1.2 Hz), 8.51 (1H, dd, <i>J</i> = 1.8 Hz, 5.0 Hz), 7.90 (1H, s), 7.72 (1H, dt, <i>J</i> = 1.8 Hz, 7.4 Hz), 7.26 (1H, m), 4.75 (1H, m), 3.97 (4H, t, <i>J</i> = 4.4 Hz), 3.84 (4H, t, <i>J</i> = 4.8 Hz), 3.58 (2H, s), 2.99 (2H, d, <i>J</i> = 5.2 Hz), 2.28 (4H, m), 1.92 (2H, d, <i>J</i> = 10.8 Hz), 1.65 (1H, s).</div></div><div id="sec5_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> 4-(4-Morpholino-1-(1-(pyridin-3-ylmethyl)piperidin-4-yl)-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-6-yl)aniline (<b>21</b>)</h3><div class="NLM_p last">6-Chloro-4-morpholin-4-yl-1-[1-(pyridin-3-ylmethyl)piperidin-4-yl]-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidine (<b>20</b>, 2.6 g, 6.4 mmol) and 4-aminophenylboronic acid, pinacol ester (1.53 g, 7.0 mmol) were dissolved in dimethoxyethane (100 mL). A 2 M aqueous solution of Na<sub>2</sub>CO<sub>3</sub> (13 mL) was added, and the flask was flushed with nitrogen. Tetrakis(triphenylphosphine)palladium(0) (512 mg) was added, and the mixture was heated under reflux for 20 h. The mixture diluted with ethyl acetate and water and filtered over Celite. The organic phase was washed with saturated NaHCO<sub>3</sub> (basified with NaOH to pH 11), dried (MgSO<sub>4</sub>), and concentrated. The crude product was applied to a silica gel column and eluted with a gradient of methanol (0−20%) in ethyl acetate containing 1% triethylamine to give the title compound as 2.43 g (5.16 mmol, 81%) of a yellow solid, which was used in the next step without further purification.</div></div><div id="sec5_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> Methyl (4-{4-Morpholin-4-yl-1-[1-(pyridin-3-ylmethyl)piperidin-4-yl]-1<i>H</i>- pyrazolo[3,4-<i>d</i>]pyrimidin-6-yl}phenyl)carbamate Hydrochloride (<b>22a</b>)</h3><div class="NLM_p">To 4-(4-morpholino-1-(1-(pyridin-3-ylmethyl)piperidin-4-yl)-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-6-yl)aniline hydrochloride (<b>21</b>, 1100 mg, 2.33 mmol) was added dichloromethane (50 mL) and triethylamine (1.43 mL) to give a yellow solution. Triphosgene (330 mg) was added, and the mixture was stirred at ambient temperature for 5 min. Methanol was added (50 mL), and the mixture was concentrated to ∼50 mL. An additional amount of methanol (50 mL) was added, and the mixture was again concentrated to ∼50 mL. This procedure was repeated one more time. The solvents were concentrated, and the mixture was dissolved in dichloromethane and washed with a solution of 0.1 N NaOH (2×). The organic phase was dried (MgSO<sub>4</sub>), filtered over Magnesol, and rinsed with dichloromethane and ethyl actetate. The organic phase was concentrated and triturated from diethyl ether to give 908 mg (1.7 mmol, 74%) of an off-white powder. An additional batch of product was obtained after concentration of the mother liquor after conversion into the free base (washed with 0.1 N NaOH) followed by column chromatography to give 260 mg of an off-white powder. The combined crops of free base product were dissolved in dichloromethane, 1.3 mL of a 4 N solution of HCl in dioxane was added, and the resulting solids were collected to give 1.081 mg (1.91 mmol, 82%) of the title compound. LCMS: 100% pure, <i>t</i><sub>R</sub> = 1.91 min, <i>m</i>/<i>z</i> 529.3 ([M + H]<sup>+</sup>). HRMS: <i>m</i>/<i>z</i> 529.267 93 ([M + H]<sup>+</sup>). Exptl − calcd= 0.29 mmu. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 11.47 (1H, bs), 9.89 (1H, s), 9.06 (1H, s), 8.88 (1H, d, <i>J</i> = 4.8 Hz), 8.54 (1H, d, <i>J</i> = 8.0 Hz), 8.40 (2H, d, <i>J</i> = 8.8 Hz), 8.32 (1H, s), 7.89 (1H, q, <i>J</i> = 5.2 HZ), 7.59 (2H, d, <i>J</i> = 8.8hz), 5.08 (m, 1H), 4.53 (2H, s), 4.00 (4H, bs), 3.78 (4H, t, <i>J</i> = 4.6 Hz), 3.69 (3H, s), 3.57 (2H, d, <i>J</i> = 12 Hz), 3.34 (2H, m), 2.60 (2H, m), 2.16 (2H, d, <i>J</i> = 12 Hz).</div><div class="NLM_p last">Additional compounds (<b>22b</b>−<b>d</b>) are summarized in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</div></div><div id="sec5_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> Isopropyl 4-(6-Chloro-4-morpholin-4-yl-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-1-yl)piperidine-1-carboxylate (<b>23b</b>)</h3><div class="NLM_p last">To 6-chloro-4-morpholin-4-yl-1-piperidin-4-yl-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidine dihydrochloride (<b>19</b>, 1 g, 2.5 mmol) in dichloromethane (20 mL) was added triethylamine (1 mL) and a 1.0 N solution of isopropyl chloroformate in toluene (3 mL). The mixture was stirred for 3 h at room temperature, diluted with dichloromethane, and washed with saturated NaHCO<sub>3</sub>. The organic phase was dried (MgSO<sub>4</sub>) and concentrated to give the title compound as 1.01 g (2.5 mmol, 99%) of an off-white solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 8.35 (1H, s), 4.81 (2H, m), 4.09 (2H, m), 3.89 (4H, t, <i>J</i> = 4.8 Hz), 3.73 (4H, t, <i>J</i> = 4.8 Hz), 3.04 (2H, bs), 1.90 (4H, m).</div></div><div id="sec5_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> <i>tert</i>-Butyl 4-(6-Chloro-4-morpholin-4-yl-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-1-yl)piperidine-1-carboxylate (<b>23c</b>)</h3><div class="NLM_p last">6-Chloro-4-morpholin-4-yl-1-piperidin-4-yl-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidine (<b>19</b>) (0.8 g, 2.48 mmol) was dissolved in dichloromethane (10.0 mL) with excess triethylamine. Di-<i>tert</i>-butyl dicarbonate (0.65 g, 2.97 mmol) was added, and the mixture was stirred at room temperature for 1 h. The mixture was washed twice with water, and the organic phase was dried over sodium sulfate, filtered through Magnesol, and concentrated to an oil. Trituration with ether/hexanes gave a white solid, which was collected by filtration using a minimum amount of ether/hexanes to give 0.93 g (89%) of the title compound. HRMS: <i>m</i>/<i>z</i> 423.191 72 ([M + H]<sup>+</sup>). Exptl − calcd = 1.12 mmu. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 8.35 (1H, s), 4.80 (1H, m), 4.05 (2H, d, <i>J</i> = 9.6 Hz), 3.89 (4H, t, <i>J</i> = 4.8 Hz), 3.74 (4H, t, <i>J</i> = 4.8 Hz), 2.99 (2H, bs), 1.88 (4H, m), 1.425 (9H, s).</div></div><div id="sec5_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> Methyl 4-[6-(4-Aminophenyl)-4-morpholin-4-yl-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-1-yl]piperidine-1-carboxylate (<b>24a</b>)</h3><div class="NLM_p last">To a solution of methyl 4-(6-chloro-4-morpholin-4-yl-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-1- yl)piperidine-1-carboxylate (<b>23a</b>, 2.3 g, 6.0 mmol) in dimethoxyethane (26 mL) was added a 2 M aqueous solution of Na<sub>2</sub>CO<sub>3</sub> (2.6 mL) and 4-aminophenylboronic acid, pinacol ester (1.67 g, 7.6 mmol). Tetrakis(triphenylphosphine)palladium(0) (690 mg) was added, and the mixture was heated under reflux for 16 h. The mixture was diluted with ethyl acetate and water, and the organic phase was washed with water, dried (MgSO<sub>4</sub>), filtered though Magnesol, and concentrated. The resulting oil was triturated with DCM and ether to give a yellow solid. The solid was collected by filtration using a minimum amount of diethyl ether to give the title compound in a yield of 1.9 g (73%). LCMS: 98% pure, <i>t</i><sub>R</sub> = 2.09 min, <i>m</i>/<i>z</i> 438.2 ([M + H]<sup>+</sup>). HRMS: <i>m</i>/<i>z</i> 438.2255 ([M + H]<sup>+</sup>). For [M + H]<sup>+</sup> mass error = 0.7 mDa or 1.58 ppm. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 8.21 (1H, s), 8.14 (2H, d, <i>J</i> = 8.4 Hz), 6.61 (2H, d, <i>J</i> = 8.4 Hz), 5.56 (2H, bs), 4.99 (1H, m), 4.11 (2H, m), 3.96 (4H, t, <i>J</i> = 4.6 Hz), 3.77 (4H, t, <i>J</i> = 4.8 Hz), 3.65 (3H, s), 3.10 (2H, bs), 2.01 (2H, dq, <i>J</i> = 4.4 Hz, <i>J</i> = 12.4 Hz), 1.92 (2H, m).</div></div><div id="sec5_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> Isopropyl 4-[6-(4-Aminophenyl)-4-morpholin-4-yl-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-1-yl]piperidine-1-carboxylate (<b>24b</b>)</h3><div class="NLM_p last">To a solution of isopropyl 4-(6-chloro-4-morpholin-4-yl-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-1- yl)piperidine-1-carboxylate (<b>23b</b>, 2.5 mmol) in dimethoxyethane (40 mL) was added a 2 M aqueous solution of Na<sub>2</sub>CO<sub>3</sub> (5 mL) and 4-aminophenylboronic acid, pinacol ester (613 mg, 2.8 mmol). Tetrakis(triphenylphosphine)palladium(0) (200 mg) was added, and the mixture was heated under reflux for 16 h. The mixture was diluted with ethyl acetate and water and filtered over Celite. The organic phase was washed with saturated NaHCO<sub>3</sub>, dried (MgSO<sub>4</sub>), and concentrated. The crude product was applied to a silica gel column and eluted with a gradient of ethyl acetate (20−80%) in hexanes to give the title compound as 632 mg (1.4 mmol, 54%) of a yellow solid. NMR indicated that the product contained a small amount of triphenylphosphinoxide. An analytically pure sample was obtained by HPLC purification of 57 mg of crude product, using TFA buffers, to give 53 mg of pure sample, used for analysis of purity and biological activity. LCMS: 93% pure, <i>t</i><sub>R</sub> = 2.35 min, <i>m</i>/<i>z</i> 466.2 ([M + H]<sup>+</sup>).</div></div><div id="sec5_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> <i>tert</i>-Butyl 4-[6-(4-Aminophenyl)-4-morpholin-4-yl-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-1-yl]piperidine-1-carboxylate (<b>24c</b>)</h3><div class="NLM_p last">To a solution of <i>tert</i>-butyl 4-(6-chloro-4-morpholin-4-yl-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-1- yl)piperidine-1-carboxylate (<b>23c</b>, 0.9 g, 2.1 mmol) in dimethoxyethane (8.5 mL) was added a 2 M aqueous solution of Na<sub>2</sub>CO<sub>3</sub> (2.0 mL) and 4-aminophenylboronic acid, pinacol ester (0.7 g, 3.2 mmol). Tetrakis(triphenylphosphine)palladium(0) (100 mg) was added, and the mixture was heated under reflux for 16 h. The mixture was diluted with ethyl acetate and water, and the organic phase was washed with water, dried (MgSO<sub>4</sub>), filtered though Magnesol, and concentrated. The resulting oil was triturated with ether and hexanes to give a yellow solid. The solid was collected by filtration using a minimum amount of diethyl ether to give the title compound in a yield of 0.85 g (85%). HRMS: <i>m</i>/<i>z</i> 480.273 25 ([M + H]<sup>+</sup>). Exptl − calcd = 1.48 mmu. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 8.21 (1H, s), 8.14 (2H, d, <i>J</i> = 8.8 Hz), 6.60 (2H, d, <i>J</i> = 8.4 Hz), 5.57 (2H, bs), 4.94 (1H, m), 4.09 (2H, m), 3.96 (4H, m), 3.77 (4H, t, <i>J</i> = 4.4 Hz), 3.02 (2H, bs), 2.02 (2H, m), 1.88 (2H, m).</div></div><div id="sec5_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> General Procedure for Formation of Ureidophenyl Compounds (<b>25</b>−<b>27</b>)</h3><div class="NLM_p">The 4-[6-(4-aminophenyl)-4-morpholin-4-yl-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-1- yl]piperidine-1-carboxylate <b>24a</b>−<b>c</b> (0.12 mmol) was dissolved in dichloromethane (1 mL), and triethylamine (65 μL) was added. The resulting solution was added dropwise to a solution of triphosgene (15 mg) in dichloromethane (1 mL), and the mixture was stirred at ambient temperature for 5 min. The mixture was then added to a solution of amine (see individual compounds for details), and the mixture was stirred for 2−16 h. The solvents were concentrated, and the crude product was purified by HPLC (TFA buffers).</div><div class="NLM_p last">The following compounds were prepared according to the general procedure.</div></div><div id="sec5_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> Methyl 4-(6-(4-(3-Methylureido)phenyl)-4-morpholino-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-1-yl)piperidine-1-carboxylate (<b>25a</b>)</h3><div class="NLM_p last">By use of the general conditions described above, methyl 4-(6-(4-aminophenyl)-4-morpholino-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-1-yl)piperidine-1-carboxylate (<b>24a</b>) was treated with methylamine to provide <b>25a</b>. Yield: 0.110 g, 53%, white solid. HPLC: 98% pure, <i>t</i><sub>R</sub> = 11.3 min. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 8.78 (1H, s), 8.31 (2H, d, <i>J</i> = 8.8 Hz), 8.27 (1H, s), 7.51 (2H, d, <i>J</i> = 8.8 Hz), 6.08 (1H, m), 5.02 (1H, m), 4.11 (2H, m), 3.99 (4H, m), 3.78 (4H, m), 3.65 (3H, s), 3.12 (2H, m), 2.66 (3H, d, <i>J</i> = 4.4 Hz), 2.01 (2H, m), 1.93 (2H, m). HRMS: <i>m</i>/<i>z</i> 495.244 92 ([M + H]<sup>+</sup> observed); <i>m</i>/<i>z</i> 495.246 28 ([M + H]<sup>+</sup> calculated).</div></div><div id="sec5_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> <i>tert</i>-Butyl 4-(6-(4-(3-Methylureido)phenyl)-4-morpholino-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-1-yl)piperidine-1-carboxylate (<b>27a</b>)</h3><div class="NLM_p"><b>27a</b> was prepared according to the general procedure, using 3.2 g of <i>tert</i>-butyl 4-[6-(4-aminophenyl)-4-morpholin-4-yl-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-1-yl]piperidine-1-carboxylate (<b>24c</b>), 1.0 g of triphosgene, and excess methylamine in THF (2 N). Yield: 3.2 g (84%). HRMS: <i>m</i>/<i>z</i> 537.293 92 ([M + H]<sup>+</sup>). Exptl − calcd = 0.69 mmu. HPLC: 99% pure, <i>t</i><sub>R</sub> = 14.1 min. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 8.77 (1H, s), 8.30 (2H, d, <i>J</i> = 8.8 Hz), 8.26 (1H, s), 7.50 (2H, d, <i>J</i> = 8.8 Hz), 6.06 (1H, dd, <i>J</i> = 4.4 Hz, <i>J</i> = 5.0 Hz), 4.97 (1H, m), 4.10 (2H, m), 3.98 (4H, m), 3.78 (4H, t, <i>J</i> = 5.2 Hz), 3.03 (2H, m), 2.66 (3H, d, <i>J</i> = 4.4 Hz), 2.04 (2H, dq, <i>J</i> = 3.6 Hz, <i>J</i> = 11.6 Hz), 1.90 (2H, d, <i>J</i> = 9.2 Hz), 1.45 (9H, s).</div><div class="NLM_p last">Additional compounds (<b>25b</b>−<b>f</b>, <b>26b</b>,<b>c</b>, <b>27b</b>,<b>c</b>) are summarized in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</div></div><div id="sec5_42" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> 1-Methyl-3-(4-(4-morpholino-1-(piperidin-4-yl)-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-6-yl)phenyl)urea (<b>28</b>)</h3><div class="NLM_p last">To a solution of <i>tert</i>-butyl 4-(6-(4-(3-methylureido)phenyl)-4-morpholino-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-1-yl)piperidine-1-carboxylate (<b>27a</b>) (3.2 g 5.97 mmol) in dichloromethane (40 mL) was added trifluoroacetic acid (excess), and the mixture was stirred at room temperature for 2 h and then concentrated. The residue was treated with 2 N HCl and extracted 2 times with dichloromethane. The aqueous phase was basified with sodium hydroxide and extracted 4 times with ethyl acetate. The combined organics were dried with sodium sulfate, filtered, and concentrated to a white solid. The solid was dissolved in acetonitrile, and a solution of HCl in MeOH was added to precipitate a white solid. The solid was collected by filtration and washed with acetonitrile to afford 2.6 g of the title compound (94%). LCMS: 99% pure, <i>t</i><sub>R</sub> = 1.69 min, <i>m</i>/<i>z</i> 437.2 ([M + H]<sup>+</sup>). HRMS: <i>m</i>/<i>z</i> 437.240 38 ([M + H]<sup>+</sup>). Exptl − calcd = −0.42 mmu. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 8.82 (1H, s), 8.34 (2H, d, <i>J</i> = 8.8 Hz), 8.31 (1H, s), 7.52 (2H, d, <i>J</i> = 8.8 Hz), 6.11 (1H, d, <i>J</i> = 4.8 Hz), 5.12 (1H, m), 4.00 (4H, m), 3.78 (4H, t, <i>J</i> = 4.8 Hz), 3.47 (2H, d, <i>J</i> = 12.8 Hz), 3.24 (2H, q, <i>J</i> = 11.2 Hz), 2.66 (3H, d, <i>J</i> = 4.4 Hz), 2.26 (2H, q, <i>J</i> = 13.2 Hz), 2.12 (2H, d, <i>J</i> = 11.6 Hz).</div></div><div id="sec5_43" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> Methyl 4-(6-(4-(3-Methylureido)phenyl)-4-morpholino-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-1-yl)piperidine-1-carboxylate (<b>25a</b>)</h3><div class="NLM_p last">To a solution of 1-methyl-3-[4-(4-morpholin-4-yl-1-piperidin-4-yl-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-6-yl)phenyl]urea (<b>28</b>, 200 mg, 0.42 mmol) in dichloromethane (4.0 mL) and triethylamine (excess) was added methyl chloroformate (0.040 mL), and the mixture was stirred at room temperature for 1 h. The mixture was washed 3 times with water, and the organics were combined and dried over sodium sulfate. The mixture was filtered over Magnesol and eluted with ethyl acetate. The filtrate was concentrated to a crude solid. The solid was recrystallized 2 times from acetonitrile to give 64 mg (31%) of the title compound. The thus obtained compound was identical to <b>25a</b> obtained according to Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>. LCMS: 92% pure, <i>t</i><sub>R</sub> = 2.18 min, <i>m</i>/<i>z</i> 495.2 ([M + H]<sup>+</sup>). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 8.78 (1H, s), 8.31 (2H, d, <i>J</i> = 8.8 Hz), 8.27 (1H, s), 7.51 (2H, d, <i>J</i> = 8.8 Hz), 6.08 (1H, m), 5.02 (1H, m), 4.11 (2H, m), 3.99 (4H, m), 3.78 (4H, m), 3.65 (3H, s), 3.12 (2H, m), 2.66 (3H, d, <i>J</i> = 4.4 Hz), 2.01 (2H, m), 1.93 (2H, m).</div></div><div id="sec5_44" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> Isopropyl 4-(6-(4-(3-Methylureido)phenyl)-4-morpholino-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-1-yl)piperidine-1-carboxylate (<b>26a</b>)</h3><div class="NLM_p last">To a solution of 1-methyl-3-[4-(4-morpholin-4-yl-1-piperidin-4-yl-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-6- yl)phenyl]urea (<b>28</b>, 40 mg, 0.08 mmol) in dichloromethane (1.0 mL) and triethylamine (excess) was added isopropyl chloroformate (excess), and the mixture was stirred at room temperature for 1 h. The crude product was purified by HPLC using TFA buffers to give 13.8 mg (31%). LCMS: 100% pure, <i>t</i><sub>R</sub> = 2.34 min, <i>m</i>/<i>z</i> 523.3 ([M + H]<sup>+</sup>).</div></div><div id="sec5_45" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> Methyl 4-(4-Morpholino-6-(4-(3-(4-(2-(pyrrolidin-1-yl)ethyl)phenyl)ureido)phenyl)-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-1-yl)piperidine-1-carboxylate (<b>25g</b>)</h3><div class="NLM_p">A solution of methyl 4-(6-(4-(3-(4-(2-hydroxyethyl)phenyl)ureido)phenyl)-4-morpholino-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-1-yl)piperidine-1-carboxylate (<b>25f</b>) (0.060 g, 0.099 mmol) in methylene chloride (1 mL) was prepared. Triethylamine (0.041 mL, 0.23 mmol) was added, followed by <i>p</i>-toluenesulfonyl chloride (0.019 g, 0.099 mmol), and the solution was stirred at room temperature for 3 h. The solution was then diluted with methylene chloride, washed with saturated sodium bicarbonate, brine, dried (Na<sub>2</sub>SO<sub>4</sub>), decanted, and concentrated under reduced pressure. The crude tosylate (0.049 mmol) was dissolved in methylene chloride (1 mL), and pyrrolidine (0.038 mL, 0.450 mmol) was added. The solution was stirred at room temperature for 14 h. Solvent was removed under reduced pressure. Purification by HPLC provided <b>25g</b>. Yield: 0.010 g, 34%, white solid. LCMS: 100% pure, <i>t</i><sub>R</sub> = 2.05 min, <i>m</i>/<i>z</i> 654.3 ([M + H]<sup>+</sup>).</div><div class="NLM_p last">Additional compounds (<b>25h</b>,<b>i</b>) are summarized in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i59"><a href="/doi/suppl/10.1021/jm9013828">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_83356" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_83356" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Experimental details for compounds <b>6a</b>,<b>b</b>,<b>e</b>,<b>f</b>, <b>16b</b>−<b>n</b>, <b>22b</b>−<b>d</b>, <b>25b</b>−<b>f</b>,<b>h</b>,<b>i</b>, <b>26b</b>,<b>c</b>, <b>27b</b>,<b>c</b>; synthesis and SAR of additional analogues; activity against a broad panel of tumor cell lines for <b>13o</b>, <b>18a</b>, <b>24a</b>, and <b>24c</b>; kinase panel selectivity data for <b>24a</b>, <b>24c</b>, and <b>29a</b>. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm9013828/suppl_file/jm9013828_si_001.pdf">jm9013828_si_001.pdf (161.03 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm9013828" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_14174" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_14174" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jeroen C. Verheijen</span> - <span class="hlFld-Affiliation affiliation">Chemical Sciences</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#f98f9c8b919c9093b98e809c8d91d79a9694"><span class="__cf_email__" data-cfemail="9ceaf9eef4f9f5f6dcebe5f9e8f4b2fff3f1">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David J. Richard</span> - <span class="hlFld-Affiliation affiliation">Chemical Sciences</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kevin Curran</span> - <span class="hlFld-Affiliation affiliation">Chemical Sciences</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joshua Kaplan</span> - <span class="hlFld-Affiliation affiliation">Chemical Sciences</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mark Lefever</span> - <span class="hlFld-Affiliation affiliation">Chemical Sciences</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Pawel Nowak</span> - <span class="hlFld-Affiliation affiliation">Chemical Sciences</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David J. Malwitz</span> - <span class="hlFld-Affiliation affiliation">Chemical Sciences</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Natasja Brooijmans</span> - <span class="hlFld-Affiliation affiliation">Chemical Sciences</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lourdes Toral-Barza</span> - <span class="hlFld-Affiliation affiliation">Oncology Research</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wei-Guo Zhang</span> - <span class="hlFld-Affiliation affiliation">Oncology Research</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Judy Lucas</span> - <span class="hlFld-Affiliation affiliation">Oncology Research</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Irwin Hollander</span> - <span class="hlFld-Affiliation affiliation">Oncology Research</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Semiramis Ayral-Kaloustian</span> - <span class="hlFld-Affiliation affiliation">Chemical Sciences</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tarek S. Mansour</span> - <span class="hlFld-Affiliation affiliation">Chemical Sciences</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ker Yu</span> - <span class="hlFld-Affiliation affiliation">Oncology Research</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Arie Zask</span> - <span class="hlFld-Affiliation affiliation">Chemical Sciences</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i58">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_42456" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_42456" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors thank Dr. Joseph Marini and Angela Bretz for nude mouse microsome assays, Dr. Li Di and Susan Li for human microsome assays, Rob Mahoney and Kenny Kim for in vivo biomarker inhibition assays, Dr. Richard Harrison, Dr. Ann Aulabaugh, Jenny Togias, and Kenneth Roberts for kinase panel assays, and Dr. Frank Loganzo, Cheng-Chung Tsao, and William Hu for ATR assays.</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i60">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_56837" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_56837" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 27 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Guertin, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabatini, D. M.</span><span> </span><span class="NLM_article-title">Defining the role of mTOR in cancer</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">9</span><span class="NLM_x">–</span> <span class="NLM_lpage">22</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2007&pages=9-22&author=D.+A.+Guertinauthor=D.+M.+Sabatini&title=Defining+the+role+of+mTOR+in+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGuertin%26aufirst%3DD.%2BA.%26aulast%3DSabatini%26aufirst%3DD.%2BM.%26atitle%3DDefining%2520the%2520role%2520of%2520mTOR%2520in%2520cancer%26jtitle%3DCancer%2520Cell%26date%3D2007%26volume%3D12%26spage%3D9%26epage%3D22" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Chiang, G. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abraham, R. T.</span><span> </span><span class="NLM_article-title">Targeting the mTOR signaling network in cancer</span> <span class="citation_source-journal">Trends Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">433</span><span class="NLM_x">–</span> <span class="NLM_lpage">442</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=433-442&author=G.+G.+Chiangauthor=R.+T.+Abraham&title=Targeting+the+mTOR+signaling+network+in+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChiang%26aufirst%3DG.%2BG.%26aulast%3DAbraham%26aufirst%3DR.%2BT.%26atitle%3DTargeting%2520the%2520mTOR%2520signaling%2520network%2520in%2520cancer%26jtitle%3DTrends%2520Mol.%2520Med.%26date%3D2007%26volume%3D13%26spage%3D433%26epage%3D442" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Yuan, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cantley, L. C.</span><span> </span><span class="NLM_article-title">PI3K pathway alterations in cancer: variations on a theme</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">5497</span><span class="NLM_x">–</span> <span class="NLM_lpage">5510</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2008&pages=5497-5510&author=T.+L.+Yuanauthor=L.+C.+Cantley&title=PI3K+pathway+alterations+in+cancer%3A+variations+on+a+theme"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYuan%26aufirst%3DT.%2BL.%26aulast%3DCantley%26aufirst%3DL.%2BC.%26atitle%3DPI3K%2520pathway%2520alterations%2520in%2520cancer%253A%2520variations%2520on%2520a%2520theme%26jtitle%3DOncogene%26date%3D2008%26volume%3D27%26spage%3D5497%26epage%3D5510" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Verheijen, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zask, A.</span><span> </span><span class="NLM_article-title">Phosphatidylinositol 3-kinase (PI3K) inhibitors as anticancer drugs</span> <span class="citation_source-journal">Drugs Future</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">537</span><span class="NLM_x">–</span> <span class="NLM_lpage">547</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm9013828&amp;key=10.1358%2Fdof.2007.032.06.1107995" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm9013828&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpslOnurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2007&pages=537-547&author=J.+C.+Verheijenauthor=A.+Zask&title=Phosphatidylinositol+3-kinase+%28PI3K%29+inhibitors+as+anticancer+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphatidylinositol 3-kinase (PI3K) inhibitors as anticancer drugs</span></div><div class="casAuthors">Verheijen, Jeroen C.; Zask, Arie</div><div class="citationInfo"><span class="NLM_cas:title">Drugs of the Future</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">537-547</span>CODEN:
                <span class="NLM_cas:coden">DRFUD4</span>;
        ISSN:<span class="NLM_cas:issn">0377-8282</span>.
    
            (<span class="NLM_cas:orgname">Prous Science</span>)
        </div><div class="casAbstract">A review.  The phosphatidylinositol 3-kinases (PI3Ks) are members of a family of lipid kinases that regulate cellular metab. and growth by phosphorylation of the 3-position of phosphatidylinositol to generate phosphatidylinositol triphosphate (PIP3).  The PI3K pathway is one of the most frequently mutated in human cancer, leading to amplification of signaling, and as such is a promising target for small-mol. inhibition, with exciting therapeutic opportunities for the treatment of cancer.  The last several years have seen an explosive increase in publications and patents concerning inhibition of PI3K.  This paper summarizes recent developments in the discovery of PI3K inhibitors as anticancer drugs.  We describe representative examples of seven structurally diverse classes of PI3K inhibitors.  These compds. represent a large arsenal of potent enzyme inhibitors (single-digit nanomolar IC50 values) with a variety of isoform specificity profiles.  Currently, the first PI3K inhibitors are making their way into the clinic and we eagerly await data that will help address questions regarding the contribution of inhibition of various PI3K isoforms to tumor suppression and the assocd. side effect profiles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqASvfhKcFeRrVg90H21EOLACvtfcHk0liEbileM0-Lhg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpslOnurg%253D&md5=2b8c482282151eb7b611acef0216ed1c</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1358%2Fdof.2007.032.06.1107995&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1358%252Fdof.2007.032.06.1107995%26sid%3Dliteratum%253Aachs%26aulast%3DVerheijen%26aufirst%3DJ.%2BC.%26aulast%3DZask%26aufirst%3DA.%26atitle%3DPhosphatidylinositol%25203-kinase%2520%2528PI3K%2529%2520inhibitors%2520as%2520anticancer%2520drugs%26jtitle%3DDrugs%2520Future%26date%3D2007%26volume%3D32%26spage%3D537%26epage%3D547" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Verheijen, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zask, A.</span><span> </span><span class="NLM_article-title">mTOR Inhibitors in Oncology</span> <span class="citation_source-journal">Annu. Rep. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">189</span><span class="NLM_x">–</span> <span class="NLM_lpage">202</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2008&pages=189-202&author=J.+C.+Verheijenauthor=K.+Yuauthor=A.+Zask&title=mTOR+Inhibitors+in+Oncology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVerheijen%26aufirst%3DJ.%2BC.%26aulast%3DYu%26aufirst%3DK.%26aulast%3DZask%26aufirst%3DA.%26atitle%3DmTOR%2520Inhibitors%2520in%2520Oncology%26jtitle%3DAnnu.%2520Rep.%2520Med.%2520Chem.%26date%3D2008%26volume%3D43%26spage%3D189%26epage%3D202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Sarbassov, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ali, S. m.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guertin, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Latek, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erdjument-Bromage, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tempst, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabatini, D. M.</span><span> </span><span class="NLM_article-title">Rictor, a novel binding partnet of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton</span> <span class="citation_source-journal">Curr. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1296</span><span class="NLM_x">–</span> <span class="NLM_lpage">1302</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm9013828&amp;key=10.1016%2Fj.cub.2004.06.054" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm9013828&amp;key=15268862" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm9013828&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmtVamsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=1296-1302&author=D.+D.+Sarbassovauthor=S.+m.+Aliauthor=D.+H.+Kimauthor=D.+A.+Guertinauthor=R.+R.+Latekauthor=H.+Erdjument-Bromageauthor=P.+Tempstauthor=D.+M.+Sabatini&title=Rictor%2C+a+novel+binding+partnet+of+mTOR%2C+defines+a+rapamycin-insensitive+and+raptor-independent+pathway+that+regulates+the+cytoskeleton"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Rictor, a Novel Binding Partner of mTOR, Defines a Rapamycin-Insensitive and Raptor-Independent Pathway that Regulates the Cytoskeleton</span></div><div class="casAuthors">Sarbassov, Dos D.; Ali, Siraj M.; Kim, Do-Hyung; Guertin, David A.; Latek, Robert R.; Erdjument-Bromage, Hediye; Tempst, Paul; Sabatini, David M.</div><div class="citationInfo"><span class="NLM_cas:title">Current Biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1296-1302</span>CODEN:
                <span class="NLM_cas:coden">CUBLE2</span>;
        ISSN:<span class="NLM_cas:issn">0960-9822</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The mammalian TOR (mTOR) pathway integrates nutrient- and growth factor-derived signals to regulate growth, the process whereby cells accumulate mass and increase in size.  MTOR is a large protein kinase and the target of rapamycin, an immunosuppressant that also blocks vessel restenosis and has potential anticancer applications.  MTOR interacts with the raptor and GβL proteins to form a complex that is the target of rapamycin.  Here, we demonstrate that mTOR is also part of a distinct complex defined by the novel protein rictor (rapamycin-insensitive companion of mTOR).  Rictor shares homol. with the previously described pianissimo from D. discoidieum, STE20p from S. pombe, and AVO3p from S. cerevisiae.  Interestingly, AVO3p is part of a rapamycin-insensitive TOR complex that does not contain the yeast homolog of raptor and signals to the actin cytoskeleton through PKC1.  Consistent with this finding, the rictor-contg. mTOR complex contains GβL but not raptor and it neither regulates the mTOR effector S6K1 nor is it bound by FKBP12-rapamycin.  We find that the rictor-mTOR complex modulates the phosphorylation of Protein Kinase C α (PKCα) and the actin cytoskeleton, suggesting that this aspect of TOR signaling is conserved between yeast and mammals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXWNgQt5KXB7Vg90H21EOLACvtfcHk0ljxKiZF6gG8MQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmtVamsLs%253D&md5=78362bf097ed96b9bfc0053e3a54818c</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.cub.2004.06.054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cub.2004.06.054%26sid%3Dliteratum%253Aachs%26aulast%3DSarbassov%26aufirst%3DD.%2BD.%26aulast%3DAli%26aufirst%3DS.%2Bm.%26aulast%3DKim%26aufirst%3DD.%2BH.%26aulast%3DGuertin%26aufirst%3DD.%2BA.%26aulast%3DLatek%26aufirst%3DR.%2BR.%26aulast%3DErdjument-Bromage%26aufirst%3DH.%26aulast%3DTempst%26aufirst%3DP.%26aulast%3DSabatini%26aufirst%3DD.%2BM.%26atitle%3DRictor%252C%2520a%2520novel%2520binding%2520partnet%2520of%2520mTOR%252C%2520defines%2520a%2520rapamycin-insensitive%2520and%2520raptor-independent%2520pathway%2520that%2520regulates%2520the%2520cytoskeleton%26jtitle%3DCurr.%2520Biol.%26date%3D2004%26volume%3D14%26spage%3D1296%26epage%3D1302" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Sarbassov, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guertin, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ali, S.m.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabatini, D. M.</span><span> </span><span class="NLM_article-title">Phosphorylation and regulation of Akt/PKB by the Rictor-mTOR complex</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">307</span><span class="NLM_x">, </span> <span class="NLM_fpage">1098</span><span class="NLM_x">–</span> <span class="NLM_lpage">1101</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm9013828&amp;key=10.1126%2Fscience.1106148" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm9013828&amp;key=15718470" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm9013828&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlSrtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=307&publication_year=2005&pages=1098-1101&author=D.+D.+Sarbassovauthor=D.+A.+Guertinauthor=S.m.+Aliauthor=D.+M.+Sabatini&title=Phosphorylation+and+regulation+of+Akt%2FPKB+by+the+Rictor-mTOR+complex"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphorylation and Regulation of Akt/PKB by the Rictor-mTOR Complex</span></div><div class="casAuthors">Sarbassov, Dos D.; Guertin, David A.; Ali, Siraj M.; Sabatini, David M.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">307</span>
        (<span class="NLM_cas:issue">5712</span>),
    <span class="NLM_cas:pages">1098-1101</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Deregulation of Akt/protein kinase B (PKB) is implicated in the pathogenesis of cancer and diabetes.  Akt/PKB activation requires the phosphorylation of Thr308 in the activation loop by the phosphoinositide-dependent kinase 1 (PDK1) and Ser473 within the carboxyl-terminal hydrophobic motif by an unknown kinase.  We show that in Drosophila and human cells the target of rapamycin (TOR) kinase and its assocd. protein rictor are necessary for Ser473 phosphorylation and that a redn. in rictor or mammalian TOR (mTOR) expression inhibited an Akt/PKB effector.  The rictor-mTOR complex directly phosphorylated Akt/PKB on Ser473 in vitro and facilitated Thr308 phosphorylation by PDK1.  Rictor-mTOR may serve as a drug target in tumors that have lost the expression of PTEN, a tumor suppressor that opposes Akt/PKB activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfO1KyVE3glrVg90H21EOLACvtfcHk0ljxKiZF6gG8MQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlSrtbY%253D&md5=de758fd8128561e34301e67a42ae13a6</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1126%2Fscience.1106148&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1106148%26sid%3Dliteratum%253Aachs%26aulast%3DSarbassov%26aufirst%3DD.%2BD.%26aulast%3DGuertin%26aufirst%3DD.%2BA.%26aulast%3DAli%26aufirst%3DS.m.%26aulast%3DSabatini%26aufirst%3DD.%2BM.%26atitle%3DPhosphorylation%2520and%2520regulation%2520of%2520Akt%252FPKB%2520by%2520the%2520Rictor-mTOR%2520complex%26jtitle%3DScience%26date%3D2005%26volume%3D307%26spage%3D1098%26epage%3D1101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Carracedo, A</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pandolfi, P. P.</span><span> </span><span class="NLM_article-title">The PTEN-PI3K pathway: of feedbacks and cross-talks</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">5527</span><span class="NLM_x">–</span> <span class="NLM_lpage">5541</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2008&pages=5527-5541&author=A+Carracedoauthor=P.+P.+Pandolfi&title=The+PTEN-PI3K+pathway%3A+of+feedbacks+and+cross-talks"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCarracedo%26aufirst%3DA%26aulast%3DPandolfi%26aufirst%3DP.%2BP.%26atitle%3DThe%2520PTEN-PI3K%2520pathway%253A%2520of%2520feedbacks%2520and%2520cross-talks%26jtitle%3DOncogene%26date%3D2008%26volume%3D27%26spage%3D5527%26epage%3D5541" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Choo, A. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoon, S. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roux, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blenis, J.</span><span> </span><span class="NLM_article-title">Rapamycin differentially inhibits S6Ks and 4E-BP1 to mediate cell-type-specific repression of mRNA translation</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">17414</span><span class="NLM_x">–</span> <span class="NLM_lpage">17419</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=17414-17419&author=A.+Y.+Chooauthor=S.+O.+Yoonauthor=S.+G.+Kimauthor=P.+P.+Rouxauthor=J.+Blenis&title=Rapamycin+differentially+inhibits+S6Ks+and+4E-BP1+to+mediate+cell-type-specific+repression+of+mRNA+translation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChoo%26aufirst%3DA.%2BY.%26aulast%3DYoon%26aufirst%3DS.%2BO.%26aulast%3DKim%26aufirst%3DS.%2BG.%26aulast%3DRoux%26aufirst%3DP.%2BP.%26aulast%3DBlenis%26aufirst%3DJ.%26atitle%3DRapamycin%2520differentially%2520inhibits%2520S6Ks%2520and%25204E-BP1%2520to%2520mediate%2520cell-type-specific%2520repression%2520of%2520mRNA%2520translation%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2008%26volume%3D105%26spage%3D17414%26epage%3D17419" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Guertin, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabatini, D. M.</span><span> </span><span class="NLM_article-title">The Pharmacology of mTOR Inhibition</span> <span class="citation_source-journal">Sci. Signaling</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">6</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm9013828&amp;key=10.1126%2Fscisignal.267pe24" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm9013828&amp;key=19318623" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2009&pages=1-6&author=D.+A.+Guertinauthor=D.+M.+Sabatini&title=The+Pharmacology+of+mTOR+Inhibition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1126%2Fscisignal.267pe24&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscisignal.267pe24%26sid%3Dliteratum%253Aachs%26aulast%3DGuertin%26aufirst%3DD.%2BA.%26aulast%3DSabatini%26aufirst%3DD.%2BM.%26atitle%3DThe%2520Pharmacology%2520of%2520mTOR%2520Inhibition%26jtitle%3DSci.%2520Signaling%26date%3D2009%26volume%3D2%26spage%3D1%26epage%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Folkes, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmadi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alderton, W. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alix, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Box, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chuckowree, I. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Depledge, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eccles, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hancox, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kugendradas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lensun, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olivero, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pergl-Wilson, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raynaud, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saghir, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salphati, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sohal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ultsch, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valenti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallweber, H. J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiesmann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhyvoloup, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zvelebil, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shuttleworth, S. J.</span><span> </span><span class="NLM_article-title">The identification of 2-(1<i>H</i>-indazol-4-yl)-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-<i>d</i>]pyrimidine (GDC-0941) as a potent, selective, orally bioavailable inhibitor of class I PI3 kinase for the treatment of cancer</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">5522</span><span class="NLM_x">–</span> <span class="NLM_lpage">5532</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800295d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm9013828&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVCmsr7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=5522-5532&author=A.+J.+Folkesauthor=K.+Ahmadiauthor=W.+K.+Aldertonauthor=S.+Alixauthor=S.+J.+Bakerauthor=G.+Boxauthor=I.+S.+Chuckowreeauthor=P.+A.+Clarkeauthor=P.+Depledgeauthor=S.+A.+Ecclesauthor=L.+S.+Friedmanauthor=A.+Hayesauthor=T.+C.+Hancoxauthor=A.+Kugendradasauthor=L.+Lensunauthor=P.+Mooreauthor=A.+G.+Oliveroauthor=J.+Pangauthor=S.+Patelauthor=G.+H.+Pergl-Wilsonauthor=F.+I.+Raynaudauthor=A.+Robsonauthor=N.+Saghirauthor=L.+Salphatiauthor=S.+Sohalauthor=M.+H.+Ultschauthor=M.+Valentiauthor=H.+J.+A.+Wallweberauthor=N.+C.+Wanauthor=C.+Wiesmannauthor=P.+Workmanauthor=A.+Zhyvoloupauthor=M.+J.+Zvelebilauthor=S.+J.+Shuttleworth&title=The+identification+of+2-%281H-indazol-4-yl%29-6-%284-methanesulfonyl-piperazin-1-ylmethyl%29-4-morpholin-4-yl-thieno%5B3%2C2-d%5Dpyrimidine+%28GDC-0941%29+as+a+potent%2C+selective%2C+orally+bioavailable+inhibitor+of+class+I+PI3+kinase+for+the+treatment+of+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">The identification of 2-(1H-indazol-4-yl)-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidine (GDC-0941) as a potent, selective, orally bioavailable inhibitor of class I PI3 kinase for the treatment of cancer</span></div><div class="casAuthors">Folkes, Adrian J.; Ahmadi, Khatereh; Alderton, Wendy K.; Alix, Sonia; Baker, Stewart J.; Box, Gary; Chuckowree, Irina S.; Clarke, Paul A.; Depledge, Paul; Eccles, Suzanne A.; Friedman, Lori S.; Hayes, Angela; Hancox, Timothy C.; Kugendradas, Arumugam; Lensun, Letitia; Moore, Pauline; Olivero, Alan G.; Pang, Jodie; Patel, Sonal; Pergl-Wilson, Giles H.; Raynaud, Florence I.; Robson, Anthony; Saghir, Nahid; Salphati, Laurent; Sohal, Sukhjit; Ultsch, Mark H.; Valenti, Melanie; Wallweber, Heidi J. A.; Wan, Nan Chi; Wiesmann, Christian; Workman, Paul; Zhyvoloup, Alexander; Zvelebil, Marketa J.; Shuttleworth, Stephen J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">5522-5532</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Phosphatidylinositol-3-kinase (PI3K) is an important target in cancer due to the deregulation of the PI3K/Akt signaling pathway in a wide variety of tumors.  A series of thieno[3,2-d]pyrimidine derivs. were prepd. and evaluated as inhibitors of PI3 kinase p110α.  The synthesis, biol. activity, and further profiling of these compds. are described.  This work resulted in the discovery of GDC-0941 (I) which is a potent, selective, orally bioavailable inhibitor of PI3K and is currently being evaluated in human clin. trials for the treatment of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojkFv29FXqO7Vg90H21EOLACvtfcHk0ljdsCV3NhM7rg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVCmsr7E&md5=742084954685353ceaf18660ab3a0703</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Fjm800295d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800295d%26sid%3Dliteratum%253Aachs%26aulast%3DFolkes%26aufirst%3DA.%2BJ.%26aulast%3DAhmadi%26aufirst%3DK.%26aulast%3DAlderton%26aufirst%3DW.%2BK.%26aulast%3DAlix%26aufirst%3DS.%26aulast%3DBaker%26aufirst%3DS.%2BJ.%26aulast%3DBox%26aufirst%3DG.%26aulast%3DChuckowree%26aufirst%3DI.%2BS.%26aulast%3DClarke%26aufirst%3DP.%2BA.%26aulast%3DDepledge%26aufirst%3DP.%26aulast%3DEccles%26aufirst%3DS.%2BA.%26aulast%3DFriedman%26aufirst%3DL.%2BS.%26aulast%3DHayes%26aufirst%3DA.%26aulast%3DHancox%26aufirst%3DT.%2BC.%26aulast%3DKugendradas%26aufirst%3DA.%26aulast%3DLensun%26aufirst%3DL.%26aulast%3DMoore%26aufirst%3DP.%26aulast%3DOlivero%26aufirst%3DA.%2BG.%26aulast%3DPang%26aufirst%3DJ.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DPergl-Wilson%26aufirst%3DG.%2BH.%26aulast%3DRaynaud%26aufirst%3DF.%2BI.%26aulast%3DRobson%26aufirst%3DA.%26aulast%3DSaghir%26aufirst%3DN.%26aulast%3DSalphati%26aufirst%3DL.%26aulast%3DSohal%26aufirst%3DS.%26aulast%3DUltsch%26aufirst%3DM.%2BH.%26aulast%3DValenti%26aufirst%3DM.%26aulast%3DWallweber%26aufirst%3DH.%2BJ.%2BA.%26aulast%3DWan%26aufirst%3DN.%2BC.%26aulast%3DWiesmann%26aufirst%3DC.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DZhyvoloup%26aufirst%3DA.%26aulast%3DZvelebil%26aufirst%3DM.%2BJ.%26aulast%3DShuttleworth%26aufirst%3DS.%2BJ.%26atitle%3DThe%2520identification%2520of%25202-%25281H-indazol-4-yl%2529-6-%25284-methanesulfonyl-piperazin-1-ylmethyl%2529-4-morpholin-4-yl-thieno%255B3%252C2-d%255Dpyrimidine%2520%2528GDC-0941%2529%2520as%2520a%2520potent%252C%2520selective%252C%2520orally%2520bioavailable%2520inhibitor%2520of%2520class%2520I%2520PI3%2520kinase%2520for%2520the%2520treatment%2520of%2520cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D5522%26epage%3D5532" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Maira, S.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stauffer, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brueggen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnell, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fritsch, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brachmann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chene, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Pover, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoemaker, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fabbro, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabriel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simonen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sellers, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Echeverria, C.</span><span> </span><span class="NLM_article-title">Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1851</span><span class="NLM_x">–</span> <span class="NLM_lpage">1863</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm9013828&amp;key=10.1158%2F1535-7163.MCT-08-0017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm9013828&amp;key=18606717" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm9013828&amp;key=1%3ACAS%3A528%3ADC%252BD1cXoslCgtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=1851-1863&author=S.-M.+Mairaauthor=F.+Staufferauthor=J.+Brueggenauthor=P.+Furetauthor=C.+Schnellauthor=C.+Fritschauthor=S.+Brachmannauthor=P.+Cheneauthor=A.+De+Poverauthor=K.+Schoemakerauthor=D.+Fabbroauthor=D.+Gabrielauthor=M.+Simonenauthor=L.+Murphyauthor=P.+Finanauthor=W.+Sellersauthor=C.+Garcia-Echeverria&title=Identification+and+characterization+of+NVP-BEZ235%2C+a+new+orally+available+dual+phosphatidylinositol+3-kinase%2Fmammalian+target+of+rapamycin+inhibitor+with+potent+in+vivo+antitumor+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity</span></div><div class="casAuthors">Maira, Sauveur-Michel; Stauffer, Frederic; Brueggen, Josef; Furet, Pascal; Schnell, Christian; Fritsch, Christine; Brachmann, Saskia; Chene, Patrick; De Pover, Alain; Schoemaker, Kevin; Fabbro, Doriano; Gabriel, Daniela; Simonen, Marjo; Murphy, Leon; Finan, Peter; Sellers, William; Garcia-Echeverria, Carlos</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1851-1863</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The phosphatidylinositol 3-kinase (PI3K)/Akt/mammalian target of rapamycin inhibitor (mTOR) pathway is often constitutively activated in human tumor cells, providing unique opportunities for anticancer therapeutic intervention.  NVP-BEZ235 is an imidazo[4,5-c]quinoline deriv. that inhibits PI3K and mTOR kinase activity by binding to the ATP-binding cleft of these enzymes.  In cellular settings using human tumor cell lines, this mol. is able to effectively and specifically block the dysfunctional activation of the PI3K pathway, inducing G1 arrest.  The cellular activity of NVP-BEZ235 translates well in in vivo models of human cancer.  Thus, the compd. was well tolerated, displayed disease stasis when administered orally, and enhanced the efficacy of other anticancer agents when used in in vivo combination studies.  Ex vivo pharmacokinetic/pharmacodynamic analyses of tumor tissues showed a time-dependent correlation between compd. concn. and PI3K/Akt pathway inhibition.  Collectively, the preclin. data show that NVP-BEZ235 is a potent dual PI3K/mTOR modulator with favorable pharmaceutical properties.  NVP-BEZ235 is currently in phase I clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyO784qv52vrVg90H21EOLACvtfcHk0ljdsCV3NhM7rg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXoslCgtb4%253D&md5=5b1979e134dd12065198d86dbc11ce15</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-08-0017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-08-0017%26sid%3Dliteratum%253Aachs%26aulast%3DMaira%26aufirst%3DS.-M.%26aulast%3DStauffer%26aufirst%3DF.%26aulast%3DBrueggen%26aufirst%3DJ.%26aulast%3DFuret%26aufirst%3DP.%26aulast%3DSchnell%26aufirst%3DC.%26aulast%3DFritsch%26aufirst%3DC.%26aulast%3DBrachmann%26aufirst%3DS.%26aulast%3DChene%26aufirst%3DP.%26aulast%3DDe%2BPover%26aufirst%3DA.%26aulast%3DSchoemaker%26aufirst%3DK.%26aulast%3DFabbro%26aufirst%3DD.%26aulast%3DGabriel%26aufirst%3DD.%26aulast%3DSimonen%26aufirst%3DM.%26aulast%3DMurphy%26aufirst%3DL.%26aulast%3DFinan%26aufirst%3DP.%26aulast%3DSellers%26aufirst%3DW.%26aulast%3DGarcia-Echeverria%26aufirst%3DC.%26atitle%3DIdentification%2520and%2520characterization%2520of%2520NVP-BEZ235%252C%2520a%2520new%2520orally%2520available%2520dual%2520phosphatidylinositol%25203-kinase%252Fmammalian%2520target%2520of%2520rapamycin%2520inhibitor%2520with%2520potent%2520in%2520vivo%2520antitumor%2520activity%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2008%26volume%3D7%26spage%3D1851%26epage%3D1863" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Knight, Z. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feldman, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zunder, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldenberg, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loewith, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stokoe, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balla, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toth, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balla, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shokat, K.M. A</span><span> </span><span class="NLM_article-title">Pharmacological map of the PI3-K family defines a role for p110α in insulin signaling</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">125</span><span class="NLM_x">, </span> <span class="NLM_fpage">733</span><span class="NLM_x">–</span> <span class="NLM_lpage">747</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2006&pages=733-747&author=Z.+A.+Knightauthor=B.+Gonzalezauthor=M.+E.+Feldmanauthor=E.+R.+Zunderauthor=D.+D.+Goldenbergauthor=O.+Williamsauthor=R.+Loewithauthor=D.+Stokoeauthor=A.+Ballaauthor=B.+Tothauthor=T.+Ballaauthor=W.+A.+Weissauthor=R.+L.+Williamsauthor=K.M.+A+Shokat&title=Pharmacological+map+of+the+PI3-K+family+defines+a+role+for+p110%CE%B1+in+insulin+signaling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKnight%26aufirst%3DZ.%2BA.%26aulast%3DGonzalez%26aufirst%3DB.%26aulast%3DFeldman%26aufirst%3DM.%2BE.%26aulast%3DZunder%26aufirst%3DE.%2BR.%26aulast%3DGoldenberg%26aufirst%3DD.%2BD.%26aulast%3DWilliams%26aufirst%3DO.%26aulast%3DLoewith%26aufirst%3DR.%26aulast%3DStokoe%26aufirst%3DD.%26aulast%3DBalla%26aufirst%3DA.%26aulast%3DToth%26aufirst%3DB.%26aulast%3DBalla%26aufirst%3DT.%26aulast%3DWeiss%26aufirst%3DW.%2BA.%26aulast%3DWilliams%26aufirst%3DR.%2BL.%26aulast%3DShokat%26aufirst%3DK.M.%2BA%26atitle%3DPharmacological%2520map%2520of%2520the%2520PI3-K%2520family%2520defines%2520a%2520role%2520for%2520p110%25CE%25B1%2520in%2520insulin%2520signaling%26jtitle%3DCell%26date%3D2006%26volume%3D125%26spage%3D733%26epage%3D747" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Feldman, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Apsel, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uotila, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loewith, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knight, Z. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruggero, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shokat, K. M.</span><span> </span><span class="NLM_article-title">Active-site inhibitors of mTOR target rapamycin-resistant outputs of mTORC1 and mTORC2</span> <span class="citation_source-journal">PLoS Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">371</span><span class="NLM_x">–</span> <span class="NLM_lpage">383</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2009&pages=371-383&author=M.+E.+Feldmanauthor=B.+Apselauthor=A.+Uotilaauthor=R.+Loewithauthor=Z.+A.+Knightauthor=D.+Ruggeroauthor=K.+M.+Shokat&title=Active-site+inhibitors+of+mTOR+target+rapamycin-resistant+outputs+of+mTORC1+and+mTORC2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFeldman%26aufirst%3DM.%2BE.%26aulast%3DApsel%26aufirst%3DB.%26aulast%3DUotila%26aufirst%3DA.%26aulast%3DLoewith%26aufirst%3DR.%26aulast%3DKnight%26aufirst%3DZ.%2BA.%26aulast%3DRuggero%26aufirst%3DD.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26atitle%3DActive-site%2520inhibitors%2520of%2520mTOR%2520target%2520rapamycin-resistant%2520outputs%2520of%2520mTORC1%2520and%2520mTORC2%26jtitle%3DPLoS%2520Biol.%26date%3D2009%26volume%3D7%26spage%3D371%26epage%3D383" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Thoreen, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reichling, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sim, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabatini, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span> </span><span class="NLM_article-title">An ATP-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">284</span><span class="NLM_x">, </span> <span class="NLM_fpage">8023</span><span class="NLM_x">–</span> <span class="NLM_lpage">8032</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm9013828&amp;key=10.1074%2Fjbc.M900301200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm9013828&amp;key=19150980" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm9013828&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjtVSmtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2009&pages=8023-8032&author=C.+C.+Thoreenauthor=S.+A.+Kangauthor=J.+W.+Changauthor=Q.+Liuauthor=J.+Zhangauthor=Y.+Gaoauthor=L.+J.+Reichlingauthor=T.+Simauthor=D.+M.+Sabatiniauthor=N.+S.+Gray&title=An+ATP-competitive+mammalian+target+of+rapamycin+inhibitor+reveals+rapamycin-resistant+functions+of+mTORC1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">An ATP-competitive Mammalian Target of Rapamycin Inhibitor Reveals Rapamycin-resistant Functions of mTORC1</span></div><div class="casAuthors">Thoreen, Carson C.; Kang, Seong A.; Chang, Jae Won; Liu, Qingsong; Zhang, Jianming; Gao, Yi; Reichling, Laurie J.; Sim, Taebo; Sabatini, David M.; Gray, Nathanael S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">284</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">8023-8032</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The mammalian target of rapamycin (mTOR) kinase is the catalytic subunit of two functionally distinct complexes, mTORC1 and mTORC2, that coordinately promote cell growth, proliferation, and survival.  Rapamycin is a potent allosteric mTORC1 inhibitor with clin. applications as an immunosuppressant and anti-cancer agent.  Here we find that Torin1, a highly potent and selective ATP-competitive mTOR inhibitor that directly inhibits both complexes, impairs cell growth and proliferation to a far greater degree than rapamycin.  Surprisingly, these effects are independent of mTORC2 inhibition and are instead because of suppression of rapamycin-resistant functions of mTORC1 that are necessary for cap-dependent translation and suppression of autophagy.  These effects are at least partly mediated by mTORC1-dependent and rapamycin-resistant phosphorylation of 4E-BP1.  Our findings challenge the assumption that rapamycin completely inhibits mTORC1 and indicate that direct inhibitors of mTORC1 kinase activity may be more successful than rapamycin at inhibiting tumors that depend on mTORC1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiRNo9IcTXArVg90H21EOLACvtfcHk0lj1jY5i-FBpmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjtVSmtLY%253D&md5=ea4476b6a55a6b8964fc5c041c80039f</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M900301200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M900301200%26sid%3Dliteratum%253Aachs%26aulast%3DThoreen%26aufirst%3DC.%2BC.%26aulast%3DKang%26aufirst%3DS.%2BA.%26aulast%3DChang%26aufirst%3DJ.%2BW.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DReichling%26aufirst%3DL.%2BJ.%26aulast%3DSim%26aufirst%3DT.%26aulast%3DSabatini%26aufirst%3DD.%2BM.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DAn%2520ATP-competitive%2520mammalian%2520target%2520of%2520rapamycin%2520inhibitor%2520reveals%2520rapamycin-resistant%2520functions%2520of%2520mTORC1%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2009%26volume%3D284%26spage%3D8023%26epage%3D8032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">García-Martínez, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moran, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cosulich, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chresta, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alessi, D. R.</span><span> </span><span class="NLM_article-title">Ku-0063794 is a specific inhibitor of the mammalian target of rapamycin (mTOR)</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">421</span><span class="NLM_x">, </span> <span class="NLM_fpage">29</span><span class="NLM_x">–</span> <span class="NLM_lpage">42</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=421&publication_year=2009&pages=29-42&author=J.+M.+Garc%C3%ADa-Mart%C3%ADnezauthor=J.+Moranauthor=R.+G.+Clarkeauthor=A.+Grayauthor=S.+C.+Cosulichauthor=C.+M.+Chrestaauthor=D.+R.+Alessi&title=Ku-0063794+is+a+specific+inhibitor+of+the+mammalian+target+of+rapamycin+%28mTOR%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGarc%25C3%25ADa-Mart%25C3%25ADnez%26aufirst%3DJ.%2BM.%26aulast%3DMoran%26aufirst%3DJ.%26aulast%3DClarke%26aufirst%3DR.%2BG.%26aulast%3DGray%26aufirst%3DA.%26aulast%3DCosulich%26aufirst%3DS.%2BC.%26aulast%3DChresta%26aufirst%3DC.%2BM.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26atitle%3DKu-0063794%2520is%2520a%2520specific%2520inhibitor%2520of%2520the%2520mammalian%2520target%2520of%2520rapamycin%2520%2528mTOR%2529%26jtitle%3DBiochem.%2520J.%26date%3D2009%26volume%3D421%26spage%3D29%26epage%3D42" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Menear, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malagu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blackburn, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cockroft, X.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ewen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fundo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Gall, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hermann, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sebastian, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sunose, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Presnot, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torode, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickson, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, N. M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, G. C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pike, K. G.</span><span> </span><span class="NLM_article-title">Identification and optimization of novel and selective small molecular weight kinase inhibitors of mTOR</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">5898</span><span class="NLM_x">–</span> <span class="NLM_lpage">5901</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=5898-5901&author=K.+A.+Menearauthor=S.+Gomezauthor=K.+Malaguauthor=C.+Baileyauthor=K.+Blackburnauthor=X.-L.+Cockroftauthor=S.+Ewenauthor=A.+Fundoauthor=A.+Le+Gallauthor=G.+Hermannauthor=L.+Sebastianauthor=M.+Sunoseauthor=T.+Presnotauthor=E.+Torodeauthor=I.+Hicksonauthor=N.+M.+B.+Martinauthor=G.+C.+M.+Smithauthor=K.+G.+Pike&title=Identification+and+optimization+of+novel+and+selective+small+molecular+weight+kinase+inhibitors+of+mTOR"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMenear%26aufirst%3DK.%2BA.%26aulast%3DGomez%26aufirst%3DS.%26aulast%3DMalagu%26aufirst%3DK.%26aulast%3DBailey%26aufirst%3DC.%26aulast%3DBlackburn%26aufirst%3DK.%26aulast%3DCockroft%26aufirst%3DX.-L.%26aulast%3DEwen%26aufirst%3DS.%26aulast%3DFundo%26aufirst%3DA.%26aulast%3DLe%2BGall%26aufirst%3DA.%26aulast%3DHermann%26aufirst%3DG.%26aulast%3DSebastian%26aufirst%3DL.%26aulast%3DSunose%26aufirst%3DM.%26aulast%3DPresnot%26aufirst%3DT.%26aulast%3DTorode%26aufirst%3DE.%26aulast%3DHickson%26aufirst%3DI.%26aulast%3DMartin%26aufirst%3DN.%2BM.%2BB.%26aulast%3DSmith%26aufirst%3DG.%2BC.%2BM.%26aulast%3DPike%26aufirst%3DK.%2BG.%26atitle%3DIdentification%2520and%2520optimization%2520of%2520novel%2520and%2520selective%2520small%2520molecular%2520weight%2520kinase%2520inhibitors%2520of%2520mTOR%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D5898%26epage%3D5901" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Malagu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duggan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menear, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hummersone, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drzewiecki, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leroux, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quesada, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hermann, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maine, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molyneaux, C.-A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Gall, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pullen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickson, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maguire, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pass, M.</span><span> </span><span class="NLM_article-title">The discovery and optimization of pyrido[2,3-<i>d</i>]pyrimidine-2,4-diamines as potent and selective inhibitors of mTOR kinase</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">5950</span><span class="NLM_x">–</span> <span class="NLM_lpage">5953</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=5950-5953&author=K.+Malaguauthor=H.+Dugganauthor=K.+Menearauthor=M.+Hummersoneauthor=S.+Gomezauthor=C.+Baileyauthor=P.+Edwardsauthor=J.+Drzewieckiauthor=F.+Lerouxauthor=M.+J.+Quesadaauthor=G.+Hermannauthor=S.+Maineauthor=C.-A.+Molyneauxauthor=A.+Le+Gallauthor=J.+Pullenauthor=I.+Hicksonauthor=L.+Smithauthor=S.+Maguireauthor=N.+Martinauthor=G.+Smithauthor=M.+Pass&title=The+discovery+and+optimization+of+pyrido%5B2%2C3-d%5Dpyrimidine-2%2C4-diamines+as+potent+and+selective+inhibitors+of+mTOR+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMalagu%26aufirst%3DK.%26aulast%3DDuggan%26aufirst%3DH.%26aulast%3DMenear%26aufirst%3DK.%26aulast%3DHummersone%26aufirst%3DM.%26aulast%3DGomez%26aufirst%3DS.%26aulast%3DBailey%26aufirst%3DC.%26aulast%3DEdwards%26aufirst%3DP.%26aulast%3DDrzewiecki%26aufirst%3DJ.%26aulast%3DLeroux%26aufirst%3DF.%26aulast%3DQuesada%26aufirst%3DM.%2BJ.%26aulast%3DHermann%26aufirst%3DG.%26aulast%3DMaine%26aufirst%3DS.%26aulast%3DMolyneaux%26aufirst%3DC.-A.%26aulast%3DLe%2BGall%26aufirst%3DA.%26aulast%3DPullen%26aufirst%3DJ.%26aulast%3DHickson%26aufirst%3DI.%26aulast%3DSmith%26aufirst%3DL.%26aulast%3DMaguire%26aufirst%3DS.%26aulast%3DMartin%26aufirst%3DN.%26aulast%3DSmith%26aufirst%3DG.%26aulast%3DPass%26aufirst%3DM.%26atitle%3DThe%2520discovery%2520and%2520optimization%2520of%2520pyrido%255B2%252C3-d%255Dpyrimidine-2%252C4-diamines%2520as%2520potent%2520and%2520selective%2520inhibitors%2520of%2520mTOR%2520kinase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D5950%26epage%3D5953" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Zask, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verheijen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaplan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curran, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richard, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooijmans, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toral-Barza, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.-G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollander, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbons, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abraham, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayral-Kaloustian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansour, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, K.</span><span> </span><span class="NLM_article-title">Design and synthesis of potent and selective ATP competitive inhibitors of the mammalian target of rapamycin</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">5013</span><span class="NLM_x">–</span> <span class="NLM_lpage">5016</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900851f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=5013-5016&author=A.+Zaskauthor=J.+Verheijenauthor=J.+Kaplanauthor=K.+Curranauthor=D.+Richardauthor=N.+Brooijmansauthor=J.+Lucasauthor=L.+Toral-Barzaauthor=W.-G.+Zhangauthor=I.+Hollanderauthor=J.+Gibbonsauthor=R.+Abrahamauthor=S.+Ayral-Kaloustianauthor=T.+Mansourauthor=K.+Yu&title=Design+and+synthesis+of+potent+and+selective+ATP+competitive+inhibitors+of+the+mammalian+target+of+rapamycin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm900851f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900851f%26sid%3Dliteratum%253Aachs%26aulast%3DZask%26aufirst%3DA.%26aulast%3DVerheijen%26aufirst%3DJ.%26aulast%3DKaplan%26aufirst%3DJ.%26aulast%3DCurran%26aufirst%3DK.%26aulast%3DRichard%26aufirst%3DD.%26aulast%3DBrooijmans%26aufirst%3DN.%26aulast%3DLucas%26aufirst%3DJ.%26aulast%3DToral-Barza%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DW.-G.%26aulast%3DHollander%26aufirst%3DI.%26aulast%3DGibbons%26aufirst%3DJ.%26aulast%3DAbraham%26aufirst%3DR.%26aulast%3DAyral-Kaloustian%26aufirst%3DS.%26aulast%3DMansour%26aufirst%3DT.%26aulast%3DYu%26aufirst%3DK.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520potent%2520and%2520selective%2520ATP%2520competitive%2520inhibitors%2520of%2520the%2520mammalian%2520target%2520of%2520rapamycin%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D5013%26epage%3D5016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Nowak, P.; Brooijmans, N.; Cole, D. C.; Curran, K. J.; Ellingboe, J.; Gibbons, J. J.; Hu, Y.; Hollander, I.; Kaplan, J.; Malwitz, D. J.; Toral-Barza, L.; Verheijen, J.; Zask, A.; Zhang, W.-G.; Yu, K.</span><span> </span><span class="NLM_article-title">Discovery of potent and selective inhibitors of the mammalian target of rapamycin (mTOR) kinase</span>.  <span class="citation_source-journal">J. Med. Chem.</span> DOI: <span class="refDoi"> DOI: 10.1021/jm9012642</span> .</span><div class="citationLinks">[<a href="/doi/10.1021/jm9012642" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Nowak%2C+P.%3B+Brooijmans%2C+N.%3B+Cole%2C+D.+C.%3B+Curran%2C+K.+J.%3B+Ellingboe%2C+J.%3B+Gibbons%2C+J.+J.%3B+Hu%2C+Y.%3B+Hollander%2C+I.%3B+Kaplan%2C+J.%3B+Malwitz%2C+D.+J.%3B+Toral-Barza%2C+L.%3B+Verheijen%2C+J.%3B+Zask%2C+A.%3B+Zhang%2C+W.-G.%3B+Yu%2C+K.+Discovery+of+potent+and+selective+inhibitors+of+the+mammalian+target+of+rapamycin+%28mTOR%29+kinase.+J.+Med.+Chem.+DOI%3A+10.1021%2Fjm9012642."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm9012642&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9012642%26sid%3Dliteratum%253Aachs%26aulast%3DNowak%26aufirst%3DP.%26atitle%3DDiscovery%2520of%2520potent%2520and%2520selective%2520inhibitors%2520of%2520the%2520mammalian%2520target%2520of%2520rapamycin%2520%2528mTOR%2529%2520kinase%26jtitle%3DJ.%2520Med.%2520Chem.%26doi%3D10.1021%2Fjm9012642" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Yu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toral-Barza, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.-G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shor, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verheijen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curran, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malwitz, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellingboe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayral-Kaloustian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansour, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbons, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abraham, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nowak, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zask, A.</span><span> </span><span class="NLM_article-title">Biochemical, cellular and in vivo activity of novel ATP-competitive and selective inhibitors of the mammalian target of rapamycin</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">6232</span><span class="NLM_x">–</span> <span class="NLM_lpage">6240</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2009&pages=6232-6240&author=Y.+Yuauthor=L.+Toral-Barzaauthor=C.+Shiauthor=W.-G.+Zhangauthor=J.+Lucasauthor=B.+Shorauthor=J.+Kimauthor=J.+Verheijenauthor=K.+Curranauthor=D.+J.+Malwitzauthor=D.+C.+Coleauthor=J.+Ellingboeauthor=S.+Ayral-Kaloustianauthor=T.+S.+Mansourauthor=J.+J.+Gibbonsauthor=R.+T.+Abrahamauthor=P.+Nowakauthor=A.+Zask&title=Biochemical%2C+cellular+and+in+vivo+activity+of+novel+ATP-competitive+and+selective+inhibitors+of+the+mammalian+target+of+rapamycin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DY.%26aulast%3DToral-Barza%26aufirst%3DL.%26aulast%3DShi%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DW.-G.%26aulast%3DLucas%26aufirst%3DJ.%26aulast%3DShor%26aufirst%3DB.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DVerheijen%26aufirst%3DJ.%26aulast%3DCurran%26aufirst%3DK.%26aulast%3DMalwitz%26aufirst%3DD.%2BJ.%26aulast%3DCole%26aufirst%3DD.%2BC.%26aulast%3DEllingboe%26aufirst%3DJ.%26aulast%3DAyral-Kaloustian%26aufirst%3DS.%26aulast%3DMansour%26aufirst%3DT.%2BS.%26aulast%3DGibbons%26aufirst%3DJ.%2BJ.%26aulast%3DAbraham%26aufirst%3DR.%2BT.%26aulast%3DNowak%26aufirst%3DP.%26aulast%3DZask%26aufirst%3DA.%26atitle%3DBiochemical%252C%2520cellular%2520and%2520in%2520vivo%2520activity%2520of%2520novel%2520ATP-competitive%2520and%2520selective%2520inhibitors%2520of%2520the%2520mammalian%2520target%2520of%2520rapamycin%26jtitle%3DCancer%2520Res.%26date%3D2009%26volume%3D69%26spage%3D6232%26epage%3D6240" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Fenniri, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathivanan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vidale, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherman, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hallenga, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, K. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stowell, J. G.</span><span> </span><span class="NLM_article-title">Helical rosette nanotubes: design, self-assembly, and characterization</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">123</span><span class="NLM_x">, </span> <span class="NLM_fpage">3854</span><span class="NLM_x">–</span> <span class="NLM_lpage">3855</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja005886l" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm9013828&amp;key=1%3ACAS%3A528%3ADC%252BD3MXit12hsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2001&pages=3854-3855&author=H.+Fenniriauthor=P.+Mathivananauthor=K.+L.+Vidaleauthor=D.+M.+Shermanauthor=K.+Hallengaauthor=K.+V.+Woodauthor=J.+G.+Stowell&title=Helical+rosette+nanotubes%3A+design%2C+self-assembly%2C+and+characterization"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Helical Rosette Nanotubes: Design, Self-Assembly, and Characterization</span></div><div class="casAuthors">Fenniri, Hicham; Mathivanan, Packiarajan; Vidale, Kenrick L.; Sherman, Debra M.; Hallenga, Klaas; Wood, Karl V.; Stowell, Joseph G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">123</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">3854-3855</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The combination of NMR (NOE), ESI-MS, and CD spectroscopies indicated that the module N-[2-(4,7-diaminopyrimido[4,5-d]pyrimidine-2,5-dione-1-yl)ethyl]-L-lysine (I.CF3CO2H) undergoes a cooperative, hierarchical self-assembly process with the formation of helically stacked rosettes (planar 6-mers) that display supramol. chirality.  Dynamic light scattering revealed a narrow size distribution of columnar stacks (92% in the range 19-69 nm) with an av. apparent hydrodynamic radius of 30.4 nm.  TEM provided further evidence of nanotube formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2iYU2I79tmrVg90H21EOLACvtfcHk0liJoPwYc9NIRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXit12hsbk%253D&md5=ece0e0815609889a8f65041c9a30459a</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fja005886l&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja005886l%26sid%3Dliteratum%253Aachs%26aulast%3DFenniri%26aufirst%3DH.%26aulast%3DMathivanan%26aufirst%3DP.%26aulast%3DVidale%26aufirst%3DK.%2BL.%26aulast%3DSherman%26aufirst%3DD.%2BM.%26aulast%3DHallenga%26aufirst%3DK.%26aulast%3DWood%26aufirst%3DK.%2BV.%26aulast%3DStowell%26aufirst%3DJ.%2BG.%26atitle%3DHelical%2520rosette%2520nanotubes%253A%2520design%252C%2520self-assembly%252C%2520and%2520characterization%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2001%26volume%3D123%26spage%3D3854%26epage%3D3855" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Toral-Barza, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamison, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larocque, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbons, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, K.</span><span> </span><span class="NLM_article-title">Characterization of the cloned full-length and a truncated human target of rapamycin: activity, specificity, and enzyme inhibition as studied by a high capacity assay</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">332</span><span class="NLM_x">, </span> <span class="NLM_fpage">304</span><span class="NLM_x">–</span> <span class="NLM_lpage">310</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=332&publication_year=2005&pages=304-310&author=L.+Toral-Barzaauthor=W.+G.+Zhangauthor=C.+Lamisonauthor=J.+Larocqueauthor=J.+Gibbonsauthor=K.+Yu&title=Characterization+of+the+cloned+full-length+and+a+truncated+human+target+of+rapamycin%3A+activity%2C+specificity%2C+and+enzyme+inhibition+as+studied+by+a+high+capacity+assay"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DToral-Barza%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DW.%2BG.%26aulast%3DLamison%26aufirst%3DC.%26aulast%3DLarocque%26aufirst%3DJ.%26aulast%3DGibbons%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DK.%26atitle%3DCharacterization%2520of%2520the%2520cloned%2520full-length%2520and%2520a%2520truncated%2520human%2520target%2520of%2520rapamycin%253A%2520activity%252C%2520specificity%252C%2520and%2520enzyme%2520inhibition%2520as%2520studied%2520by%2520a%2520high%2520capacity%2520assay%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2005%26volume%3D332%26spage%3D304%26epage%3D310" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Zask, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaplan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toral-Barza, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollander, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tischler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaydos, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cinque, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, K.</span><span> </span><span class="NLM_article-title">Synthesis and structure−activity relationship of ring-opened 17-hydroxywortmannins: potent phosphoinositide 3-kinase inhibitors with improved properties and anticancer efficacy</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">1319</span><span class="NLM_x">–</span> <span class="NLM_lpage">1323</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm7012858" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=1319-1323&author=A.+Zaskauthor=J.+Kaplanauthor=L.+Toral-Barzaauthor=I.+Hollanderauthor=M.+Youngauthor=M.+Tischlerauthor=C.+Gaydosauthor=M.+Cinqueauthor=J.+Lucasauthor=K.+Yu&title=Synthesis+and+structure%E2%88%92activity+relationship+of+ring-opened+17-hydroxywortmannins%3A+potent+phosphoinositide+3-kinase+inhibitors+with+improved+properties+and+anticancer+efficacy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjm7012858&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm7012858%26sid%3Dliteratum%253Aachs%26aulast%3DZask%26aufirst%3DA.%26aulast%3DKaplan%26aufirst%3DJ.%26aulast%3DToral-Barza%26aufirst%3DL.%26aulast%3DHollander%26aufirst%3DI.%26aulast%3DYoung%26aufirst%3DM.%26aulast%3DTischler%26aufirst%3DM.%26aulast%3DGaydos%26aufirst%3DC.%26aulast%3DCinque%26aufirst%3DM.%26aulast%3DLucas%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DK.%26atitle%3DSynthesis%2520and%2520structure%25E2%2588%2592activity%2520relationship%2520of%2520ring-opened%252017-hydroxywortmannins%253A%2520potent%2520phosphoinositide%25203-kinase%2520inhibitors%2520with%2520improved%2520properties%2520and%2520anticancer%2520efficacy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D1319%26epage%3D1323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Yu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toral-Barza, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Discafani, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skotnicki, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frost, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbons, J.</span><span> </span><span class="NLM_article-title">mTOR, a novel target in breast cancer: the effect of CCI-779, an mTOR inhibitor, in preclinical models of breast cancer</span> <span class="citation_source-journal">Endocr.-Relat. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">249</span><span class="NLM_x">–</span> <span class="NLM_lpage">258</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2001&pages=249-258&author=K.+Yuauthor=L.+Toral-Barzaauthor=C.+Discafaniauthor=W.+G.+Zhangauthor=J.+Skotnickiauthor=P.+Frostauthor=J.+Gibbons&title=mTOR%2C+a+novel+target+in+breast+cancer%3A+the+effect+of+CCI-779%2C+an+mTOR+inhibitor%2C+in+preclinical+models+of+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DK.%26aulast%3DToral-Barza%26aufirst%3DL.%26aulast%3DDiscafani%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DW.%2BG.%26aulast%3DSkotnicki%26aufirst%3DJ.%26aulast%3DFrost%26aufirst%3DP.%26aulast%3DGibbons%26aufirst%3DJ.%26atitle%3DmTOR%252C%2520a%2520novel%2520target%2520in%2520breast%2520cancer%253A%2520the%2520effect%2520of%2520CCI-779%252C%2520an%2520mTOR%2520inhibitor%252C%2520in%2520preclinical%2520models%2520of%2520breast%2520cancer%26jtitle%3DEndocr.-Relat.%2520Cancer%26date%3D2001%26volume%3D8%26spage%3D249%26epage%3D258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Yu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zask, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaydos, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toral-Barza, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaudhary, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lotvin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petersen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruppen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fawzi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayral-Kaloustian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skotnicki, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansour, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frost, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbons, J.</span><span> </span><span class="NLM_article-title">PWT-458, a novel pegylated-17-hydroxywortmannin, inhibits phosphatidylinositol 3-kinase signaling and suppresses growth of solid tumors</span> <span class="citation_source-journal">Cancer Biol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">538</span><span class="NLM_x">–</span> <span class="NLM_lpage">545</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=538-545&author=K.+Yuauthor=J.+Lucasauthor=T.+Zhuauthor=A.+Zaskauthor=C.+Gaydosauthor=L.+Toral-Barzaauthor=J.+Guauthor=F.+Liauthor=I.+Chaudharyauthor=P.+Caiauthor=J.+Lotvinauthor=R.+Petersenauthor=M.+Ruppenauthor=M.+Fawziauthor=S.+Ayral-Kaloustianauthor=J.+Skotnickiauthor=T.+Mansourauthor=P.+Frostauthor=J.+Gibbons&title=PWT-458%2C+a+novel+pegylated-17-hydroxywortmannin%2C+inhibits+phosphatidylinositol+3-kinase+signaling+and+suppresses+growth+of+solid+tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DK.%26aulast%3DLucas%26aufirst%3DJ.%26aulast%3DZhu%26aufirst%3DT.%26aulast%3DZask%26aufirst%3DA.%26aulast%3DGaydos%26aufirst%3DC.%26aulast%3DToral-Barza%26aufirst%3DL.%26aulast%3DGu%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DF.%26aulast%3DChaudhary%26aufirst%3DI.%26aulast%3DCai%26aufirst%3DP.%26aulast%3DLotvin%26aufirst%3DJ.%26aulast%3DPetersen%26aufirst%3DR.%26aulast%3DRuppen%26aufirst%3DM.%26aulast%3DFawzi%26aufirst%3DM.%26aulast%3DAyral-Kaloustian%26aufirst%3DS.%26aulast%3DSkotnicki%26aufirst%3DJ.%26aulast%3DMansour%26aufirst%3DT.%26aulast%3DFrost%26aufirst%3DP.%26aulast%3DGibbons%26aufirst%3DJ.%26atitle%3DPWT-458%252C%2520a%2520novel%2520pegylated-17-hydroxywortmannin%252C%2520inhibits%2520phosphatidylinositol%25203-kinase%2520signaling%2520and%2520suppresses%2520growth%2520of%2520solid%2520tumors%26jtitle%3DCancer%2520Biol.%2520Ther.%26date%3D2005%26volume%3D5%26spage%3D538%26epage%3D545" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Tsou, H.-R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birnberg, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaplan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otteng, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kutterer, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suayan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zask, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ravi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bretz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grillo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGinnis, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rabindran, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayral-Kaloustian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansour, T. S.</span><span> </span><span class="NLM_article-title">Discovery of 4-(benzylaminomethylene)isoquinoline-1,3-(2<i>H</i>,4<i>H</i>)-diones and 4-[(pyridylmethyl)aminomethylene]isoquinoline-1,3-(2<i>H</i>,4<i>H</i>)-diones as potent and selective inhibitors of the cyclin-dependent kinase 4</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">2289</span><span class="NLM_x">–</span> <span class="NLM_lpage">2310</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm801026e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=2289-2310&author=H.-R.+Tsouauthor=X.+Liuauthor=G.+Birnbergauthor=J.+Kaplanauthor=M.+Ottengauthor=T.+Tranauthor=K.+Kuttererauthor=Z.+Tangauthor=R.+Suayanauthor=A.+Zaskauthor=M.+Raviauthor=A.+Bretzauthor=M.+Grilloauthor=J.+P.+McGinnisauthor=S.+K.+Rabindranauthor=S.+Ayral-Kaloustianauthor=T.+S.+Mansour&title=Discovery+of+4-%28benzylaminomethylene%29isoquinoline-1%2C3-%282H%2C4H%29-diones+and+4-%5B%28pyridylmethyl%29aminomethylene%5Disoquinoline-1%2C3-%282H%2C4H%29-diones+as+potent+and+selective+inhibitors+of+the+cyclin-dependent+kinase+4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm801026e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801026e%26sid%3Dliteratum%253Aachs%26aulast%3DTsou%26aufirst%3DH.-R.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DBirnberg%26aufirst%3DG.%26aulast%3DKaplan%26aufirst%3DJ.%26aulast%3DOtteng%26aufirst%3DM.%26aulast%3DTran%26aufirst%3DT.%26aulast%3DKutterer%26aufirst%3DK.%26aulast%3DTang%26aufirst%3DZ.%26aulast%3DSuayan%26aufirst%3DR.%26aulast%3DZask%26aufirst%3DA.%26aulast%3DRavi%26aufirst%3DM.%26aulast%3DBretz%26aufirst%3DA.%26aulast%3DGrillo%26aufirst%3DM.%26aulast%3DMcGinnis%26aufirst%3DJ.%2BP.%26aulast%3DRabindran%26aufirst%3DS.%2BK.%26aulast%3DAyral-Kaloustian%26aufirst%3DS.%26aulast%3DMansour%26aufirst%3DT.%2BS.%26atitle%3DDiscovery%2520of%25204-%2528benzylaminomethylene%2529isoquinoline-1%252C3-%25282H%252C4H%2529-diones%2520and%25204-%255B%2528pyridylmethyl%2529aminomethylene%255Disoquinoline-1%252C3-%25282H%252C4H%2529-diones%2520as%2520potent%2520and%2520selective%2520inhibitors%2520of%2520the%2520cyclin-dependent%2520kinase%25204%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D2289%26epage%3D2310" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 41 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Yong Chen, Xue Yuan, Wanhua Zhang, Minghai Tang, Li Zheng, Fang Wang, Wei Yan, Shengyong Yang, Yuquan Wei, Jun He, <span class="NLM_string-name hlFld-ContribAuthor">Lijuan Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Novel Dual Histone Deacetylase and Mammalian Target of Rapamycin Target Inhibitors as a Promising Strategy for Cancer Therapy. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (3)
                                     , 1577-1592. <a href="https://doi.org/10.1021/acs.jmedchem.8b01825" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01825</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01825&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01825%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BNovel%252BDual%252BHistone%252BDeacetylase%252Band%252BMammalian%252BTarget%252Bof%252BRapamycin%252BTarget%252BInhibitors%252Bas%252Ba%252BPromising%252BStrategy%252Bfor%252BCancer%252BTherapy%26aulast%3DChen%26aufirst%3DYong%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D22112018%26date%3D24012019%26date%3D10012019%26volume%3D62%26issue%3D3%26spage%3D1577%26epage%3D1592" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">S. Vijay  Kumar</span> and <span class="hlFld-ContribAuthor ">Dawei  Ma</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis of N-(Hetero)aryl Carbamates via CuI/MNAO Catalyzed Cross-Coupling of (Hetero)aryl Halides with Potassium Cyanate in Alcohols. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2018,</strong> <em>83 </em>
                                    (5)
                                     , 2706-2713. <a href="https://doi.org/10.1021/acs.joc.7b03175" title="DOI URL">https://doi.org/10.1021/acs.joc.7b03175</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.7b03175&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.7b03175%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSynthesis%252Bof%252BN-%252528Hetero%252529aryl%252BCarbamates%252Bvia%252BCuI%25252FMNAO%252BCatalyzed%252BCross-Coupling%252Bof%252B%252528Hetero%252529aryl%252BHalides%252Bwith%252BPotassium%252BCyanate%252Bin%252BAlcohols%26aulast%3DKumar%26aufirst%3DS.%2BVijay%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D17122017%26date%3D16022018%26date%3D02032018%26date%3D06022018%26volume%3D83%26issue%3D5%26spage%3D2706%26epage%3D2713" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qingxiang  Guo</span>, <span class="hlFld-ContribAuthor ">Chenhua  Yu</span>, <span class="hlFld-ContribAuthor ">Chao  Zhang</span>, <span class="hlFld-ContribAuthor ">Yongtao  Li</span>, <span class="hlFld-ContribAuthor ">Tianqi  Wang</span>, <span class="hlFld-ContribAuthor ">Zhi  Huang</span>, <span class="hlFld-ContribAuthor ">Xin  Wang</span>, <span class="hlFld-ContribAuthor ">Wei  Zhou</span>, <span class="hlFld-ContribAuthor ">Yao  Li</span>, <span class="hlFld-ContribAuthor ">Zhongxiang  Qin</span>, <span class="hlFld-ContribAuthor ">Cheng  Wang</span>, <span class="hlFld-ContribAuthor ">Ruifang  Gao</span>, <span class="hlFld-ContribAuthor ">Yongwei  Nie</span>, <span class="hlFld-ContribAuthor ">Yakun  Ma</span>, <span class="hlFld-ContribAuthor ">Yi  Shi</span>, <span class="hlFld-ContribAuthor ">Jianyu  Zheng</span>, <span class="hlFld-ContribAuthor ">Shengyong  Yang</span>, <span class="hlFld-ContribAuthor ">Yan  Fan</span>, and <span class="hlFld-ContribAuthor ">Rong  Xiang</span>  . </span><span class="cited-content_cbyCitation_article-title">Highly Selective, Potent, and Oral mTOR Inhibitor for Treatment of Cancer as Autophagy Inducer. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (3)
                                     , 881-904. <a href="https://doi.org/10.1021/acs.jmedchem.7b01402" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01402</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01402&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01402%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DHighly%252BSelective%25252C%252BPotent%25252C%252Band%252BOral%252BmTOR%252BInhibitor%252Bfor%252BTreatment%252Bof%252BCancer%252Bas%252BAutophagy%252BInducer%26aulast%3DGuo%26aufirst%3DQingxiang%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D21092017%26date%3D27012018%26date%3D08022018%26date%3D08012018%26volume%3D61%26issue%3D3%26spage%3D881%26epage%3D904" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Martin  Andrs</span>, <span class="hlFld-ContribAuthor ">Jan  Korabecny</span>, <span class="hlFld-ContribAuthor ">Daniel  Jun</span>, <span class="hlFld-ContribAuthor ">Zdenek  Hodny</span>, <span class="hlFld-ContribAuthor ">Jiri  Bartek</span>, and <span class="hlFld-ContribAuthor ">Kamil  Kuca</span>  . </span><span class="cited-content_cbyCitation_article-title">Phosphatidylinositol 3-Kinase (PI3K) and Phosphatidylinositol 3-Kinase-Related Kinase (PIKK) Inhibitors: Importance of the Morpholine Ring. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (1)
                                     , 41-71. <a href="https://doi.org/10.1021/jm501026z" title="DOI URL">https://doi.org/10.1021/jm501026z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm501026z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm501026z%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPhosphatidylinositol%252B3-Kinase%252B%252528PI3K%252529%252Band%252BPhosphatidylinositol%252B3-Kinase-Related%252BKinase%252B%252528PIKK%252529%252BInhibitors%25253A%252BImportance%252Bof%252Bthe%252BMorpholine%252BRing%26aulast%3DAndrs%26aufirst%3DMartin%26date%3D2015%26date%3D2014%26date%3D2014%26date%3D08072014%26date%3D05122014%26date%3D08012015%26date%3D11112014%26volume%3D58%26issue%3D1%26spage%3D41%26epage%3D71" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Silvia  Schenone</span>, <span class="hlFld-ContribAuthor ">Marco  Radi</span>, <span class="hlFld-ContribAuthor ">Francesca  Musumeci</span>, <span class="hlFld-ContribAuthor ">Chiara  Brullo</span>, and <span class="hlFld-ContribAuthor ">Maurizio  Botta</span>  . </span><span class="cited-content_cbyCitation_article-title">Biologically Driven Synthesis of Pyrazolo[3,4-d]pyrimidines As Protein Kinase Inhibitors: An Old Scaffold As a New Tool for Medicinal Chemistry and Chemical Biology Studies. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2014,</strong> <em>114 </em>
                                    (14)
                                     , 7189-7238. <a href="https://doi.org/10.1021/cr400270z" title="DOI URL">https://doi.org/10.1021/cr400270z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cr400270z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcr400270z%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DBiologically%252BDriven%252BSynthesis%252Bof%252BPyrazolo%25255B3%25252C4-d%25255Dpyrimidines%252BAs%252BProtein%252BKinase%252BInhibitors%25253A%252BAn%252BOld%252BScaffold%252BAs%252Ba%252BNew%252BTool%252Bfor%252BMedicinal%252BChemistry%252Band%252BChemical%252BBiology%252BStudies%26aulast%3DSchenone%26aufirst%3DSilvia%26date%3D2014%26date%3D2014%26date%3D2013%26date%3D16052013%26date%3D29052014%26date%3D23072014%26volume%3D114%26issue%3D14%26spage%3D7189%26epage%3D7238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thibault  Saurat</span>, <span class="hlFld-ContribAuthor ">Frédéric  Buron</span>, <span class="hlFld-ContribAuthor ">Nuno  Rodrigues</span>, <span class="hlFld-ContribAuthor ">Marie-Ludivine  de Tauzia</span>, <span class="hlFld-ContribAuthor ">Lionel  Colliandre</span>, <span class="hlFld-ContribAuthor ">Stéphane  Bourg</span>, <span class="hlFld-ContribAuthor ">Pascal  Bonnet</span>, <span class="hlFld-ContribAuthor ">Gérald  Guillaumet</span>, <span class="hlFld-ContribAuthor ">Mohamed  Akssira</span>, <span class="hlFld-ContribAuthor ">Anne  Corlu</span>, <span class="hlFld-ContribAuthor ">Christiane  Guillouzo</span>, <span class="hlFld-ContribAuthor ">Pauline  Berthier</span>, <span class="hlFld-ContribAuthor ">Pascale  Rio</span>, <span class="hlFld-ContribAuthor ">Marie-Lise  Jourdan</span>, <span class="hlFld-ContribAuthor ">Hélène  Bénédetti</span>, and <span class="hlFld-ContribAuthor ">Sylvain  Routier</span>  . </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Biological Activity of Pyridopyrimidine Scaffolds as Novel PI3K/mTOR Dual Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (3)
                                     , 613-631. <a href="https://doi.org/10.1021/jm401138v" title="DOI URL">https://doi.org/10.1021/jm401138v</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm401138v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm401138v%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BBiological%252BActivity%252Bof%252BPyridopyrimidine%252BScaffolds%252Bas%252BNovel%252BPI3K%25252FmTOR%252BDual%252BInhibitors%26aulast%3DSaurat%26aufirst%3DThibault%26date%3D2014%26date%3D2014%26date%3D2013%26date%3D26072013%26date%3D21012014%26date%3D13022014%26date%3D17122013%26volume%3D57%26issue%3D3%26spage%3D613%26epage%3D631" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Suresh  Babu</span>, <span class="hlFld-ContribAuthor ">Christie  Morrill</span>, <span class="hlFld-ContribAuthor ">Neil G.  Almstead</span>, and <span class="hlFld-ContribAuthor ">Young-Choon  Moon</span>  . </span><span class="cited-content_cbyCitation_article-title">Selective Synthesis of 1-Substituted 4-Chloropyrazolo[3,4-d]pyrimidines. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2013,</strong> <em>15 </em>
                                    (8)
                                     , 1882-1885. <a href="https://doi.org/10.1021/ol4005382" title="DOI URL">https://doi.org/10.1021/ol4005382</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ol4005382&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fol4005382%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DSelective%252BSynthesis%252Bof%252B1-Substituted%252B4-Chloropyrazolo%25255B3%25252C4-d%25255Dpyrimidines%26aulast%3DBabu%26aufirst%3DSuresh%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D26022013%26date%3D10042013%26date%3D19042013%26volume%3D15%26issue%3D8%26spage%3D1882%26epage%3D1885" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Craig S.  Takeuchi</span>, <span class="hlFld-ContribAuthor ">Byung Gyu  Kim</span>, <span class="hlFld-ContribAuthor ">Charles M.  Blazey</span>, <span class="hlFld-ContribAuthor ">Sunghoon  Ma</span>, <span class="hlFld-ContribAuthor ">Henry W. B.  Johnson</span>, <span class="hlFld-ContribAuthor ">Neel K.  Anand</span>, <span class="hlFld-ContribAuthor ">Arlyn  Arcalas</span>, <span class="hlFld-ContribAuthor ">Tae Gon  Baik</span>, <span class="hlFld-ContribAuthor ">Chris A.  Buhr</span>, <span class="hlFld-ContribAuthor ">Jonah  Cannoy</span>, <span class="hlFld-ContribAuthor ">Sergey  Epshteyn</span>, <span class="hlFld-ContribAuthor ">Anagha  Joshi</span>, <span class="hlFld-ContribAuthor ">Katherine  Lara</span>, <span class="hlFld-ContribAuthor ">Matthew S.  Lee</span>, <span class="hlFld-ContribAuthor ">Longcheng  Wang</span>, <span class="hlFld-ContribAuthor ">James W.  Leahy</span>, <span class="hlFld-ContribAuthor ">John M.  Nuss</span>, <span class="hlFld-ContribAuthor ">Naing  Aay</span>, <span class="hlFld-ContribAuthor ">Ron  Aoyama</span>, <span class="hlFld-ContribAuthor ">Paul  Foster</span>, <span class="hlFld-ContribAuthor ">Jae  Lee</span>, <span class="hlFld-ContribAuthor ">Isabelle  Lehoux</span>, <span class="hlFld-ContribAuthor ">Narsimha  Munagala</span>, <span class="hlFld-ContribAuthor ">Arthur  Plonowski</span>, <span class="hlFld-ContribAuthor ">Sharmila  Rajan</span>, <span class="hlFld-ContribAuthor ">John  Woolfrey</span>, <span class="hlFld-ContribAuthor ">Kyoko  Yamaguchi</span>, <span class="hlFld-ContribAuthor ">Peter  Lamb</span>, and <span class="hlFld-ContribAuthor ">Nicole  Miller</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of a Novel Class of Highly Potent, Selective, ATP-Competitive, and Orally Bioavailable Inhibitors of the Mammalian Target of Rapamycin (mTOR). </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (6)
                                     , 2218-2234. <a href="https://doi.org/10.1021/jm3007933" title="DOI URL">https://doi.org/10.1021/jm3007933</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm3007933&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm3007933%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Ba%252BNovel%252BClass%252Bof%252BHighly%252BPotent%25252C%252BSelective%25252C%252BATP-Competitive%25252C%252Band%252BOrally%252BBioavailable%252BInhibitors%252Bof%252Bthe%252BMammalian%252BTarget%252Bof%252BRapamycin%252B%252528mTOR%252529%26aulast%3DTakeuchi%26aufirst%3DCraig%2BS.%26date%3D2013%26date%3D2013%26date%3D2012%26date%3D06062012%26date%3D07032013%26date%3D28032013%26date%3D08022013%26volume%3D56%26issue%3D6%26spage%3D2218%26epage%3D2234" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">P. Jake  Slavish</span>, <span class="hlFld-ContribAuthor ">Jeanine E.  Price</span>, <span class="hlFld-ContribAuthor ">Parimala  Hanumesh</span>, and <span class="hlFld-ContribAuthor ">Thomas R.  Webb</span>. </span><span class="cited-content_cbyCitation_article-title">Efficient Synthesis of Pyrazolopyrimidine Libraries. </span><span class="cited-content_cbyCitation_journal-name">Journal of Combinatorial Chemistry</span><span> <strong>2010,</strong> <em>12 </em>
                                    (6)
                                     , 807-809. <a href="https://doi.org/10.1021/cc1001204" title="DOI URL">https://doi.org/10.1021/cc1001204</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cc1001204&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcc1001204%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Combinatorial%2520Chemistry%26atitle%3DEfficient%252BSynthesis%252Bof%252BPyrazolopyrimidine%252BLibraries%26aulast%3DSlavish%26aufirst%3DP.%2BJake%26date%3D2010%26date%3D2010%26date%3D2010%26date%3D21%252006%25202010%26date%3D30082010%26date%3D08112010%26volume%3D12%26issue%3D6%26spage%3D807%26epage%3D809" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chiara  Borsari</span>, <span class="hlFld-ContribAuthor ">Martina  De Pascale</span>, <span class="hlFld-ContribAuthor ">Matthias P.  Wymann</span>. </span><span class="cited-content_cbyCitation_article-title">Chemical and Structural Strategies to Selectively Target mTOR Kinase. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2021,</strong> <em>9 </em><a href="https://doi.org/10.1002/cmdc.202100332" title="DOI URL">https://doi.org/10.1002/cmdc.202100332</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.202100332&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.202100332%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DChemical%252Band%252BStructural%252BStrategies%252Bto%252BSelectively%252BTarget%252BmTOR%252BKinase%26aulast%3DBorsari%26aufirst%3DChiara%26date%3D2021%26date%3D2021%26volume%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Busra O.  Aydin</span>, <span class="hlFld-ContribAuthor ">Derya  Anil</span>, <span class="hlFld-ContribAuthor ">Yeliz  Demir</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of
              N
              ‐alkylated pyrazolo[3,4‐
              d
              ]pyrimidine analogs and evaluation of acetylcholinesterase and carbonic anhydrase inhibition properties. </span><span class="cited-content_cbyCitation_journal-name">Archiv der Pharmazie</span><span> <strong>2021,</strong> <em>354 </em>
                                    (5)
                                     , 2000330. <a href="https://doi.org/10.1002/ardp.202000330" title="DOI URL">https://doi.org/10.1002/ardp.202000330</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ardp.202000330&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fardp.202000330%26sid%3Dliteratum%253Aachs%26jtitle%3DArchiv%2520der%2520Pharmazie%26atitle%3DSynthesis%252Bof%252BN%252B%2525E2%252580%252590alkylated%252Bpyrazolo%25255B3%25252C4%2525E2%252580%252590%252Bd%252B%25255Dpyrimidine%252Banalogs%252Band%252Bevaluation%252Bof%252Bacetylcholinesterase%252Band%252Bcarbonic%252Banhydrase%252Binhibition%252Bproperties%26aulast%3DAydin%26aufirst%3DBusra%2BO.%26date%3D2021%26date%3D2021%26volume%3D354%26issue%3D5%26spage%3D2000330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eddie L  Myers</span>. </span><span class="cited-content_cbyCitation_article-title">Bicyclic 5–6 Systems: Other Four Heteroatoms 2:2. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,<a href="https://doi.org/10.1016/B978-0-12-818655-8.00056-1" title="DOI URL">https://doi.org/10.1016/B978-0-12-818655-8.00056-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-818655-8.00056-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-818655-8.00056-1%26sid%3Dliteratum%253Aachs%26atitle%3DBicyclic%252B5%2525E2%252580%2525936%252BSystems%25253A%252BOther%252BFour%252BHeteroatoms%252B2%25253A2%26aulast%3DMyers%26aufirst%3DEddie%2BL%26date%3D2021%26pub%3DElsevier%26atitle%3DReference%252BModule%252Bin%252BChemistry%25252C%252BMolecular%252BSciences%252Band%252BChemical%252BEngineering%26date%3D2021%26volume%3D22" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Supreet  Gaonkar</span>, <span class="hlFld-ContribAuthor ">Mohammed Azharuddin  Savanur</span>, <span class="hlFld-ContribAuthor ">AfraQuasar A.  Nadaf</span>, <span class="hlFld-ContribAuthor ">Mahesh S.  Najare</span>, <span class="hlFld-ContribAuthor ">Shivaraj  Mantur</span>, <span class="hlFld-ContribAuthor ">Manjunatha  Garbhagudi</span>, <span class="hlFld-ContribAuthor ">Sikandar I.  Mulla</span>, <span class="hlFld-ContribAuthor ">Imtiyaz Ahmed M.  Khazi</span>. </span><span class="cited-content_cbyCitation_article-title">Novel pyrazolo[3,4‐
              d
              ]pyrimidine derivatives inhibit human cancer cell proliferation and induce apoptosis by ROS generation. </span><span class="cited-content_cbyCitation_journal-name">Archiv der Pharmazie</span><span> <strong>2020,</strong> <em>353 </em>
                                    (4)
                                     , 1900296. <a href="https://doi.org/10.1002/ardp.201900296" title="DOI URL">https://doi.org/10.1002/ardp.201900296</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ardp.201900296&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fardp.201900296%26sid%3Dliteratum%253Aachs%26jtitle%3DArchiv%2520der%2520Pharmazie%26atitle%3DNovel%252Bpyrazolo%25255B3%25252C4%2525E2%252580%252590%252Bd%252B%25255Dpyrimidine%252Bderivatives%252Binhibit%252Bhuman%252Bcancer%252Bcell%252Bproliferation%252Band%252Binduce%252Bapoptosis%252Bby%252BROS%252Bgeneration%26aulast%3DGaonkar%26aufirst%3DSupreet%26date%3D2020%26volume%3D353%26issue%3D4%26spage%3D1900296" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Archana  Kumari</span>, <span class="hlFld-ContribAuthor ">Rajesh K.  Singh</span>. </span><span class="cited-content_cbyCitation_article-title">Morpholine as ubiquitous pharmacophore in medicinal chemistry: Deep insight into the structure-activity relationship (SAR). </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>96 </em>, 103578. <a href="https://doi.org/10.1016/j.bioorg.2020.103578" title="DOI URL">https://doi.org/10.1016/j.bioorg.2020.103578</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2020.103578&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2020.103578%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DMorpholine%252Bas%252Bubiquitous%252Bpharmacophore%252Bin%252Bmedicinal%252Bchemistry%25253A%252BDeep%252Binsight%252Binto%252Bthe%252Bstructure-activity%252Brelationship%252B%252528SAR%252529%26aulast%3DKumari%26aufirst%3DArchana%26date%3D2020%26volume%3D96%26spage%3D103578" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ying-Qi  Feng</span>, <span class="hlFld-ContribAuthor ">Shuang-Xi  Gu</span>, <span class="hlFld-ContribAuthor ">Yong-Shou  Chen</span>, <span class="hlFld-ContribAuthor ">Xu-Dong  Gao</span>, <span class="hlFld-ContribAuthor ">Yi-Xin  Ren</span>, <span class="hlFld-ContribAuthor ">Jian-Chao  Chen</span>, <span class="hlFld-ContribAuthor ">Yin-Ying  Lu</span>, <span class="hlFld-ContribAuthor ">Heng  Zhang</span>, <span class="hlFld-ContribAuthor ">Shuang  Cao</span>. </span><span class="cited-content_cbyCitation_article-title"><p>Virtual Screening and Optimization of Novel mTOR Inhibitors for Radiosensitization of Hepatocellular Carcinoma</p>. </span><span class="cited-content_cbyCitation_journal-name">Drug Design, Development and Therapy</span><span> <strong>2020,</strong> <em>Volume 14 </em>, 1779-1798. <a href="https://doi.org/10.2147/DDDT.S249156" title="DOI URL">https://doi.org/10.2147/DDDT.S249156</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2147/DDDT.S249156&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2147%2FDDDT.S249156%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Design%252C%2520Development%2520and%2520Therapy%26atitle%3D%25253Cp%25253EVirtual%252BScreening%252Band%252BOptimization%252Bof%252BNovel%252BmTOR%252BInhibitors%252Bfor%252BRadiosensitization%252Bof%252BHepatocellular%252BCarcinoma%25253C%25252Fp%25253E%26aulast%3DFeng%26aufirst%3DYing-Qi%26date%3D2020%26date%3D2020%26volume%3DVolume%252014%26spage%3D1779%26epage%3D1798" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Supreet  Gaonkar</span>, <span class="hlFld-ContribAuthor ">Mohammed Azharuddin  Savanur</span>, <span class="hlFld-ContribAuthor ">Manjunath G.  Sunagar</span>, <span class="hlFld-ContribAuthor ">Bijesh  Puthusseri</span>, <span class="hlFld-ContribAuthor ">Narahari  Deshapande</span>, <span class="hlFld-ContribAuthor ">Afra A.  Nadaf</span>, <span class="hlFld-ContribAuthor ">Imtiyaz Ahmed M.  Khazi</span>. </span><span class="cited-content_cbyCitation_article-title">Exploring the potential of newly synthesized 4-methyl-6-morpholino-pyrimidine derivatives as antiproliferative agents. </span><span class="cited-content_cbyCitation_journal-name">New Journal of Chemistry</span><span> <strong>2018,</strong> <em>42 </em>
                                    (4)
                                     , 2790-2803. <a href="https://doi.org/10.1039/C7NJ04157H" title="DOI URL">https://doi.org/10.1039/C7NJ04157H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7NJ04157H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7NJ04157H%26sid%3Dliteratum%253Aachs%26jtitle%3DNew%2520Journal%2520of%2520Chemistry%26atitle%3DExploring%252Bthe%252Bpotential%252Bof%252Bnewly%252Bsynthesized%252B4-methyl-6-morpholino-pyrimidine%252Bderivatives%252Bas%252Bantiproliferative%252Bagents%26aulast%3DGaonkar%26aufirst%3DSupreet%26date%3D2018%26date%3D2018%26volume%3D42%26issue%3D4%26spage%3D2790%26epage%3D2803" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yu  Liu</span>, <span class="hlFld-ContribAuthor ">Wen-zhu  Wan</span>, <span class="hlFld-ContribAuthor ">Yan  Li</span>, <span class="hlFld-ContribAuthor ">Guan-lian  Zhou</span>, <span class="hlFld-ContribAuthor ">Xin-guang  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Recent development of ATP-competitive small molecule phosphatidylinostitol-3-kinase inhibitors as anticancer agents. </span><span class="cited-content_cbyCitation_journal-name">Oncotarget</span><span> <strong>2017,</strong> <em>8 </em>
                                    (4)
                                     , 7181-7200. <a href="https://doi.org/10.18632/oncotarget.12742" title="DOI URL">https://doi.org/10.18632/oncotarget.12742</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18632/oncotarget.12742&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18632%2Foncotarget.12742%26sid%3Dliteratum%253Aachs%26jtitle%3DOncotarget%26atitle%3DRecent%252Bdevelopment%252Bof%252BATP-competitive%252Bsmall%252Bmolecule%252Bphosphatidylinostitol-3-kinase%252Binhibitors%252Bas%252Banticancer%252Bagents%26aulast%3DLiu%26aufirst%3DYu%26date%3D2017%26date%3D2016%26volume%3D8%26issue%3D4%26spage%3D7181%26epage%3D7200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Klaas  Verschueren</span>, <span class="hlFld-ContribAuthor ">Mathias  Cobbaut</span>, <span class="hlFld-ContribAuthor ">Joachim  Demaerel</span>, <span class="hlFld-ContribAuthor ">Lina  Saadah</span>, <span class="hlFld-ContribAuthor ">Arnout R. D.  Voet</span>, <span class="hlFld-ContribAuthor ">Johan  Van Lint</span>, <span class="hlFld-ContribAuthor ">Wim M.  De Borggraeve</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a potent protein kinase D inhibitor: insights in the binding mode of pyrazolo[3,4-d]pyrimidine analogues. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2017,</strong> <em>8 </em>
                                    (3)
                                     , 640-646. <a href="https://doi.org/10.1039/C6MD00675B" title="DOI URL">https://doi.org/10.1039/C6MD00675B</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6MD00675B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6MD00675B%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DDiscovery%252Bof%252Ba%252Bpotent%252Bprotein%252Bkinase%252BD%252Binhibitor%25253A%252Binsights%252Bin%252Bthe%252Bbinding%252Bmode%252Bof%252Bpyrazolo%25255B3%25252C4-d%25255Dpyrimidine%252Banalogues%26aulast%3DVerschueren%26aufirst%3DKlaas%26date%3D2017%26date%3D2017%26volume%3D8%26issue%3D3%26spage%3D640%26epage%3D646" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shuang  Cao</span>, <span class="hlFld-ContribAuthor ">Ruiyuan  Cao</span>, <span class="hlFld-ContribAuthor ">Xialing  Liu</span>, <span class="hlFld-ContribAuthor ">Xiang  Luo</span>, <span class="hlFld-ContribAuthor ">Wu  Zhong</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis and Biological Evaluation of Novel Benzothiazole Derivatives as Selective PI3Kβ Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2016,</strong> <em>21 </em>
                                    (7)
                                     , 876. <a href="https://doi.org/10.3390/molecules21070876" title="DOI URL">https://doi.org/10.3390/molecules21070876</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules21070876&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules21070876%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DDesign%25252C%252BSynthesis%252Band%252BBiological%252BEvaluation%252Bof%252BNovel%252BBenzothiazole%252BDerivatives%252Bas%252BSelective%252BPI3K%2525CE%2525B2%252BInhibitors%26aulast%3DCao%26aufirst%3DShuang%26date%3D2016%26date%3D2016%26volume%3D21%26issue%3D7%26spage%3D876" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maria Elena  Meza-Aviña</span>, <span class="hlFld-ContribAuthor ">Mary A.  Lingerfelt</span>, <span class="hlFld-ContribAuthor ">Linda M.  Console-Bram</span>, <span class="hlFld-ContribAuthor ">Thomas F.  Gamage</span>, <span class="hlFld-ContribAuthor ">Haleli  Sharir</span>, <span class="hlFld-ContribAuthor ">Kristen E.  Gettys</span>, <span class="hlFld-ContribAuthor ">Dow P.  Hurst</span>, <span class="hlFld-ContribAuthor ">Evangelia  Kotsikorou</span>, <span class="hlFld-ContribAuthor ">Derek M.  Shore</span>, <span class="hlFld-ContribAuthor ">Marc G.  Caron</span>, <span class="hlFld-ContribAuthor ">Narasinga  Rao</span>, <span class="hlFld-ContribAuthor ">Larry S.  Barak</span>, <span class="hlFld-ContribAuthor ">Mary E.  Abood</span>, <span class="hlFld-ContribAuthor ">Patricia H.  Reggio</span>, <span class="hlFld-ContribAuthor ">Mitchell P.  Croatt</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, and analysis of antagonists of GPR55: Piperidine-substituted 1,3,4-oxadiazol-2-ones. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>26 </em>
                                    (7)
                                     , 1827-1830. <a href="https://doi.org/10.1016/j.bmcl.2016.02.030" title="DOI URL">https://doi.org/10.1016/j.bmcl.2016.02.030</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2016.02.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2016.02.030%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Band%252Banalysis%252Bof%252Bantagonists%252Bof%252BGPR55%25253A%252BPiperidine-substituted%252B1%25252C3%25252C4-oxadiazol-2-ones%26aulast%3DMeza-Avi%25C3%25B1a%26aufirst%3DMaria%2BElena%26date%3D2016%26volume%3D26%26issue%3D7%26spage%3D1827%26epage%3D1830" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Narsidas J.  Parmar</span>, <span class="hlFld-ContribAuthor ">Bhavesh R.  Pansuriya</span>, <span class="hlFld-ContribAuthor ">Bhagyashri D.  Parmar</span>, <span class="hlFld-ContribAuthor ">Hitesh A.  Barad</span>. </span><span class="cited-content_cbyCitation_article-title">Solvent-free, one-pot synthesis and biological evaluation of some new dipyrazolo [3,4-b:4′,3′-e]pyranylquinolones and their precursors. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2014,</strong> <em>23 </em>
                                    (1)
                                     , 42-56. <a href="https://doi.org/10.1007/s00044-013-0608-2" title="DOI URL">https://doi.org/10.1007/s00044-013-0608-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-013-0608-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-013-0608-2%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3DSolvent-free%25252C%252Bone-pot%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bsome%252Bnew%252Bdipyrazolo%252B%25255B3%25252C4-b%25253A4%2525E2%252580%2525B2%25252C3%2525E2%252580%2525B2-e%25255Dpyranylquinolones%252Band%252Btheir%252Bprecursors%26aulast%3DParmar%26aufirst%3DNarsidas%2BJ.%26date%3D2014%26date%3D2013%26volume%3D23%26issue%3D1%26spage%3D42%26epage%3D56" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shahnaz  Rostamizadeh</span>, <span class="hlFld-ContribAuthor ">Masoomeh  Nojavan</span>, <span class="hlFld-ContribAuthor ">Reza  Aryan</span>, <span class="hlFld-ContribAuthor ">Elyass  Isapoor</span>. </span><span class="cited-content_cbyCitation_article-title">A Facile Synthesis of New Pyrazolo[3,4-
              d
              ]pyrimidine Derivatives
              via
              a One-Pot Four-Component Reaction with Sodium Acetate Supported on Basic Alumina as Promoter. </span><span class="cited-content_cbyCitation_journal-name">Helvetica Chimica Acta</span><span> <strong>2013,</strong> <em>96 </em>
                                    (12)
                                     , 2267-2275. <a href="https://doi.org/10.1002/hlca.201300060" title="DOI URL">https://doi.org/10.1002/hlca.201300060</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/hlca.201300060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fhlca.201300060%26sid%3Dliteratum%253Aachs%26jtitle%3DHelvetica%2520Chimica%2520Acta%26atitle%3DA%252BFacile%252BSynthesis%252Bof%252BNew%252BPyrazolo%25255B3%25252C4-%252Bd%252B%25255Dpyrimidine%252BDerivatives%252Bvia%252Ba%252BOne-Pot%252BFour-Component%252BReaction%252Bwith%252BSodium%252BAcetate%252BSupported%252Bon%252BBasic%252BAlumina%252Bas%252BPromoter%26aulast%3DRostamizadeh%26aufirst%3DShahnaz%26date%3D2013%26date%3D2013%26volume%3D96%26issue%3D12%26spage%3D2267%26epage%3D2275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Manuj  Tandon</span>, <span class="hlFld-ContribAuthor ">James  Johnson</span>, <span class="hlFld-ContribAuthor ">Zhihong  Li</span>, <span class="hlFld-ContribAuthor ">Shuping  Xu</span>, <span class="hlFld-ContribAuthor ">Peter  Wipf</span>, <span class="hlFld-ContribAuthor ">Qiming Jane  Wang</span>, . </span><span class="cited-content_cbyCitation_article-title">New Pyrazolopyrimidine Inhibitors of Protein Kinase D as Potent Anticancer Agents for Prostate Cancer Cells. </span><span class="cited-content_cbyCitation_journal-name">PLoS ONE</span><span> <strong>2013,</strong> <em>8 </em>
                                    (9)
                                     , e75601. <a href="https://doi.org/10.1371/journal.pone.0075601" title="DOI URL">https://doi.org/10.1371/journal.pone.0075601</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0075601&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0075601%26sid%3Dliteratum%253Aachs%26jtitle%3DPLoS%2520ONE%26atitle%3DNew%252BPyrazolopyrimidine%252BInhibitors%252Bof%252BProtein%252BKinase%252BD%252Bas%252BPotent%252BAnticancer%252BAgents%252Bfor%252BProstate%252BCancer%252BCells%26aulast%3DTandon%26aufirst%3DManuj%26date%3D2013%26date%3D2013%26volume%3D8%26issue%3D9%26spage%3De75601" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wendy  Lee</span>, <span class="hlFld-ContribAuthor ">Daniel F.  Ortwine</span>, <span class="hlFld-ContribAuthor ">Philippe  Bergeron</span>, <span class="hlFld-ContribAuthor ">Kevin  Lau</span>, <span class="hlFld-ContribAuthor ">Lichuan  Lin</span>, <span class="hlFld-ContribAuthor ">Shiva  Malek</span>, <span class="hlFld-ContribAuthor ">Jim  Nonomiya</span>, <span class="hlFld-ContribAuthor ">Zhonghua  Pei</span>, <span class="hlFld-ContribAuthor ">Kirk D.  Robarge</span>, <span class="hlFld-ContribAuthor ">Stephen  Schmidt</span>, <span class="hlFld-ContribAuthor ">Steve  Sideris</span>, <span class="hlFld-ContribAuthor ">Joseph P.  Lyssikatos</span>. </span><span class="cited-content_cbyCitation_article-title">A hit to lead discovery of novel N-methylated imidazolo-, pyrrolo-, and pyrazolo-pyrimidines as potent and selective mTOR inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>23 </em>
                                    (18)
                                     , 5097-5104. <a href="https://doi.org/10.1016/j.bmcl.2013.07.027" title="DOI URL">https://doi.org/10.1016/j.bmcl.2013.07.027</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2013.07.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2013.07.027%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DA%252Bhit%252Bto%252Blead%252Bdiscovery%252Bof%252Bnovel%252BN-methylated%252Bimidazolo-%25252C%252Bpyrrolo-%25252C%252Band%252Bpyrazolo-pyrimidines%252Bas%252Bpotent%252Band%252Bselective%252BmTOR%252Binhibitors%26aulast%3DLee%26aufirst%3DWendy%26date%3D2013%26volume%3D23%26issue%3D18%26spage%3D5097%26epage%3D5104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shahnaz  Rostamizadeh</span>, <span class="hlFld-ContribAuthor ">Masoomeh  Nojavan</span>, <span class="hlFld-ContribAuthor ">Reza  Aryan</span>, <span class="hlFld-ContribAuthor ">Hamid  Sadeghian</span>, <span class="hlFld-ContribAuthor ">Mahdieh  Davoodnejad</span>. </span><span class="cited-content_cbyCitation_article-title">A novel and efficient synthesis of pyrazolo[3,4-d]pyrimidine derivatives and the study of their anti-bacterial activity. </span><span class="cited-content_cbyCitation_journal-name">Chinese Chemical Letters</span><span> <strong>2013,</strong> <em>24 </em>
                                    (7)
                                     , 629-632. <a href="https://doi.org/10.1016/j.cclet.2013.04.035" title="DOI URL">https://doi.org/10.1016/j.cclet.2013.04.035</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cclet.2013.04.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cclet.2013.04.035%26sid%3Dliteratum%253Aachs%26jtitle%3DChinese%2520Chemical%2520Letters%26atitle%3DA%252Bnovel%252Band%252Befficient%252Bsynthesis%252Bof%252Bpyrazolo%25255B3%25252C4-d%25255Dpyrimidine%252Bderivatives%252Band%252Bthe%252Bstudy%252Bof%252Btheir%252Banti-bacterial%252Bactivity%26aulast%3DRostamizadeh%26aufirst%3DShahnaz%26date%3D2013%26volume%3D24%26issue%3D7%26spage%3D629%26epage%3D632" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xinye  Yang</span>, <span class="hlFld-ContribAuthor ">Yihua  Zhang</span>, <span class="hlFld-ContribAuthor ">Dawei  Ma</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of Aryl Carbamates
              via
              Copper‐Catalyzed Coupling of Aryl Halides with Potassium Cyanate. </span><span class="cited-content_cbyCitation_journal-name">Advanced Synthesis & Catalysis</span><span> <strong>2012,</strong> <em>354 </em>
                                    (13)
                                     , 2443-2446. <a href="https://doi.org/10.1002/adsc.201200296" title="DOI URL">https://doi.org/10.1002/adsc.201200296</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adsc.201200296&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadsc.201200296%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Synthesis%2520%2526%2520Catalysis%26atitle%3DSynthesis%252Bof%252BAryl%252BCarbamates%252Bvia%252BCopper%2525E2%252580%252590Catalyzed%252BCoupling%252Bof%252BAryl%252BHalides%252Bwith%252BPotassium%252BCyanate%26aulast%3DYang%26aufirst%3DXinye%26date%3D2012%26date%3D2012%26volume%3D354%26issue%3D13%26spage%3D2443%26epage%3D2446" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ting  Ran</span>, <span class="hlFld-ContribAuthor ">Tao  Lu</span>, <span class="hlFld-ContribAuthor ">Haoliang  Yuan</span>, <span class="hlFld-ContribAuthor ">Haichun  Liu</span>, <span class="hlFld-ContribAuthor ">Jian  Wang</span>, <span class="hlFld-ContribAuthor ">Weiwei  Zhang</span>, <span class="hlFld-ContribAuthor ">Ying  Leng</span>, <span class="hlFld-ContribAuthor ">Guowu  Lin</span>, <span class="hlFld-ContribAuthor ">Shulin  Zhuang</span>, <span class="hlFld-ContribAuthor ">Yadong  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">A selectivity study on mTOR/PI3Kα inhibitors by homology modeling and 3D-QSAR. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Modeling</span><span> <strong>2012,</strong> <em>18 </em>
                                    (1)
                                     , 171-186. <a href="https://doi.org/10.1007/s00894-011-1034-3" title="DOI URL">https://doi.org/10.1007/s00894-011-1034-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00894-011-1034-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00894-011-1034-3%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Modeling%26atitle%3DA%252Bselectivity%252Bstudy%252Bon%252BmTOR%25252FPI3K%2525CE%2525B1%252Binhibitors%252Bby%252Bhomology%252Bmodeling%252Band%252B3D-QSAR%26aulast%3DRan%26aufirst%3DTing%26date%3D2012%26date%3D2011%26volume%3D18%26issue%3D1%26spage%3D171%26epage%3D186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Deborah S.  Mortensen</span>, <span class="hlFld-ContribAuthor ">Sophie M.  Perrin-Ninkovic</span>, <span class="hlFld-ContribAuthor ">Roy  Harris</span>, <span class="hlFld-ContribAuthor ">Branden G.S.  Lee</span>, <span class="hlFld-ContribAuthor ">Graziella  Shevlin</span>, <span class="hlFld-ContribAuthor ">Matt  Hickman</span>, <span class="hlFld-ContribAuthor ">Gody  Khambatta</span>, <span class="hlFld-ContribAuthor ">Rene R.  Bisonette</span>, <span class="hlFld-ContribAuthor ">Kimberly E.  Fultz</span>, <span class="hlFld-ContribAuthor ">Sabita  Sankar</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and SAR exploration of a novel series of imidazo[4,5-b]pyrazin-2-ones as potent and selective mTOR kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2011,</strong> <em>21 </em>
                                    (22)
                                     , 6793-6799. <a href="https://doi.org/10.1016/j.bmcl.2011.09.035" title="DOI URL">https://doi.org/10.1016/j.bmcl.2011.09.035</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2011.09.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2011.09.035%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Band%252BSAR%252Bexploration%252Bof%252Ba%252Bnovel%252Bseries%252Bof%252Bimidazo%25255B4%25252C5-b%25255Dpyrazin-2-ones%252Bas%252Bpotent%252Band%252Bselective%252BmTOR%252Bkinase%252Binhibitors%26aulast%3DMortensen%26aufirst%3DDeborah%2BS.%26date%3D2011%26volume%3D21%26issue%3D22%26spage%3D6793%26epage%3D6799" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aly A.  Aly</span>, <span class="hlFld-ContribAuthor ">Iman A. Gad  El-Karim</span>. </span><span class="cited-content_cbyCitation_article-title">Facile Synthesis of New Pyrazolopyrimidine Derivatives of Potential Biosignificant Interest. </span><span class="cited-content_cbyCitation_journal-name">Journal of the Korean Chemical Society</span><span> <strong>2011,</strong> <em>55 </em>
                                    (5)
                                     , 781-786. <a href="https://doi.org/10.5012/jkcs.2011.55.5.781" title="DOI URL">https://doi.org/10.5012/jkcs.2011.55.5.781</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.5012/jkcs.2011.55.5.781&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.5012%2Fjkcs.2011.55.5.781%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520Korean%2520Chemical%2520Society%26atitle%3DFacile%252BSynthesis%252Bof%252BNew%252BPyrazolopyrimidine%252BDerivatives%252Bof%252BPotential%252BBiosignificant%252BInterest%26aulast%3DAly%26aufirst%3DAly%2BA.%26date%3D2011%26volume%3D55%26issue%3D5%26spage%3D781%26epage%3D786" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Arie  Zask</span>, <span class="hlFld-ContribAuthor ">Jeroen C  Verheijen</span>, <span class="hlFld-ContribAuthor ">David J  Richard</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances in the discovery of small-molecule ATP competitive mTOR inhibitors: a patent review. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2011,</strong> <em>21 </em>
                                    (7)
                                     , 1109-1127. <a href="https://doi.org/10.1517/13543776.2011.584871" title="DOI URL">https://doi.org/10.1517/13543776.2011.584871</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543776.2011.584871&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543776.2011.584871%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DRecent%252Badvances%252Bin%252Bthe%252Bdiscovery%252Bof%252Bsmall-molecule%252BATP%252Bcompetitive%252BmTOR%252Binhibitors%25253A%252Ba%252Bpatent%252Breview%26aulast%3DZask%26aufirst%3DArie%26date%3D2011%26date%3D2011%26volume%3D21%26issue%3D7%26spage%3D1109%26epage%3D1127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stéphane  Sengmany</span>, <span class="hlFld-ContribAuthor ">Erwan  Le Gall</span>, <span class="hlFld-ContribAuthor ">Eric  Léonel</span>. </span><span class="cited-content_cbyCitation_article-title">An Electrochemical Synthesis of Functionalized Arylpyrimidines from 4-Amino-6-Chloropyrimidines and Aryl Halides. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2011,</strong> <em>16 </em>
                                    (7)
                                     , 5550-5560. <a href="https://doi.org/10.3390/molecules16075550" title="DOI URL">https://doi.org/10.3390/molecules16075550</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules16075550&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules16075550%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DAn%252BElectrochemical%252BSynthesis%252Bof%252BFunctionalized%252BArylpyrimidines%252Bfrom%252B4-Amino-6-Chloropyrimidines%252Band%252BAryl%252BHalides%26aulast%3DSengmany%26aufirst%3DSt%25C3%25A9phane%26date%3D2011%26date%3D2011%26volume%3D16%26issue%3D7%26spage%3D5550%26epage%3D5560" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Robert  Mallon</span>, <span class="hlFld-ContribAuthor ">Larry R.  Feldberg</span>, <span class="hlFld-ContribAuthor ">Judy  Lucas</span>, <span class="hlFld-ContribAuthor ">Inder  Chaudhary</span>, <span class="hlFld-ContribAuthor ">Christoph  Dehnhardt</span>, <span class="hlFld-ContribAuthor ">Efren Delos  Santos</span>, <span class="hlFld-ContribAuthor ">Zecheng  Chen</span>, <span class="hlFld-ContribAuthor ">Osvaldo  dos Santos</span>, <span class="hlFld-ContribAuthor ">Semiramis  Ayral-Kaloustian</span>, <span class="hlFld-ContribAuthor ">Aranapakam  Venkatesan</span>, <span class="hlFld-ContribAuthor ">Irwin  Hollander</span>. </span><span class="cited-content_cbyCitation_article-title">Antitumor Efficacy of PKI-587, a Highly Potent Dual PI3K/mTOR Kinase Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Clinical Cancer Research</span><span> <strong>2011,</strong> <em>17 </em>
                                    (10)
                                     , 3193-3203. <a href="https://doi.org/10.1158/1078-0432.CCR-10-1694" title="DOI URL">https://doi.org/10.1158/1078-0432.CCR-10-1694</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1078-0432.CCR-10-1694&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1078-0432.CCR-10-1694%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Cancer%2520Research%26atitle%3DAntitumor%252BEfficacy%252Bof%252BPKI-587%25252C%252Ba%252BHighly%252BPotent%252BDual%252BPI3K%25252FmTOR%252BKinase%252BInhibitor%26aulast%3DMallon%26aufirst%3DRobert%26date%3D2011%26date%3D2011%26volume%3D17%26issue%3D10%26spage%3D3193%26epage%3D3203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Carlos  García-Echeverría</span>. </span><span class="cited-content_cbyCitation_article-title">Allosteric and ATP-competitive kinase inhibitors of mTOR for cancer treatment. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2010,</strong> <em>20 </em>
                                    (15)
                                     , 4308-4312. <a href="https://doi.org/10.1016/j.bmcl.2010.05.099" title="DOI URL">https://doi.org/10.1016/j.bmcl.2010.05.099</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2010.05.099&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2010.05.099%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DAllosteric%252Band%252BATP-competitive%252Bkinase%252Binhibitors%252Bof%252BmTOR%252Bfor%252Bcancer%252Btreatment%26aulast%3DGarc%25C3%25ADa-Echeverr%25C3%25ADa%26aufirst%3DCarlos%26date%3D2010%26volume%3D20%26issue%3D15%26spage%3D4308%26epage%3D4312" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hwei-Ru  Tsou</span>, <span class="hlFld-ContribAuthor ">Gloria  MacEwan</span>, <span class="hlFld-ContribAuthor ">Gary  Birnberg</span>, <span class="hlFld-ContribAuthor ">George  Grosu</span>, <span class="hlFld-ContribAuthor ">Matthew G.  Bursavich</span>, <span class="hlFld-ContribAuthor ">Joel  Bard</span>, <span class="hlFld-ContribAuthor ">Natasja  Brooijmans</span>, <span class="hlFld-ContribAuthor ">Lourdes  Toral-Barza</span>, <span class="hlFld-ContribAuthor ">Irwin  Hollander</span>, <span class="hlFld-ContribAuthor ">Tarek S.  Mansour</span>, <span class="hlFld-ContribAuthor ">Semiramis  Ayral-Kaloustian</span>, <span class="hlFld-ContribAuthor ">Ker  Yu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and optimization of 2-(4-substituted-pyrrolo[2,3-b]pyridin-3-yl)methylene-4-hydroxybenzofuran-3(2H)-ones as potent and selective ATP-competitive inhibitors of the mammalian target of rapamycin (mTOR). </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2010,</strong> <em>20 </em>
                                    (7)
                                     , 2321-2325. <a href="https://doi.org/10.1016/j.bmcl.2010.01.135" title="DOI URL">https://doi.org/10.1016/j.bmcl.2010.01.135</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2010.01.135&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2010.01.135%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Band%252Boptimization%252Bof%252B2-%2525284-substituted-pyrrolo%25255B2%25252C3-b%25255Dpyridin-3-yl%252529methylene-4-hydroxybenzofuran-3%2525282H%252529-ones%252Bas%252Bpotent%252Band%252Bselective%252BATP-competitive%252Binhibitors%252Bof%252Bthe%252Bmammalian%252Btarget%252Bof%252Brapamycin%252B%252528mTOR%252529%26aulast%3DTsou%26aufirst%3DHwei-Ru%26date%3D2010%26volume%3D20%26issue%3D7%26spage%3D2321%26epage%3D2325" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hwei-Ru  Tsou</span>, <span class="hlFld-ContribAuthor ">Gloria  MacEwan</span>, <span class="hlFld-ContribAuthor ">Gary  Birnberg</span>, <span class="hlFld-ContribAuthor ">Nan  Zhang</span>, <span class="hlFld-ContribAuthor ">Natasja  Brooijmans</span>, <span class="hlFld-ContribAuthor ">Lourdes  Toral-Barza</span>, <span class="hlFld-ContribAuthor ">Irwin  Hollander</span>, <span class="hlFld-ContribAuthor ">Semiramis  Ayral-Kaloustian</span>, <span class="hlFld-ContribAuthor ">Ker  Yu</span>. </span><span class="cited-content_cbyCitation_article-title">4-Substituted-7-azaindoles bearing a ureidobenzofuranone moiety as potent and selective, ATP-competitive inhibitors of the mammalian target of rapamycin (mTOR). </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2010,</strong> <em>20 </em>
                                    (7)
                                     , 2259-2263. <a href="https://doi.org/10.1016/j.bmcl.2010.02.012" title="DOI URL">https://doi.org/10.1016/j.bmcl.2010.02.012</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2010.02.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2010.02.012%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3D4-Substituted-7-azaindoles%252Bbearing%252Ba%252Bureidobenzofuranone%252Bmoiety%252Bas%252Bpotent%252Band%252Bselective%25252C%252BATP-competitive%252Binhibitors%252Bof%252Bthe%252Bmammalian%252Btarget%252Bof%252Brapamycin%252B%252528mTOR%252529%26aulast%3DTsou%26aufirst%3DHwei-Ru%26date%3D2010%26volume%3D20%26issue%3D7%26spage%3D2259%26epage%3D2263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">David J.  Richard</span>, <span class="hlFld-ContribAuthor ">Jeroen C.  Verheijen</span>, <span class="hlFld-ContribAuthor ">Ker  Yu</span>, <span class="hlFld-ContribAuthor ">Arie  Zask</span>. </span><span class="cited-content_cbyCitation_article-title">Triazines incorporating (R)-3-methylmorpholine are potent inhibitors of the mammalian target of rapamycin (mTOR) with selectivity over PI3Kα. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2010,</strong> <em>20 </em>
                                    (8)
                                     , 2654-2657. <a href="https://doi.org/10.1016/j.bmcl.2010.02.029" title="DOI URL">https://doi.org/10.1016/j.bmcl.2010.02.029</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2010.02.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2010.02.029%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DTriazines%252Bincorporating%252B%252528R%252529-3-methylmorpholine%252Bare%252Bpotent%252Binhibitors%252Bof%252Bthe%252Bmammalian%252Btarget%252Bof%252Brapamycin%252B%252528mTOR%252529%252Bwith%252Bselectivity%252Bover%252BPI3K%2525CE%2525B1%26aulast%3DRichard%26aufirst%3DDavid%2BJ.%26date%3D2010%26volume%3D20%26issue%3D8%26spage%3D2654%26epage%3D2657" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jeroen C.  Verheijen</span>, <span class="hlFld-ContribAuthor ">David J.  Richard</span>, <span class="hlFld-ContribAuthor ">Kevin  Curran</span>, <span class="hlFld-ContribAuthor ">Joshua  Kaplan</span>, <span class="hlFld-ContribAuthor ">Ker  Yu</span>, <span class="hlFld-ContribAuthor ">Arie  Zask</span>. </span><span class="cited-content_cbyCitation_article-title">2-Arylureidophenyl-4-(3-oxa-8-azabicyclo[3.2.1]octan-8-yl)triazines as highly potent and selective ATP competitive mTOR inhibitors: Optimization of human microsomal stability. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2010,</strong> <em>20 </em>
                                    (8)
                                     , 2648-2653. <a href="https://doi.org/10.1016/j.bmcl.2010.02.031" title="DOI URL">https://doi.org/10.1016/j.bmcl.2010.02.031</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2010.02.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2010.02.031%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3D2-Arylureidophenyl-4-%2525283-oxa-8-azabicyclo%25255B3.2.1%25255Doctan-8-yl%252529triazines%252Bas%252Bhighly%252Bpotent%252Band%252Bselective%252BATP%252Bcompetitive%252BmTOR%252Binhibitors%25253A%252BOptimization%252Bof%252Bhuman%252Bmicrosomal%252Bstability%26aulast%3DVerheijen%26aufirst%3DJeroen%2BC.%26date%3D2010%26volume%3D20%26issue%3D8%26spage%3D2648%26epage%3D2653" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Arie  Zask</span>, <span class="hlFld-ContribAuthor ">Jeroen C.  Verheijen</span>, <span class="hlFld-ContribAuthor ">David J.  Richard</span>, <span class="hlFld-ContribAuthor ">Joshua  Kaplan</span>, <span class="hlFld-ContribAuthor ">Kevin  Curran</span>, <span class="hlFld-ContribAuthor ">Lourdes  Toral-Barza</span>, <span class="hlFld-ContribAuthor ">Judy  Lucas</span>, <span class="hlFld-ContribAuthor ">Irwin  Hollander</span>, <span class="hlFld-ContribAuthor ">Ker  Yu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of 2-ureidophenyltriazines bearing bridged morpholines as potent and selective ATP-competitive mTOR inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2010,</strong> <em>20 </em>
                                    (8)
                                     , 2644-2647. <a href="https://doi.org/10.1016/j.bmcl.2010.02.045" title="DOI URL">https://doi.org/10.1016/j.bmcl.2010.02.045</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2010.02.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2010.02.045%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252B2-ureidophenyltriazines%252Bbearing%252Bbridged%252Bmorpholines%252Bas%252Bpotent%252Band%252Bselective%252BATP-competitive%252BmTOR%252Binhibitors%26aulast%3DZask%26aufirst%3DArie%26date%3D2010%26volume%3D20%26issue%3D8%26spage%3D2644%26epage%3D2647" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jeroen C.  Verheijen</span>, <span class="hlFld-ContribAuthor ">Ker  Yu</span>, <span class="hlFld-ContribAuthor ">Lourdes  Toral-Barza</span>, <span class="hlFld-ContribAuthor ">Irwin  Hollander</span>, <span class="hlFld-ContribAuthor ">Arie  Zask</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of 2-arylthieno[3,2-d]pyrimidines containing 8-oxa-3-azabi-cyclo[3.2.1]octane in the 4-position as potent inhibitors of mTOR with selectivity over PI3K. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2010,</strong> <em>20 </em>
                                    (1)
                                     , 375-379. <a href="https://doi.org/10.1016/j.bmcl.2009.10.075" title="DOI URL">https://doi.org/10.1016/j.bmcl.2009.10.075</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2009.10.075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2009.10.075%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252B2-arylthieno%25255B3%25252C2-d%25255Dpyrimidines%252Bcontaining%252B8-oxa-3-azabi-cyclo%25255B3.2.1%25255Doctane%252Bin%252Bthe%252B4-position%252Bas%252Bpotent%252Binhibitors%252Bof%252BmTOR%252Bwith%252Bselectivity%252Bover%252BPI3K%26aulast%3DVerheijen%26aufirst%3DJeroen%2BC.%26date%3D2010%26volume%3D20%26issue%3D1%26spage%3D375%26epage%3D379" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Joshua  Kaplan</span>, <span class="hlFld-ContribAuthor ">Jeroen C.  Verheijen</span>, <span class="hlFld-ContribAuthor ">Natasja  Brooijmans</span>, <span class="hlFld-ContribAuthor ">Lourdes  Toral-Barza</span>, <span class="hlFld-ContribAuthor ">Irwin  Hollander</span>, <span class="hlFld-ContribAuthor ">Ker  Yu</span>, <span class="hlFld-ContribAuthor ">Arie  Zask</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of 3,6-dihydro-2H-pyran as a morpholine replacement in 6-aryl-1H-pyrazolo[3,4-d]pyrimidines and 2-arylthieno[3,2-d]pyrimidines: ATP-competitive inhibitors of the mammalian target of rapamycin (mTOR). </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2010,</strong> <em>20 </em>
                                    (2)
                                     , 640-643. <a href="https://doi.org/10.1016/j.bmcl.2009.11.050" title="DOI URL">https://doi.org/10.1016/j.bmcl.2009.11.050</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2009.11.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2009.11.050%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252B3%25252C6-dihydro-2H-pyran%252Bas%252Ba%252Bmorpholine%252Breplacement%252Bin%252B6-aryl-1H-pyrazolo%25255B3%25252C4-d%25255Dpyrimidines%252Band%252B2-arylthieno%25255B3%25252C2-d%25255Dpyrimidines%25253A%252BATP-competitive%252Binhibitors%252Bof%252Bthe%252Bmammalian%252Btarget%252Bof%252Brapamycin%252B%252528mTOR%252529%26aulast%3DKaplan%26aufirst%3DJoshua%26date%3D2010%26volume%3D20%26issue%3D2%26spage%3D640%26epage%3D643" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">David J.  Richard</span>, <span class="hlFld-ContribAuthor ">Jeroen C.  Verheijen</span>, <span class="hlFld-ContribAuthor ">Kevin  Curran</span>, <span class="hlFld-ContribAuthor ">Joshua  Kaplan</span>, <span class="hlFld-ContribAuthor ">Lourdes  Toral-Barza</span>, <span class="hlFld-ContribAuthor ">Irwin  Hollander</span>, <span class="hlFld-ContribAuthor ">Judy  Lucas</span>, <span class="hlFld-ContribAuthor ">Ker  Yu</span>, <span class="hlFld-ContribAuthor ">Arie  Zask</span>. </span><span class="cited-content_cbyCitation_article-title">Incorporation of water-solubilizing groups in pyrazolopyrimidine mTOR inhibitors: Discovery of highly potent and selective analogs with improved human microsomal stability. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2009,</strong> <em>19 </em>
                                    (24)
                                     , 6830-6835. <a href="https://doi.org/10.1016/j.bmcl.2009.10.096" title="DOI URL">https://doi.org/10.1016/j.bmcl.2009.10.096</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2009.10.096&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2009.10.096%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DIncorporation%252Bof%252Bwater-solubilizing%252Bgroups%252Bin%252Bpyrazolopyrimidine%252BmTOR%252Binhibitors%25253A%252BDiscovery%252Bof%252Bhighly%252Bpotent%252Band%252Bselective%252Banalogs%252Bwith%252Bimproved%252Bhuman%252Bmicrosomal%252Bstability%26aulast%3DRichard%26aufirst%3DDavid%2BJ.%26date%3D2009%26volume%3D19%26issue%3D24%26spage%3D6830%26epage%3D6835" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-24/jm9013828/production/images/medium/jm-2009-013828_0023.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-24/jm9013828/production/images/large/jm-2009-013828_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9013828&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-24/jm9013828/production/images/medium/jm-2009-013828_0025.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-24/jm9013828/production/images/large/jm-2009-013828_0025.jpeg" id="rightTab-_i2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Pyrazolopyrimidine mTOR inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-24/jm9013828/production/images/large/jm-2009-013828_0025.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9013828&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-24/jm9013828/production/images/medium/jm-2009-013828_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-24/jm9013828/production/images/large/jm-2009-013828_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-24/jm9013828/production/images/large/jm-2009-013828_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9013828&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) phenylhydrazine; (b) morpholine, NEt<sub>3</sub>; (c) ArB(OR)<sub>2</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>; (d) Ac<sub>2</sub>O.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-24/jm9013828/production/images/medium/jm-2009-013828_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-24/jm9013828/production/images/large/jm-2009-013828_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-24/jm9013828/production/images/large/jm-2009-013828_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9013828&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) benzoic hydrazide; (b) conc HCl, reflux; (c) <b>10</b>, NEt<sub>3</sub>; (d) morpholine, NEt<sub>3</sub>; (e) ArB(OR)<sub>2</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>.</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-24/jm9013828/production/images/medium/jm-2009-013828_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-24/jm9013828/production/images/large/jm-2009-013828_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-24/jm9013828/production/images/large/jm-2009-013828_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9013828&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) R<sub>1</sub>R<sub>2</sub>NH; (b) <b>12</b>, Pd(PPh<sub>3</sub>)<sub>4</sub>.</p></p></figure><figure data-id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-24/jm9013828/production/images/medium/jm-2009-013828_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-24/jm9013828/production/images/large/jm-2009-013828_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 4. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-24/jm9013828/production/images/large/jm-2009-013828_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9013828&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) ArB(OR)<sub>2</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>; (b) (1) triphosgene, NEt<sub>3</sub>; (2) RNH<sub>2</sub>; (c) MeNH<sub>2</sub>, EDC.</p></p></figure><figure data-id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-24/jm9013828/production/images/medium/jm-2009-013828_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-24/jm9013828/production/images/large/jm-2009-013828_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 5. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-24/jm9013828/production/images/large/jm-2009-013828_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9013828&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) R<sup>1</sup>OCOCl; (b) ACE-Cl; (c) 3-pyridine carboxaldehyde, NaHB(OAc)<sub>3</sub>; (d) ArB(OR)<sub>2</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>; (e) (1) triphosgene, NEt<sub>3</sub>, (2) R<sup>2</sup>OH/R<sup>2</sup>NH<sub>2</sub>.</p></p></figure><figure data-id="sch6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-24/jm9013828/production/images/medium/jm-2009-013828_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-24/jm9013828/production/images/large/jm-2009-013828_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 6. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-24/jm9013828/production/images/large/jm-2009-013828_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9013828&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) TFA; (b) ROCOCl.</p></p></figure><figure data-id="sch7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-24/jm9013828/production/images/medium/jm-2009-013828_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-24/jm9013828/production/images/large/jm-2009-013828_0007.jpeg" id="rightTab-_i4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 7. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-24/jm9013828/production/images/large/jm-2009-013828_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9013828&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NEt<sub>3</sub>, TsCl, then R<sub>1</sub>R<sub>2</sub>NH.</p></p></figure><figure data-id="fig2" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-24/jm9013828/production/images/medium/jm-2009-013828_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-24/jm9013828/production/images/large/jm-2009-013828_0010.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Close-up of binding interactions of inhibitors with mTOR homology model: (A) binding mode of aminopyridine <b>6d</b> showing hydrogen bonds (dashed lines) with Asp2195, Lys2187, and Glu2190 and the salt bridge between Lys2187 and Glu2190; (B) interactions of acetamide <b>6g</b> showing hydrogen bonds between the acetamide and Asp2195 and Lys2187 and the salt bridge between Lys2187 and Glu2190. Comparison of parts A and B highlights the observed concerted motion by Lys2187 and Glu2190 to maintain hydrogen bonding interactions with the inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-24/jm9013828/production/images/large/jm-2009-013828_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9013828&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-24/jm9013828/production/images/medium/jm-2009-013828_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-24/jm9013828/production/images/large/jm-2009-013828_0013.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Close-up of binding interactions of inhibitors with mTOR homology model: (A) binding mode of hydroxyethyl carbamate <b>22b</b>; (B) interactions of methylurea <b>22c</b>. Hydrogen bonds are indicated by dashed blue lines. mTOR residue numbers are shown in part A.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-24/jm9013828/production/images/large/jm-2009-013828_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9013828&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-24/jm9013828/production/images/medium/jm-2009-013828_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-24/jm9013828/production/images/large/jm-2009-013828_0018.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Inhibition of mTOR signaling after treatment with mTOR kinase inhibitors. U87MG cells were treated in growth medium for 6 h with the indicated concentrations of <b>22a</b>, <b>25a</b>, and <b>27a</b>. Total cell lysates were prepared and subjected to immunoblotting with antibodies against P-S6K, P-4EBP1 (T70), 4EBP1, P-Akt (S473), P-Akt (T308). The blots were also stained for Ponceau-S, a dye for total protein, for sample loading control.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-24/jm9013828/production/images/large/jm-2009-013828_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9013828&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-24/jm9013828/production/images/medium/jm-2009-013828_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-24/jm9013828/production/images/large/jm-2009-013828_0019.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Inhibition of mTOR signaling in vivo following a single dose of mTOR kinase inhibitors. Nude mice bearing sc PC3MM2 tumors were injected iv with vehicle or 50 mg/kg test article. Tumor lysates were prepared 1 h after injection and were immunoblotted with antibodies against P-S6K (T389), P-Akt (S473), P-Akt (T308), P-S6, and β-actin.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-24/jm9013828/production/images/large/jm-2009-013828_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9013828&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-24/jm9013828/production/images/medium/jm-2009-013828_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-24/jm9013828/production/images/large/jm-2009-013828_0020.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Surface representations of the mTOR binding site highlighting the tight fit of inhibitors as exemplified by phenylureidophenyl <b>25d</b>. (A) Overview of the mTOR catalytic domain in cartoon representation and the binding site in surface representation. <b>25d</b> is sandwiched between the N-lobe and C-lobe of the catalytic domain. (B) Close-up view of <b>25d</b> rotated 90° compared to part A. The hydrogen atom in the 4-position of the terminal phenyl ring is shown to illustrate the directionality toward solvent from this position. Hydrogen bonds between the urea and Lys2187 and Asp2195 are maintained (cf. Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>B) and are shown by dashed lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-24/jm9013828/production/images/large/jm-2009-013828_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9013828&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i60">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_54838" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_54838" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 27 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Guertin, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabatini, D. M.</span><span> </span><span class="NLM_article-title">Defining the role of mTOR in cancer</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">9</span><span class="NLM_x">–</span> <span class="NLM_lpage">22</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2007&pages=9-22&author=D.+A.+Guertinauthor=D.+M.+Sabatini&title=Defining+the+role+of+mTOR+in+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGuertin%26aufirst%3DD.%2BA.%26aulast%3DSabatini%26aufirst%3DD.%2BM.%26atitle%3DDefining%2520the%2520role%2520of%2520mTOR%2520in%2520cancer%26jtitle%3DCancer%2520Cell%26date%3D2007%26volume%3D12%26spage%3D9%26epage%3D22" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Chiang, G. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abraham, R. T.</span><span> </span><span class="NLM_article-title">Targeting the mTOR signaling network in cancer</span> <span class="citation_source-journal">Trends Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">433</span><span class="NLM_x">–</span> <span class="NLM_lpage">442</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=433-442&author=G.+G.+Chiangauthor=R.+T.+Abraham&title=Targeting+the+mTOR+signaling+network+in+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChiang%26aufirst%3DG.%2BG.%26aulast%3DAbraham%26aufirst%3DR.%2BT.%26atitle%3DTargeting%2520the%2520mTOR%2520signaling%2520network%2520in%2520cancer%26jtitle%3DTrends%2520Mol.%2520Med.%26date%3D2007%26volume%3D13%26spage%3D433%26epage%3D442" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Yuan, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cantley, L. C.</span><span> </span><span class="NLM_article-title">PI3K pathway alterations in cancer: variations on a theme</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">5497</span><span class="NLM_x">–</span> <span class="NLM_lpage">5510</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2008&pages=5497-5510&author=T.+L.+Yuanauthor=L.+C.+Cantley&title=PI3K+pathway+alterations+in+cancer%3A+variations+on+a+theme"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYuan%26aufirst%3DT.%2BL.%26aulast%3DCantley%26aufirst%3DL.%2BC.%26atitle%3DPI3K%2520pathway%2520alterations%2520in%2520cancer%253A%2520variations%2520on%2520a%2520theme%26jtitle%3DOncogene%26date%3D2008%26volume%3D27%26spage%3D5497%26epage%3D5510" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Verheijen, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zask, A.</span><span> </span><span class="NLM_article-title">Phosphatidylinositol 3-kinase (PI3K) inhibitors as anticancer drugs</span> <span class="citation_source-journal">Drugs Future</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">537</span><span class="NLM_x">–</span> <span class="NLM_lpage">547</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm9013828&amp;key=10.1358%2Fdof.2007.032.06.1107995" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm9013828&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpslOnurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2007&pages=537-547&author=J.+C.+Verheijenauthor=A.+Zask&title=Phosphatidylinositol+3-kinase+%28PI3K%29+inhibitors+as+anticancer+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphatidylinositol 3-kinase (PI3K) inhibitors as anticancer drugs</span></div><div class="casAuthors">Verheijen, Jeroen C.; Zask, Arie</div><div class="citationInfo"><span class="NLM_cas:title">Drugs of the Future</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">537-547</span>CODEN:
                <span class="NLM_cas:coden">DRFUD4</span>;
        ISSN:<span class="NLM_cas:issn">0377-8282</span>.
    
            (<span class="NLM_cas:orgname">Prous Science</span>)
        </div><div class="casAbstract">A review.  The phosphatidylinositol 3-kinases (PI3Ks) are members of a family of lipid kinases that regulate cellular metab. and growth by phosphorylation of the 3-position of phosphatidylinositol to generate phosphatidylinositol triphosphate (PIP3).  The PI3K pathway is one of the most frequently mutated in human cancer, leading to amplification of signaling, and as such is a promising target for small-mol. inhibition, with exciting therapeutic opportunities for the treatment of cancer.  The last several years have seen an explosive increase in publications and patents concerning inhibition of PI3K.  This paper summarizes recent developments in the discovery of PI3K inhibitors as anticancer drugs.  We describe representative examples of seven structurally diverse classes of PI3K inhibitors.  These compds. represent a large arsenal of potent enzyme inhibitors (single-digit nanomolar IC50 values) with a variety of isoform specificity profiles.  Currently, the first PI3K inhibitors are making their way into the clinic and we eagerly await data that will help address questions regarding the contribution of inhibition of various PI3K isoforms to tumor suppression and the assocd. side effect profiles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqASvfhKcFeRrVg90H21EOLACvtfcHk0lg45VS0m5KQuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpslOnurg%253D&md5=2b8c482282151eb7b611acef0216ed1c</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1358%2Fdof.2007.032.06.1107995&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1358%252Fdof.2007.032.06.1107995%26sid%3Dliteratum%253Aachs%26aulast%3DVerheijen%26aufirst%3DJ.%2BC.%26aulast%3DZask%26aufirst%3DA.%26atitle%3DPhosphatidylinositol%25203-kinase%2520%2528PI3K%2529%2520inhibitors%2520as%2520anticancer%2520drugs%26jtitle%3DDrugs%2520Future%26date%3D2007%26volume%3D32%26spage%3D537%26epage%3D547" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Verheijen, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zask, A.</span><span> </span><span class="NLM_article-title">mTOR Inhibitors in Oncology</span> <span class="citation_source-journal">Annu. Rep. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">189</span><span class="NLM_x">–</span> <span class="NLM_lpage">202</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2008&pages=189-202&author=J.+C.+Verheijenauthor=K.+Yuauthor=A.+Zask&title=mTOR+Inhibitors+in+Oncology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVerheijen%26aufirst%3DJ.%2BC.%26aulast%3DYu%26aufirst%3DK.%26aulast%3DZask%26aufirst%3DA.%26atitle%3DmTOR%2520Inhibitors%2520in%2520Oncology%26jtitle%3DAnnu.%2520Rep.%2520Med.%2520Chem.%26date%3D2008%26volume%3D43%26spage%3D189%26epage%3D202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Sarbassov, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ali, S. m.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guertin, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Latek, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erdjument-Bromage, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tempst, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabatini, D. M.</span><span> </span><span class="NLM_article-title">Rictor, a novel binding partnet of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton</span> <span class="citation_source-journal">Curr. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1296</span><span class="NLM_x">–</span> <span class="NLM_lpage">1302</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm9013828&amp;key=10.1016%2Fj.cub.2004.06.054" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm9013828&amp;key=15268862" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm9013828&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmtVamsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=1296-1302&author=D.+D.+Sarbassovauthor=S.+m.+Aliauthor=D.+H.+Kimauthor=D.+A.+Guertinauthor=R.+R.+Latekauthor=H.+Erdjument-Bromageauthor=P.+Tempstauthor=D.+M.+Sabatini&title=Rictor%2C+a+novel+binding+partnet+of+mTOR%2C+defines+a+rapamycin-insensitive+and+raptor-independent+pathway+that+regulates+the+cytoskeleton"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Rictor, a Novel Binding Partner of mTOR, Defines a Rapamycin-Insensitive and Raptor-Independent Pathway that Regulates the Cytoskeleton</span></div><div class="casAuthors">Sarbassov, Dos D.; Ali, Siraj M.; Kim, Do-Hyung; Guertin, David A.; Latek, Robert R.; Erdjument-Bromage, Hediye; Tempst, Paul; Sabatini, David M.</div><div class="citationInfo"><span class="NLM_cas:title">Current Biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1296-1302</span>CODEN:
                <span class="NLM_cas:coden">CUBLE2</span>;
        ISSN:<span class="NLM_cas:issn">0960-9822</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The mammalian TOR (mTOR) pathway integrates nutrient- and growth factor-derived signals to regulate growth, the process whereby cells accumulate mass and increase in size.  MTOR is a large protein kinase and the target of rapamycin, an immunosuppressant that also blocks vessel restenosis and has potential anticancer applications.  MTOR interacts with the raptor and GβL proteins to form a complex that is the target of rapamycin.  Here, we demonstrate that mTOR is also part of a distinct complex defined by the novel protein rictor (rapamycin-insensitive companion of mTOR).  Rictor shares homol. with the previously described pianissimo from D. discoidieum, STE20p from S. pombe, and AVO3p from S. cerevisiae.  Interestingly, AVO3p is part of a rapamycin-insensitive TOR complex that does not contain the yeast homolog of raptor and signals to the actin cytoskeleton through PKC1.  Consistent with this finding, the rictor-contg. mTOR complex contains GβL but not raptor and it neither regulates the mTOR effector S6K1 nor is it bound by FKBP12-rapamycin.  We find that the rictor-mTOR complex modulates the phosphorylation of Protein Kinase C α (PKCα) and the actin cytoskeleton, suggesting that this aspect of TOR signaling is conserved between yeast and mammals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXWNgQt5KXB7Vg90H21EOLACvtfcHk0ljE3JYnG1D3Dg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmtVamsLs%253D&md5=78362bf097ed96b9bfc0053e3a54818c</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.cub.2004.06.054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cub.2004.06.054%26sid%3Dliteratum%253Aachs%26aulast%3DSarbassov%26aufirst%3DD.%2BD.%26aulast%3DAli%26aufirst%3DS.%2Bm.%26aulast%3DKim%26aufirst%3DD.%2BH.%26aulast%3DGuertin%26aufirst%3DD.%2BA.%26aulast%3DLatek%26aufirst%3DR.%2BR.%26aulast%3DErdjument-Bromage%26aufirst%3DH.%26aulast%3DTempst%26aufirst%3DP.%26aulast%3DSabatini%26aufirst%3DD.%2BM.%26atitle%3DRictor%252C%2520a%2520novel%2520binding%2520partnet%2520of%2520mTOR%252C%2520defines%2520a%2520rapamycin-insensitive%2520and%2520raptor-independent%2520pathway%2520that%2520regulates%2520the%2520cytoskeleton%26jtitle%3DCurr.%2520Biol.%26date%3D2004%26volume%3D14%26spage%3D1296%26epage%3D1302" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Sarbassov, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guertin, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ali, S.m.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabatini, D. M.</span><span> </span><span class="NLM_article-title">Phosphorylation and regulation of Akt/PKB by the Rictor-mTOR complex</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">307</span><span class="NLM_x">, </span> <span class="NLM_fpage">1098</span><span class="NLM_x">–</span> <span class="NLM_lpage">1101</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm9013828&amp;key=10.1126%2Fscience.1106148" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm9013828&amp;key=15718470" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm9013828&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlSrtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=307&publication_year=2005&pages=1098-1101&author=D.+D.+Sarbassovauthor=D.+A.+Guertinauthor=S.m.+Aliauthor=D.+M.+Sabatini&title=Phosphorylation+and+regulation+of+Akt%2FPKB+by+the+Rictor-mTOR+complex"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphorylation and Regulation of Akt/PKB by the Rictor-mTOR Complex</span></div><div class="casAuthors">Sarbassov, Dos D.; Guertin, David A.; Ali, Siraj M.; Sabatini, David M.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">307</span>
        (<span class="NLM_cas:issue">5712</span>),
    <span class="NLM_cas:pages">1098-1101</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Deregulation of Akt/protein kinase B (PKB) is implicated in the pathogenesis of cancer and diabetes.  Akt/PKB activation requires the phosphorylation of Thr308 in the activation loop by the phosphoinositide-dependent kinase 1 (PDK1) and Ser473 within the carboxyl-terminal hydrophobic motif by an unknown kinase.  We show that in Drosophila and human cells the target of rapamycin (TOR) kinase and its assocd. protein rictor are necessary for Ser473 phosphorylation and that a redn. in rictor or mammalian TOR (mTOR) expression inhibited an Akt/PKB effector.  The rictor-mTOR complex directly phosphorylated Akt/PKB on Ser473 in vitro and facilitated Thr308 phosphorylation by PDK1.  Rictor-mTOR may serve as a drug target in tumors that have lost the expression of PTEN, a tumor suppressor that opposes Akt/PKB activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfO1KyVE3glrVg90H21EOLACvtfcHk0ljE3JYnG1D3Dg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlSrtbY%253D&md5=de758fd8128561e34301e67a42ae13a6</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1126%2Fscience.1106148&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1106148%26sid%3Dliteratum%253Aachs%26aulast%3DSarbassov%26aufirst%3DD.%2BD.%26aulast%3DGuertin%26aufirst%3DD.%2BA.%26aulast%3DAli%26aufirst%3DS.m.%26aulast%3DSabatini%26aufirst%3DD.%2BM.%26atitle%3DPhosphorylation%2520and%2520regulation%2520of%2520Akt%252FPKB%2520by%2520the%2520Rictor-mTOR%2520complex%26jtitle%3DScience%26date%3D2005%26volume%3D307%26spage%3D1098%26epage%3D1101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Carracedo, A</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pandolfi, P. P.</span><span> </span><span class="NLM_article-title">The PTEN-PI3K pathway: of feedbacks and cross-talks</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">5527</span><span class="NLM_x">–</span> <span class="NLM_lpage">5541</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2008&pages=5527-5541&author=A+Carracedoauthor=P.+P.+Pandolfi&title=The+PTEN-PI3K+pathway%3A+of+feedbacks+and+cross-talks"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCarracedo%26aufirst%3DA%26aulast%3DPandolfi%26aufirst%3DP.%2BP.%26atitle%3DThe%2520PTEN-PI3K%2520pathway%253A%2520of%2520feedbacks%2520and%2520cross-talks%26jtitle%3DOncogene%26date%3D2008%26volume%3D27%26spage%3D5527%26epage%3D5541" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Choo, A. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoon, S. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roux, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blenis, J.</span><span> </span><span class="NLM_article-title">Rapamycin differentially inhibits S6Ks and 4E-BP1 to mediate cell-type-specific repression of mRNA translation</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">17414</span><span class="NLM_x">–</span> <span class="NLM_lpage">17419</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=17414-17419&author=A.+Y.+Chooauthor=S.+O.+Yoonauthor=S.+G.+Kimauthor=P.+P.+Rouxauthor=J.+Blenis&title=Rapamycin+differentially+inhibits+S6Ks+and+4E-BP1+to+mediate+cell-type-specific+repression+of+mRNA+translation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChoo%26aufirst%3DA.%2BY.%26aulast%3DYoon%26aufirst%3DS.%2BO.%26aulast%3DKim%26aufirst%3DS.%2BG.%26aulast%3DRoux%26aufirst%3DP.%2BP.%26aulast%3DBlenis%26aufirst%3DJ.%26atitle%3DRapamycin%2520differentially%2520inhibits%2520S6Ks%2520and%25204E-BP1%2520to%2520mediate%2520cell-type-specific%2520repression%2520of%2520mRNA%2520translation%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2008%26volume%3D105%26spage%3D17414%26epage%3D17419" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Guertin, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabatini, D. M.</span><span> </span><span class="NLM_article-title">The Pharmacology of mTOR Inhibition</span> <span class="citation_source-journal">Sci. Signaling</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">6</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm9013828&amp;key=10.1126%2Fscisignal.267pe24" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm9013828&amp;key=19318623" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2009&pages=1-6&author=D.+A.+Guertinauthor=D.+M.+Sabatini&title=The+Pharmacology+of+mTOR+Inhibition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1126%2Fscisignal.267pe24&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscisignal.267pe24%26sid%3Dliteratum%253Aachs%26aulast%3DGuertin%26aufirst%3DD.%2BA.%26aulast%3DSabatini%26aufirst%3DD.%2BM.%26atitle%3DThe%2520Pharmacology%2520of%2520mTOR%2520Inhibition%26jtitle%3DSci.%2520Signaling%26date%3D2009%26volume%3D2%26spage%3D1%26epage%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Folkes, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmadi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alderton, W. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alix, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Box, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chuckowree, I. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Depledge, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eccles, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hancox, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kugendradas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lensun, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olivero, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pergl-Wilson, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raynaud, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saghir, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salphati, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sohal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ultsch, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valenti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallweber, H. J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiesmann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhyvoloup, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zvelebil, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shuttleworth, S. J.</span><span> </span><span class="NLM_article-title">The identification of 2-(1<i>H</i>-indazol-4-yl)-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-<i>d</i>]pyrimidine (GDC-0941) as a potent, selective, orally bioavailable inhibitor of class I PI3 kinase for the treatment of cancer</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">5522</span><span class="NLM_x">–</span> <span class="NLM_lpage">5532</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800295d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm9013828&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVCmsr7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=5522-5532&author=A.+J.+Folkesauthor=K.+Ahmadiauthor=W.+K.+Aldertonauthor=S.+Alixauthor=S.+J.+Bakerauthor=G.+Boxauthor=I.+S.+Chuckowreeauthor=P.+A.+Clarkeauthor=P.+Depledgeauthor=S.+A.+Ecclesauthor=L.+S.+Friedmanauthor=A.+Hayesauthor=T.+C.+Hancoxauthor=A.+Kugendradasauthor=L.+Lensunauthor=P.+Mooreauthor=A.+G.+Oliveroauthor=J.+Pangauthor=S.+Patelauthor=G.+H.+Pergl-Wilsonauthor=F.+I.+Raynaudauthor=A.+Robsonauthor=N.+Saghirauthor=L.+Salphatiauthor=S.+Sohalauthor=M.+H.+Ultschauthor=M.+Valentiauthor=H.+J.+A.+Wallweberauthor=N.+C.+Wanauthor=C.+Wiesmannauthor=P.+Workmanauthor=A.+Zhyvoloupauthor=M.+J.+Zvelebilauthor=S.+J.+Shuttleworth&title=The+identification+of+2-%281H-indazol-4-yl%29-6-%284-methanesulfonyl-piperazin-1-ylmethyl%29-4-morpholin-4-yl-thieno%5B3%2C2-d%5Dpyrimidine+%28GDC-0941%29+as+a+potent%2C+selective%2C+orally+bioavailable+inhibitor+of+class+I+PI3+kinase+for+the+treatment+of+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">The identification of 2-(1H-indazol-4-yl)-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidine (GDC-0941) as a potent, selective, orally bioavailable inhibitor of class I PI3 kinase for the treatment of cancer</span></div><div class="casAuthors">Folkes, Adrian J.; Ahmadi, Khatereh; Alderton, Wendy K.; Alix, Sonia; Baker, Stewart J.; Box, Gary; Chuckowree, Irina S.; Clarke, Paul A.; Depledge, Paul; Eccles, Suzanne A.; Friedman, Lori S.; Hayes, Angela; Hancox, Timothy C.; Kugendradas, Arumugam; Lensun, Letitia; Moore, Pauline; Olivero, Alan G.; Pang, Jodie; Patel, Sonal; Pergl-Wilson, Giles H.; Raynaud, Florence I.; Robson, Anthony; Saghir, Nahid; Salphati, Laurent; Sohal, Sukhjit; Ultsch, Mark H.; Valenti, Melanie; Wallweber, Heidi J. A.; Wan, Nan Chi; Wiesmann, Christian; Workman, Paul; Zhyvoloup, Alexander; Zvelebil, Marketa J.; Shuttleworth, Stephen J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">5522-5532</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Phosphatidylinositol-3-kinase (PI3K) is an important target in cancer due to the deregulation of the PI3K/Akt signaling pathway in a wide variety of tumors.  A series of thieno[3,2-d]pyrimidine derivs. were prepd. and evaluated as inhibitors of PI3 kinase p110α.  The synthesis, biol. activity, and further profiling of these compds. are described.  This work resulted in the discovery of GDC-0941 (I) which is a potent, selective, orally bioavailable inhibitor of PI3K and is currently being evaluated in human clin. trials for the treatment of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojkFv29FXqO7Vg90H21EOLACvtfcHk0lizKtA8ruiB8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVCmsr7E&md5=742084954685353ceaf18660ab3a0703</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Fjm800295d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800295d%26sid%3Dliteratum%253Aachs%26aulast%3DFolkes%26aufirst%3DA.%2BJ.%26aulast%3DAhmadi%26aufirst%3DK.%26aulast%3DAlderton%26aufirst%3DW.%2BK.%26aulast%3DAlix%26aufirst%3DS.%26aulast%3DBaker%26aufirst%3DS.%2BJ.%26aulast%3DBox%26aufirst%3DG.%26aulast%3DChuckowree%26aufirst%3DI.%2BS.%26aulast%3DClarke%26aufirst%3DP.%2BA.%26aulast%3DDepledge%26aufirst%3DP.%26aulast%3DEccles%26aufirst%3DS.%2BA.%26aulast%3DFriedman%26aufirst%3DL.%2BS.%26aulast%3DHayes%26aufirst%3DA.%26aulast%3DHancox%26aufirst%3DT.%2BC.%26aulast%3DKugendradas%26aufirst%3DA.%26aulast%3DLensun%26aufirst%3DL.%26aulast%3DMoore%26aufirst%3DP.%26aulast%3DOlivero%26aufirst%3DA.%2BG.%26aulast%3DPang%26aufirst%3DJ.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DPergl-Wilson%26aufirst%3DG.%2BH.%26aulast%3DRaynaud%26aufirst%3DF.%2BI.%26aulast%3DRobson%26aufirst%3DA.%26aulast%3DSaghir%26aufirst%3DN.%26aulast%3DSalphati%26aufirst%3DL.%26aulast%3DSohal%26aufirst%3DS.%26aulast%3DUltsch%26aufirst%3DM.%2BH.%26aulast%3DValenti%26aufirst%3DM.%26aulast%3DWallweber%26aufirst%3DH.%2BJ.%2BA.%26aulast%3DWan%26aufirst%3DN.%2BC.%26aulast%3DWiesmann%26aufirst%3DC.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DZhyvoloup%26aufirst%3DA.%26aulast%3DZvelebil%26aufirst%3DM.%2BJ.%26aulast%3DShuttleworth%26aufirst%3DS.%2BJ.%26atitle%3DThe%2520identification%2520of%25202-%25281H-indazol-4-yl%2529-6-%25284-methanesulfonyl-piperazin-1-ylmethyl%2529-4-morpholin-4-yl-thieno%255B3%252C2-d%255Dpyrimidine%2520%2528GDC-0941%2529%2520as%2520a%2520potent%252C%2520selective%252C%2520orally%2520bioavailable%2520inhibitor%2520of%2520class%2520I%2520PI3%2520kinase%2520for%2520the%2520treatment%2520of%2520cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D5522%26epage%3D5532" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Maira, S.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stauffer, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brueggen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnell, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fritsch, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brachmann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chene, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Pover, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoemaker, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fabbro, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabriel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simonen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sellers, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Echeverria, C.</span><span> </span><span class="NLM_article-title">Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1851</span><span class="NLM_x">–</span> <span class="NLM_lpage">1863</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm9013828&amp;key=10.1158%2F1535-7163.MCT-08-0017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm9013828&amp;key=18606717" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm9013828&amp;key=1%3ACAS%3A528%3ADC%252BD1cXoslCgtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=1851-1863&author=S.-M.+Mairaauthor=F.+Staufferauthor=J.+Brueggenauthor=P.+Furetauthor=C.+Schnellauthor=C.+Fritschauthor=S.+Brachmannauthor=P.+Cheneauthor=A.+De+Poverauthor=K.+Schoemakerauthor=D.+Fabbroauthor=D.+Gabrielauthor=M.+Simonenauthor=L.+Murphyauthor=P.+Finanauthor=W.+Sellersauthor=C.+Garcia-Echeverria&title=Identification+and+characterization+of+NVP-BEZ235%2C+a+new+orally+available+dual+phosphatidylinositol+3-kinase%2Fmammalian+target+of+rapamycin+inhibitor+with+potent+in+vivo+antitumor+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity</span></div><div class="casAuthors">Maira, Sauveur-Michel; Stauffer, Frederic; Brueggen, Josef; Furet, Pascal; Schnell, Christian; Fritsch, Christine; Brachmann, Saskia; Chene, Patrick; De Pover, Alain; Schoemaker, Kevin; Fabbro, Doriano; Gabriel, Daniela; Simonen, Marjo; Murphy, Leon; Finan, Peter; Sellers, William; Garcia-Echeverria, Carlos</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1851-1863</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The phosphatidylinositol 3-kinase (PI3K)/Akt/mammalian target of rapamycin inhibitor (mTOR) pathway is often constitutively activated in human tumor cells, providing unique opportunities for anticancer therapeutic intervention.  NVP-BEZ235 is an imidazo[4,5-c]quinoline deriv. that inhibits PI3K and mTOR kinase activity by binding to the ATP-binding cleft of these enzymes.  In cellular settings using human tumor cell lines, this mol. is able to effectively and specifically block the dysfunctional activation of the PI3K pathway, inducing G1 arrest.  The cellular activity of NVP-BEZ235 translates well in in vivo models of human cancer.  Thus, the compd. was well tolerated, displayed disease stasis when administered orally, and enhanced the efficacy of other anticancer agents when used in in vivo combination studies.  Ex vivo pharmacokinetic/pharmacodynamic analyses of tumor tissues showed a time-dependent correlation between compd. concn. and PI3K/Akt pathway inhibition.  Collectively, the preclin. data show that NVP-BEZ235 is a potent dual PI3K/mTOR modulator with favorable pharmaceutical properties.  NVP-BEZ235 is currently in phase I clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyO784qv52vrVg90H21EOLACvtfcHk0lizKtA8ruiB8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXoslCgtb4%253D&md5=5b1979e134dd12065198d86dbc11ce15</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-08-0017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-08-0017%26sid%3Dliteratum%253Aachs%26aulast%3DMaira%26aufirst%3DS.-M.%26aulast%3DStauffer%26aufirst%3DF.%26aulast%3DBrueggen%26aufirst%3DJ.%26aulast%3DFuret%26aufirst%3DP.%26aulast%3DSchnell%26aufirst%3DC.%26aulast%3DFritsch%26aufirst%3DC.%26aulast%3DBrachmann%26aufirst%3DS.%26aulast%3DChene%26aufirst%3DP.%26aulast%3DDe%2BPover%26aufirst%3DA.%26aulast%3DSchoemaker%26aufirst%3DK.%26aulast%3DFabbro%26aufirst%3DD.%26aulast%3DGabriel%26aufirst%3DD.%26aulast%3DSimonen%26aufirst%3DM.%26aulast%3DMurphy%26aufirst%3DL.%26aulast%3DFinan%26aufirst%3DP.%26aulast%3DSellers%26aufirst%3DW.%26aulast%3DGarcia-Echeverria%26aufirst%3DC.%26atitle%3DIdentification%2520and%2520characterization%2520of%2520NVP-BEZ235%252C%2520a%2520new%2520orally%2520available%2520dual%2520phosphatidylinositol%25203-kinase%252Fmammalian%2520target%2520of%2520rapamycin%2520inhibitor%2520with%2520potent%2520in%2520vivo%2520antitumor%2520activity%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2008%26volume%3D7%26spage%3D1851%26epage%3D1863" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Knight, Z. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feldman, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zunder, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldenberg, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loewith, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stokoe, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balla, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toth, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balla, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shokat, K.M. A</span><span> </span><span class="NLM_article-title">Pharmacological map of the PI3-K family defines a role for p110α in insulin signaling</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">125</span><span class="NLM_x">, </span> <span class="NLM_fpage">733</span><span class="NLM_x">–</span> <span class="NLM_lpage">747</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2006&pages=733-747&author=Z.+A.+Knightauthor=B.+Gonzalezauthor=M.+E.+Feldmanauthor=E.+R.+Zunderauthor=D.+D.+Goldenbergauthor=O.+Williamsauthor=R.+Loewithauthor=D.+Stokoeauthor=A.+Ballaauthor=B.+Tothauthor=T.+Ballaauthor=W.+A.+Weissauthor=R.+L.+Williamsauthor=K.M.+A+Shokat&title=Pharmacological+map+of+the+PI3-K+family+defines+a+role+for+p110%CE%B1+in+insulin+signaling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKnight%26aufirst%3DZ.%2BA.%26aulast%3DGonzalez%26aufirst%3DB.%26aulast%3DFeldman%26aufirst%3DM.%2BE.%26aulast%3DZunder%26aufirst%3DE.%2BR.%26aulast%3DGoldenberg%26aufirst%3DD.%2BD.%26aulast%3DWilliams%26aufirst%3DO.%26aulast%3DLoewith%26aufirst%3DR.%26aulast%3DStokoe%26aufirst%3DD.%26aulast%3DBalla%26aufirst%3DA.%26aulast%3DToth%26aufirst%3DB.%26aulast%3DBalla%26aufirst%3DT.%26aulast%3DWeiss%26aufirst%3DW.%2BA.%26aulast%3DWilliams%26aufirst%3DR.%2BL.%26aulast%3DShokat%26aufirst%3DK.M.%2BA%26atitle%3DPharmacological%2520map%2520of%2520the%2520PI3-K%2520family%2520defines%2520a%2520role%2520for%2520p110%25CE%25B1%2520in%2520insulin%2520signaling%26jtitle%3DCell%26date%3D2006%26volume%3D125%26spage%3D733%26epage%3D747" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Feldman, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Apsel, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uotila, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loewith, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knight, Z. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruggero, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shokat, K. M.</span><span> </span><span class="NLM_article-title">Active-site inhibitors of mTOR target rapamycin-resistant outputs of mTORC1 and mTORC2</span> <span class="citation_source-journal">PLoS Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">371</span><span class="NLM_x">–</span> <span class="NLM_lpage">383</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2009&pages=371-383&author=M.+E.+Feldmanauthor=B.+Apselauthor=A.+Uotilaauthor=R.+Loewithauthor=Z.+A.+Knightauthor=D.+Ruggeroauthor=K.+M.+Shokat&title=Active-site+inhibitors+of+mTOR+target+rapamycin-resistant+outputs+of+mTORC1+and+mTORC2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFeldman%26aufirst%3DM.%2BE.%26aulast%3DApsel%26aufirst%3DB.%26aulast%3DUotila%26aufirst%3DA.%26aulast%3DLoewith%26aufirst%3DR.%26aulast%3DKnight%26aufirst%3DZ.%2BA.%26aulast%3DRuggero%26aufirst%3DD.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26atitle%3DActive-site%2520inhibitors%2520of%2520mTOR%2520target%2520rapamycin-resistant%2520outputs%2520of%2520mTORC1%2520and%2520mTORC2%26jtitle%3DPLoS%2520Biol.%26date%3D2009%26volume%3D7%26spage%3D371%26epage%3D383" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Thoreen, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reichling, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sim, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabatini, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span> </span><span class="NLM_article-title">An ATP-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">284</span><span class="NLM_x">, </span> <span class="NLM_fpage">8023</span><span class="NLM_x">–</span> <span class="NLM_lpage">8032</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm9013828&amp;key=10.1074%2Fjbc.M900301200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm9013828&amp;key=19150980" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm9013828&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjtVSmtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2009&pages=8023-8032&author=C.+C.+Thoreenauthor=S.+A.+Kangauthor=J.+W.+Changauthor=Q.+Liuauthor=J.+Zhangauthor=Y.+Gaoauthor=L.+J.+Reichlingauthor=T.+Simauthor=D.+M.+Sabatiniauthor=N.+S.+Gray&title=An+ATP-competitive+mammalian+target+of+rapamycin+inhibitor+reveals+rapamycin-resistant+functions+of+mTORC1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">An ATP-competitive Mammalian Target of Rapamycin Inhibitor Reveals Rapamycin-resistant Functions of mTORC1</span></div><div class="casAuthors">Thoreen, Carson C.; Kang, Seong A.; Chang, Jae Won; Liu, Qingsong; Zhang, Jianming; Gao, Yi; Reichling, Laurie J.; Sim, Taebo; Sabatini, David M.; Gray, Nathanael S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">284</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">8023-8032</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The mammalian target of rapamycin (mTOR) kinase is the catalytic subunit of two functionally distinct complexes, mTORC1 and mTORC2, that coordinately promote cell growth, proliferation, and survival.  Rapamycin is a potent allosteric mTORC1 inhibitor with clin. applications as an immunosuppressant and anti-cancer agent.  Here we find that Torin1, a highly potent and selective ATP-competitive mTOR inhibitor that directly inhibits both complexes, impairs cell growth and proliferation to a far greater degree than rapamycin.  Surprisingly, these effects are independent of mTORC2 inhibition and are instead because of suppression of rapamycin-resistant functions of mTORC1 that are necessary for cap-dependent translation and suppression of autophagy.  These effects are at least partly mediated by mTORC1-dependent and rapamycin-resistant phosphorylation of 4E-BP1.  Our findings challenge the assumption that rapamycin completely inhibits mTORC1 and indicate that direct inhibitors of mTORC1 kinase activity may be more successful than rapamycin at inhibiting tumors that depend on mTORC1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiRNo9IcTXArVg90H21EOLACvtfcHk0lj9hygAYU8YYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjtVSmtLY%253D&md5=ea4476b6a55a6b8964fc5c041c80039f</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M900301200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M900301200%26sid%3Dliteratum%253Aachs%26aulast%3DThoreen%26aufirst%3DC.%2BC.%26aulast%3DKang%26aufirst%3DS.%2BA.%26aulast%3DChang%26aufirst%3DJ.%2BW.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DReichling%26aufirst%3DL.%2BJ.%26aulast%3DSim%26aufirst%3DT.%26aulast%3DSabatini%26aufirst%3DD.%2BM.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DAn%2520ATP-competitive%2520mammalian%2520target%2520of%2520rapamycin%2520inhibitor%2520reveals%2520rapamycin-resistant%2520functions%2520of%2520mTORC1%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2009%26volume%3D284%26spage%3D8023%26epage%3D8032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">García-Martínez, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moran, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cosulich, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chresta, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alessi, D. R.</span><span> </span><span class="NLM_article-title">Ku-0063794 is a specific inhibitor of the mammalian target of rapamycin (mTOR)</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">421</span><span class="NLM_x">, </span> <span class="NLM_fpage">29</span><span class="NLM_x">–</span> <span class="NLM_lpage">42</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=421&publication_year=2009&pages=29-42&author=J.+M.+Garc%C3%ADa-Mart%C3%ADnezauthor=J.+Moranauthor=R.+G.+Clarkeauthor=A.+Grayauthor=S.+C.+Cosulichauthor=C.+M.+Chrestaauthor=D.+R.+Alessi&title=Ku-0063794+is+a+specific+inhibitor+of+the+mammalian+target+of+rapamycin+%28mTOR%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGarc%25C3%25ADa-Mart%25C3%25ADnez%26aufirst%3DJ.%2BM.%26aulast%3DMoran%26aufirst%3DJ.%26aulast%3DClarke%26aufirst%3DR.%2BG.%26aulast%3DGray%26aufirst%3DA.%26aulast%3DCosulich%26aufirst%3DS.%2BC.%26aulast%3DChresta%26aufirst%3DC.%2BM.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26atitle%3DKu-0063794%2520is%2520a%2520specific%2520inhibitor%2520of%2520the%2520mammalian%2520target%2520of%2520rapamycin%2520%2528mTOR%2529%26jtitle%3DBiochem.%2520J.%26date%3D2009%26volume%3D421%26spage%3D29%26epage%3D42" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Menear, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malagu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blackburn, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cockroft, X.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ewen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fundo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Gall, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hermann, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sebastian, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sunose, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Presnot, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torode, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickson, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, N. M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, G. C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pike, K. G.</span><span> </span><span class="NLM_article-title">Identification and optimization of novel and selective small molecular weight kinase inhibitors of mTOR</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">5898</span><span class="NLM_x">–</span> <span class="NLM_lpage">5901</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=5898-5901&author=K.+A.+Menearauthor=S.+Gomezauthor=K.+Malaguauthor=C.+Baileyauthor=K.+Blackburnauthor=X.-L.+Cockroftauthor=S.+Ewenauthor=A.+Fundoauthor=A.+Le+Gallauthor=G.+Hermannauthor=L.+Sebastianauthor=M.+Sunoseauthor=T.+Presnotauthor=E.+Torodeauthor=I.+Hicksonauthor=N.+M.+B.+Martinauthor=G.+C.+M.+Smithauthor=K.+G.+Pike&title=Identification+and+optimization+of+novel+and+selective+small+molecular+weight+kinase+inhibitors+of+mTOR"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMenear%26aufirst%3DK.%2BA.%26aulast%3DGomez%26aufirst%3DS.%26aulast%3DMalagu%26aufirst%3DK.%26aulast%3DBailey%26aufirst%3DC.%26aulast%3DBlackburn%26aufirst%3DK.%26aulast%3DCockroft%26aufirst%3DX.-L.%26aulast%3DEwen%26aufirst%3DS.%26aulast%3DFundo%26aufirst%3DA.%26aulast%3DLe%2BGall%26aufirst%3DA.%26aulast%3DHermann%26aufirst%3DG.%26aulast%3DSebastian%26aufirst%3DL.%26aulast%3DSunose%26aufirst%3DM.%26aulast%3DPresnot%26aufirst%3DT.%26aulast%3DTorode%26aufirst%3DE.%26aulast%3DHickson%26aufirst%3DI.%26aulast%3DMartin%26aufirst%3DN.%2BM.%2BB.%26aulast%3DSmith%26aufirst%3DG.%2BC.%2BM.%26aulast%3DPike%26aufirst%3DK.%2BG.%26atitle%3DIdentification%2520and%2520optimization%2520of%2520novel%2520and%2520selective%2520small%2520molecular%2520weight%2520kinase%2520inhibitors%2520of%2520mTOR%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D5898%26epage%3D5901" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Malagu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duggan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menear, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hummersone, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drzewiecki, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leroux, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quesada, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hermann, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maine, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molyneaux, C.-A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Gall, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pullen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickson, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maguire, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pass, M.</span><span> </span><span class="NLM_article-title">The discovery and optimization of pyrido[2,3-<i>d</i>]pyrimidine-2,4-diamines as potent and selective inhibitors of mTOR kinase</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">5950</span><span class="NLM_x">–</span> <span class="NLM_lpage">5953</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=5950-5953&author=K.+Malaguauthor=H.+Dugganauthor=K.+Menearauthor=M.+Hummersoneauthor=S.+Gomezauthor=C.+Baileyauthor=P.+Edwardsauthor=J.+Drzewieckiauthor=F.+Lerouxauthor=M.+J.+Quesadaauthor=G.+Hermannauthor=S.+Maineauthor=C.-A.+Molyneauxauthor=A.+Le+Gallauthor=J.+Pullenauthor=I.+Hicksonauthor=L.+Smithauthor=S.+Maguireauthor=N.+Martinauthor=G.+Smithauthor=M.+Pass&title=The+discovery+and+optimization+of+pyrido%5B2%2C3-d%5Dpyrimidine-2%2C4-diamines+as+potent+and+selective+inhibitors+of+mTOR+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMalagu%26aufirst%3DK.%26aulast%3DDuggan%26aufirst%3DH.%26aulast%3DMenear%26aufirst%3DK.%26aulast%3DHummersone%26aufirst%3DM.%26aulast%3DGomez%26aufirst%3DS.%26aulast%3DBailey%26aufirst%3DC.%26aulast%3DEdwards%26aufirst%3DP.%26aulast%3DDrzewiecki%26aufirst%3DJ.%26aulast%3DLeroux%26aufirst%3DF.%26aulast%3DQuesada%26aufirst%3DM.%2BJ.%26aulast%3DHermann%26aufirst%3DG.%26aulast%3DMaine%26aufirst%3DS.%26aulast%3DMolyneaux%26aufirst%3DC.-A.%26aulast%3DLe%2BGall%26aufirst%3DA.%26aulast%3DPullen%26aufirst%3DJ.%26aulast%3DHickson%26aufirst%3DI.%26aulast%3DSmith%26aufirst%3DL.%26aulast%3DMaguire%26aufirst%3DS.%26aulast%3DMartin%26aufirst%3DN.%26aulast%3DSmith%26aufirst%3DG.%26aulast%3DPass%26aufirst%3DM.%26atitle%3DThe%2520discovery%2520and%2520optimization%2520of%2520pyrido%255B2%252C3-d%255Dpyrimidine-2%252C4-diamines%2520as%2520potent%2520and%2520selective%2520inhibitors%2520of%2520mTOR%2520kinase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D5950%26epage%3D5953" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Zask, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verheijen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaplan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curran, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richard, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooijmans, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toral-Barza, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.-G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollander, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbons, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abraham, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayral-Kaloustian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansour, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, K.</span><span> </span><span class="NLM_article-title">Design and synthesis of potent and selective ATP competitive inhibitors of the mammalian target of rapamycin</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">5013</span><span class="NLM_x">–</span> <span class="NLM_lpage">5016</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900851f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=5013-5016&author=A.+Zaskauthor=J.+Verheijenauthor=J.+Kaplanauthor=K.+Curranauthor=D.+Richardauthor=N.+Brooijmansauthor=J.+Lucasauthor=L.+Toral-Barzaauthor=W.-G.+Zhangauthor=I.+Hollanderauthor=J.+Gibbonsauthor=R.+Abrahamauthor=S.+Ayral-Kaloustianauthor=T.+Mansourauthor=K.+Yu&title=Design+and+synthesis+of+potent+and+selective+ATP+competitive+inhibitors+of+the+mammalian+target+of+rapamycin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm900851f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900851f%26sid%3Dliteratum%253Aachs%26aulast%3DZask%26aufirst%3DA.%26aulast%3DVerheijen%26aufirst%3DJ.%26aulast%3DKaplan%26aufirst%3DJ.%26aulast%3DCurran%26aufirst%3DK.%26aulast%3DRichard%26aufirst%3DD.%26aulast%3DBrooijmans%26aufirst%3DN.%26aulast%3DLucas%26aufirst%3DJ.%26aulast%3DToral-Barza%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DW.-G.%26aulast%3DHollander%26aufirst%3DI.%26aulast%3DGibbons%26aufirst%3DJ.%26aulast%3DAbraham%26aufirst%3DR.%26aulast%3DAyral-Kaloustian%26aufirst%3DS.%26aulast%3DMansour%26aufirst%3DT.%26aulast%3DYu%26aufirst%3DK.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520potent%2520and%2520selective%2520ATP%2520competitive%2520inhibitors%2520of%2520the%2520mammalian%2520target%2520of%2520rapamycin%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D5013%26epage%3D5016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Nowak, P.; Brooijmans, N.; Cole, D. C.; Curran, K. J.; Ellingboe, J.; Gibbons, J. J.; Hu, Y.; Hollander, I.; Kaplan, J.; Malwitz, D. J.; Toral-Barza, L.; Verheijen, J.; Zask, A.; Zhang, W.-G.; Yu, K.</span><span> </span><span class="NLM_article-title">Discovery of potent and selective inhibitors of the mammalian target of rapamycin (mTOR) kinase</span>.  <span class="citation_source-journal">J. Med. Chem.</span> DOI: <span class="refDoi"> DOI: 10.1021/jm9012642</span> .</span><div class="citationLinks">[<a href="/doi/10.1021/jm9012642" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Nowak%2C+P.%3B+Brooijmans%2C+N.%3B+Cole%2C+D.+C.%3B+Curran%2C+K.+J.%3B+Ellingboe%2C+J.%3B+Gibbons%2C+J.+J.%3B+Hu%2C+Y.%3B+Hollander%2C+I.%3B+Kaplan%2C+J.%3B+Malwitz%2C+D.+J.%3B+Toral-Barza%2C+L.%3B+Verheijen%2C+J.%3B+Zask%2C+A.%3B+Zhang%2C+W.-G.%3B+Yu%2C+K.+Discovery+of+potent+and+selective+inhibitors+of+the+mammalian+target+of+rapamycin+%28mTOR%29+kinase.+J.+Med.+Chem.+DOI%3A+10.1021%2Fjm9012642."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm9012642&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9012642%26sid%3Dliteratum%253Aachs%26aulast%3DNowak%26aufirst%3DP.%26atitle%3DDiscovery%2520of%2520potent%2520and%2520selective%2520inhibitors%2520of%2520the%2520mammalian%2520target%2520of%2520rapamycin%2520%2528mTOR%2529%2520kinase%26jtitle%3DJ.%2520Med.%2520Chem.%26doi%3D10.1021%2Fjm9012642" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Yu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toral-Barza, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.-G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shor, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verheijen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curran, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malwitz, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellingboe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayral-Kaloustian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansour, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbons, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abraham, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nowak, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zask, A.</span><span> </span><span class="NLM_article-title">Biochemical, cellular and in vivo activity of novel ATP-competitive and selective inhibitors of the mammalian target of rapamycin</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">6232</span><span class="NLM_x">–</span> <span class="NLM_lpage">6240</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2009&pages=6232-6240&author=Y.+Yuauthor=L.+Toral-Barzaauthor=C.+Shiauthor=W.-G.+Zhangauthor=J.+Lucasauthor=B.+Shorauthor=J.+Kimauthor=J.+Verheijenauthor=K.+Curranauthor=D.+J.+Malwitzauthor=D.+C.+Coleauthor=J.+Ellingboeauthor=S.+Ayral-Kaloustianauthor=T.+S.+Mansourauthor=J.+J.+Gibbonsauthor=R.+T.+Abrahamauthor=P.+Nowakauthor=A.+Zask&title=Biochemical%2C+cellular+and+in+vivo+activity+of+novel+ATP-competitive+and+selective+inhibitors+of+the+mammalian+target+of+rapamycin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DY.%26aulast%3DToral-Barza%26aufirst%3DL.%26aulast%3DShi%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DW.-G.%26aulast%3DLucas%26aufirst%3DJ.%26aulast%3DShor%26aufirst%3DB.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DVerheijen%26aufirst%3DJ.%26aulast%3DCurran%26aufirst%3DK.%26aulast%3DMalwitz%26aufirst%3DD.%2BJ.%26aulast%3DCole%26aufirst%3DD.%2BC.%26aulast%3DEllingboe%26aufirst%3DJ.%26aulast%3DAyral-Kaloustian%26aufirst%3DS.%26aulast%3DMansour%26aufirst%3DT.%2BS.%26aulast%3DGibbons%26aufirst%3DJ.%2BJ.%26aulast%3DAbraham%26aufirst%3DR.%2BT.%26aulast%3DNowak%26aufirst%3DP.%26aulast%3DZask%26aufirst%3DA.%26atitle%3DBiochemical%252C%2520cellular%2520and%2520in%2520vivo%2520activity%2520of%2520novel%2520ATP-competitive%2520and%2520selective%2520inhibitors%2520of%2520the%2520mammalian%2520target%2520of%2520rapamycin%26jtitle%3DCancer%2520Res.%26date%3D2009%26volume%3D69%26spage%3D6232%26epage%3D6240" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Fenniri, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathivanan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vidale, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherman, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hallenga, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, K. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stowell, J. G.</span><span> </span><span class="NLM_article-title">Helical rosette nanotubes: design, self-assembly, and characterization</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">123</span><span class="NLM_x">, </span> <span class="NLM_fpage">3854</span><span class="NLM_x">–</span> <span class="NLM_lpage">3855</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja005886l" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm9013828&amp;key=1%3ACAS%3A528%3ADC%252BD3MXit12hsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2001&pages=3854-3855&author=H.+Fenniriauthor=P.+Mathivananauthor=K.+L.+Vidaleauthor=D.+M.+Shermanauthor=K.+Hallengaauthor=K.+V.+Woodauthor=J.+G.+Stowell&title=Helical+rosette+nanotubes%3A+design%2C+self-assembly%2C+and+characterization"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Helical Rosette Nanotubes: Design, Self-Assembly, and Characterization</span></div><div class="casAuthors">Fenniri, Hicham; Mathivanan, Packiarajan; Vidale, Kenrick L.; Sherman, Debra M.; Hallenga, Klaas; Wood, Karl V.; Stowell, Joseph G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">123</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">3854-3855</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The combination of NMR (NOE), ESI-MS, and CD spectroscopies indicated that the module N-[2-(4,7-diaminopyrimido[4,5-d]pyrimidine-2,5-dione-1-yl)ethyl]-L-lysine (I.CF3CO2H) undergoes a cooperative, hierarchical self-assembly process with the formation of helically stacked rosettes (planar 6-mers) that display supramol. chirality.  Dynamic light scattering revealed a narrow size distribution of columnar stacks (92% in the range 19-69 nm) with an av. apparent hydrodynamic radius of 30.4 nm.  TEM provided further evidence of nanotube formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2iYU2I79tmrVg90H21EOLACvtfcHk0lgnSqQKWUfZtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXit12hsbk%253D&md5=ece0e0815609889a8f65041c9a30459a</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fja005886l&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja005886l%26sid%3Dliteratum%253Aachs%26aulast%3DFenniri%26aufirst%3DH.%26aulast%3DMathivanan%26aufirst%3DP.%26aulast%3DVidale%26aufirst%3DK.%2BL.%26aulast%3DSherman%26aufirst%3DD.%2BM.%26aulast%3DHallenga%26aufirst%3DK.%26aulast%3DWood%26aufirst%3DK.%2BV.%26aulast%3DStowell%26aufirst%3DJ.%2BG.%26atitle%3DHelical%2520rosette%2520nanotubes%253A%2520design%252C%2520self-assembly%252C%2520and%2520characterization%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2001%26volume%3D123%26spage%3D3854%26epage%3D3855" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Toral-Barza, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamison, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larocque, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbons, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, K.</span><span> </span><span class="NLM_article-title">Characterization of the cloned full-length and a truncated human target of rapamycin: activity, specificity, and enzyme inhibition as studied by a high capacity assay</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">332</span><span class="NLM_x">, </span> <span class="NLM_fpage">304</span><span class="NLM_x">–</span> <span class="NLM_lpage">310</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=332&publication_year=2005&pages=304-310&author=L.+Toral-Barzaauthor=W.+G.+Zhangauthor=C.+Lamisonauthor=J.+Larocqueauthor=J.+Gibbonsauthor=K.+Yu&title=Characterization+of+the+cloned+full-length+and+a+truncated+human+target+of+rapamycin%3A+activity%2C+specificity%2C+and+enzyme+inhibition+as+studied+by+a+high+capacity+assay"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DToral-Barza%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DW.%2BG.%26aulast%3DLamison%26aufirst%3DC.%26aulast%3DLarocque%26aufirst%3DJ.%26aulast%3DGibbons%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DK.%26atitle%3DCharacterization%2520of%2520the%2520cloned%2520full-length%2520and%2520a%2520truncated%2520human%2520target%2520of%2520rapamycin%253A%2520activity%252C%2520specificity%252C%2520and%2520enzyme%2520inhibition%2520as%2520studied%2520by%2520a%2520high%2520capacity%2520assay%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2005%26volume%3D332%26spage%3D304%26epage%3D310" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Zask, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaplan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toral-Barza, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollander, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tischler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaydos, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cinque, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, K.</span><span> </span><span class="NLM_article-title">Synthesis and structure−activity relationship of ring-opened 17-hydroxywortmannins: potent phosphoinositide 3-kinase inhibitors with improved properties and anticancer efficacy</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">1319</span><span class="NLM_x">–</span> <span class="NLM_lpage">1323</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm7012858" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=1319-1323&author=A.+Zaskauthor=J.+Kaplanauthor=L.+Toral-Barzaauthor=I.+Hollanderauthor=M.+Youngauthor=M.+Tischlerauthor=C.+Gaydosauthor=M.+Cinqueauthor=J.+Lucasauthor=K.+Yu&title=Synthesis+and+structure%E2%88%92activity+relationship+of+ring-opened+17-hydroxywortmannins%3A+potent+phosphoinositide+3-kinase+inhibitors+with+improved+properties+and+anticancer+efficacy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjm7012858&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm7012858%26sid%3Dliteratum%253Aachs%26aulast%3DZask%26aufirst%3DA.%26aulast%3DKaplan%26aufirst%3DJ.%26aulast%3DToral-Barza%26aufirst%3DL.%26aulast%3DHollander%26aufirst%3DI.%26aulast%3DYoung%26aufirst%3DM.%26aulast%3DTischler%26aufirst%3DM.%26aulast%3DGaydos%26aufirst%3DC.%26aulast%3DCinque%26aufirst%3DM.%26aulast%3DLucas%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DK.%26atitle%3DSynthesis%2520and%2520structure%25E2%2588%2592activity%2520relationship%2520of%2520ring-opened%252017-hydroxywortmannins%253A%2520potent%2520phosphoinositide%25203-kinase%2520inhibitors%2520with%2520improved%2520properties%2520and%2520anticancer%2520efficacy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D1319%26epage%3D1323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Yu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toral-Barza, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Discafani, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skotnicki, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frost, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbons, J.</span><span> </span><span class="NLM_article-title">mTOR, a novel target in breast cancer: the effect of CCI-779, an mTOR inhibitor, in preclinical models of breast cancer</span> <span class="citation_source-journal">Endocr.-Relat. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">249</span><span class="NLM_x">–</span> <span class="NLM_lpage">258</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2001&pages=249-258&author=K.+Yuauthor=L.+Toral-Barzaauthor=C.+Discafaniauthor=W.+G.+Zhangauthor=J.+Skotnickiauthor=P.+Frostauthor=J.+Gibbons&title=mTOR%2C+a+novel+target+in+breast+cancer%3A+the+effect+of+CCI-779%2C+an+mTOR+inhibitor%2C+in+preclinical+models+of+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DK.%26aulast%3DToral-Barza%26aufirst%3DL.%26aulast%3DDiscafani%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DW.%2BG.%26aulast%3DSkotnicki%26aufirst%3DJ.%26aulast%3DFrost%26aufirst%3DP.%26aulast%3DGibbons%26aufirst%3DJ.%26atitle%3DmTOR%252C%2520a%2520novel%2520target%2520in%2520breast%2520cancer%253A%2520the%2520effect%2520of%2520CCI-779%252C%2520an%2520mTOR%2520inhibitor%252C%2520in%2520preclinical%2520models%2520of%2520breast%2520cancer%26jtitle%3DEndocr.-Relat.%2520Cancer%26date%3D2001%26volume%3D8%26spage%3D249%26epage%3D258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Yu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zask, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaydos, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toral-Barza, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaudhary, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lotvin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petersen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruppen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fawzi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayral-Kaloustian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skotnicki, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansour, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frost, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbons, J.</span><span> </span><span class="NLM_article-title">PWT-458, a novel pegylated-17-hydroxywortmannin, inhibits phosphatidylinositol 3-kinase signaling and suppresses growth of solid tumors</span> <span class="citation_source-journal">Cancer Biol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">538</span><span class="NLM_x">–</span> <span class="NLM_lpage">545</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=538-545&author=K.+Yuauthor=J.+Lucasauthor=T.+Zhuauthor=A.+Zaskauthor=C.+Gaydosauthor=L.+Toral-Barzaauthor=J.+Guauthor=F.+Liauthor=I.+Chaudharyauthor=P.+Caiauthor=J.+Lotvinauthor=R.+Petersenauthor=M.+Ruppenauthor=M.+Fawziauthor=S.+Ayral-Kaloustianauthor=J.+Skotnickiauthor=T.+Mansourauthor=P.+Frostauthor=J.+Gibbons&title=PWT-458%2C+a+novel+pegylated-17-hydroxywortmannin%2C+inhibits+phosphatidylinositol+3-kinase+signaling+and+suppresses+growth+of+solid+tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DK.%26aulast%3DLucas%26aufirst%3DJ.%26aulast%3DZhu%26aufirst%3DT.%26aulast%3DZask%26aufirst%3DA.%26aulast%3DGaydos%26aufirst%3DC.%26aulast%3DToral-Barza%26aufirst%3DL.%26aulast%3DGu%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DF.%26aulast%3DChaudhary%26aufirst%3DI.%26aulast%3DCai%26aufirst%3DP.%26aulast%3DLotvin%26aufirst%3DJ.%26aulast%3DPetersen%26aufirst%3DR.%26aulast%3DRuppen%26aufirst%3DM.%26aulast%3DFawzi%26aufirst%3DM.%26aulast%3DAyral-Kaloustian%26aufirst%3DS.%26aulast%3DSkotnicki%26aufirst%3DJ.%26aulast%3DMansour%26aufirst%3DT.%26aulast%3DFrost%26aufirst%3DP.%26aulast%3DGibbons%26aufirst%3DJ.%26atitle%3DPWT-458%252C%2520a%2520novel%2520pegylated-17-hydroxywortmannin%252C%2520inhibits%2520phosphatidylinositol%25203-kinase%2520signaling%2520and%2520suppresses%2520growth%2520of%2520solid%2520tumors%26jtitle%3DCancer%2520Biol.%2520Ther.%26date%3D2005%26volume%3D5%26spage%3D538%26epage%3D545" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Tsou, H.-R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birnberg, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaplan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otteng, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kutterer, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suayan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zask, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ravi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bretz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grillo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGinnis, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rabindran, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayral-Kaloustian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansour, T. S.</span><span> </span><span class="NLM_article-title">Discovery of 4-(benzylaminomethylene)isoquinoline-1,3-(2<i>H</i>,4<i>H</i>)-diones and 4-[(pyridylmethyl)aminomethylene]isoquinoline-1,3-(2<i>H</i>,4<i>H</i>)-diones as potent and selective inhibitors of the cyclin-dependent kinase 4</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">2289</span><span class="NLM_x">–</span> <span class="NLM_lpage">2310</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm801026e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=2289-2310&author=H.-R.+Tsouauthor=X.+Liuauthor=G.+Birnbergauthor=J.+Kaplanauthor=M.+Ottengauthor=T.+Tranauthor=K.+Kuttererauthor=Z.+Tangauthor=R.+Suayanauthor=A.+Zaskauthor=M.+Raviauthor=A.+Bretzauthor=M.+Grilloauthor=J.+P.+McGinnisauthor=S.+K.+Rabindranauthor=S.+Ayral-Kaloustianauthor=T.+S.+Mansour&title=Discovery+of+4-%28benzylaminomethylene%29isoquinoline-1%2C3-%282H%2C4H%29-diones+and+4-%5B%28pyridylmethyl%29aminomethylene%5Disoquinoline-1%2C3-%282H%2C4H%29-diones+as+potent+and+selective+inhibitors+of+the+cyclin-dependent+kinase+4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm801026e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801026e%26sid%3Dliteratum%253Aachs%26aulast%3DTsou%26aufirst%3DH.-R.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DBirnberg%26aufirst%3DG.%26aulast%3DKaplan%26aufirst%3DJ.%26aulast%3DOtteng%26aufirst%3DM.%26aulast%3DTran%26aufirst%3DT.%26aulast%3DKutterer%26aufirst%3DK.%26aulast%3DTang%26aufirst%3DZ.%26aulast%3DSuayan%26aufirst%3DR.%26aulast%3DZask%26aufirst%3DA.%26aulast%3DRavi%26aufirst%3DM.%26aulast%3DBretz%26aufirst%3DA.%26aulast%3DGrillo%26aufirst%3DM.%26aulast%3DMcGinnis%26aufirst%3DJ.%2BP.%26aulast%3DRabindran%26aufirst%3DS.%2BK.%26aulast%3DAyral-Kaloustian%26aufirst%3DS.%26aulast%3DMansour%26aufirst%3DT.%2BS.%26atitle%3DDiscovery%2520of%25204-%2528benzylaminomethylene%2529isoquinoline-1%252C3-%25282H%252C4H%2529-diones%2520and%25204-%255B%2528pyridylmethyl%2529aminomethylene%255Disoquinoline-1%252C3-%25282H%252C4H%2529-diones%2520as%2520potent%2520and%2520selective%2520inhibitors%2520of%2520the%2520cyclin-dependent%2520kinase%25204%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D2289%26epage%3D2310" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3IBE" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3IBE','PDB','3IBE'); return false;">PDB: 3IBE</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i59"><a href="/doi/suppl/10.1021/jm9013828">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_33852"></div></div></div></div></div><hr /></hr><p class="last">Experimental details for compounds <b>6a</b>,<b>b</b>,<b>e</b>,<b>f</b>, <b>16b</b>−<b>n</b>, <b>22b</b>−<b>d</b>, <b>25b</b>−<b>f</b>,<b>h</b>,<b>i</b>, <b>26b</b>,<b>c</b>, <b>27b</b>,<b>c</b>; synthesis and SAR of additional analogues; activity against a broad panel of tumor cell lines for <b>13o</b>, <b>18a</b>, <b>24a</b>, and <b>24c</b>; kinase panel selectivity data for <b>24a</b>, <b>24c</b>, and <b>29a</b>. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm9013828/suppl_file/jm9013828_si_001.pdf">jm9013828_si_001.pdf (161.03 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm9013828&amp;pbContext=%3Barticle%3Aarticle%3A10.1021%2Fjm9013828%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2009.52.issue-24" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm9013828" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67999a8d88543c88","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
